Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, code, cloud, nicecloud)
 

'S.E.P.'
(id=15425162 ; fe=S.E.P. ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=35865 creation date=2020-10-17 touchdate=2026-04-24 08:31:57.000)
≈ 1184 relations sortantes

  1. S.E.P. -- r_associated #0: 235 / 1 -> médecine
    n1=S.E.P. | n2=médecine | rel=r_associated | relid=0 | w=235
  2. S.E.P. -- r_associated #0: 81 / 0.345 -> sclérose en plaques
    n1=S.E.P. | n2=sclérose en plaques | rel=r_associated | relid=0 | w=81
  3. S.E.P. -- r_associated #0: 80 / 0.34 -> asthénie
    n1=S.E.P. | n2=asthénie | rel=r_associated | relid=0 | w=80
  4. S.E.P. -- r_associated #0: 80 / 0.34 -> auto-immune
    n1=S.E.P. | n2=auto-immune | rel=r_associated | relid=0 | w=80
  5. S.E.P. -- r_associated #0: 80 / 0.34 -> démyélinisation
    n1=S.E.P. | n2=démyélinisation | rel=r_associated | relid=0 | w=80
  6. S.E.P. -- r_associated #0: 80 / 0.34 -> dysarthrie
    n1=S.E.P. | n2=dysarthrie | rel=r_associated | relid=0 | w=80
  7. S.E.P. -- r_associated #0: 80 / 0.34 -> en:abducens nerve disorder
    n1=S.E.P. | n2=en:abducens nerve disorder | rel=r_associated | relid=0 | w=80
  8. S.E.P. -- r_associated #0: 80 / 0.34 -> en:abnormal pap smear
    n1=S.E.P. | n2=en:abnormal pap smear | rel=r_associated | relid=0 | w=80
  9. S.E.P. -- r_associated #0: 80 / 0.34 -> en:abnormal results investigation nos
    n1=S.E.P. | n2=en:abnormal results investigation nos | rel=r_associated | relid=0 | w=80
  10. S.E.P. -- r_associated #0: 80 / 0.34 -> en:abnormality of the cerebrospinal fluid
    n1=S.E.P. | n2=en:abnormality of the cerebrospinal fluid | rel=r_associated | relid=0 | w=80
  11. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acne
    n1=S.E.P. | n2=en:acne | rel=r_associated | relid=0 | w=80
  12. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acoustic schwannoma
    n1=S.E.P. | n2=en:acoustic schwannoma | rel=r_associated | relid=0 | w=80
  13. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acoustic trauma
    n1=S.E.P. | n2=en:acoustic trauma | rel=r_associated | relid=0 | w=80
  14. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acquired deformity of spine
    n1=S.E.P. | n2=en:acquired deformity of spine | rel=r_associated | relid=0 | w=80
  15. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acquired immunodeficiency syndrome
    n1=S.E.P. | n2=en:acquired immunodeficiency syndrome | rel=r_associated | relid=0 | w=80
  16. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acquired myelocele
    n1=S.E.P. | n2=en:acquired myelocele | rel=r_associated | relid=0 | w=80
  17. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute ascending myelitis
    n1=S.E.P. | n2=en:acute ascending myelitis | rel=r_associated | relid=0 | w=80
  18. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute bronchitis and bronchiolitis
    n1=S.E.P. | n2=en:acute bronchitis and bronchiolitis | rel=r_associated | relid=0 | w=80
  19. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute damage meniscus knee
    n1=S.E.P. | n2=en:acute damage meniscus knee | rel=r_associated | relid=0 | w=80
  20. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute episodes of neuropathic symptoms
    n1=S.E.P. | n2=en:acute episodes of neuropathic symptoms | rel=r_associated | relid=0 | w=80
  21. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute hemorrhagic leukoencephalitis
    n1=S.E.P. | n2=en:acute hemorrhagic leukoencephalitis | rel=r_associated | relid=0 | w=80
  22. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute laryngitis and/or tracheitis
    n1=S.E.P. | n2=en:acute laryngitis and/or tracheitis | rel=r_associated | relid=0 | w=80
  23. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute lymphadenitis
    n1=S.E.P. | n2=en:acute lymphadenitis | rel=r_associated | relid=0 | w=80
  24. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute miliary tuberculosis
    n1=S.E.P. | n2=en:acute miliary tuberculosis | rel=r_associated | relid=0 | w=80
  25. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute motor axonal neuropathy
    n1=S.E.P. | n2=en:acute motor axonal neuropathy | rel=r_associated | relid=0 | w=80
  26. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute myocardial infarction
    n1=S.E.P. | n2=en:acute myocardial infarction | rel=r_associated | relid=0 | w=80
  27. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute nasopharyngitis
    n1=S.E.P. | n2=en:acute nasopharyngitis | rel=r_associated | relid=0 | w=80
  28. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute non-infective transverse myelitis
    n1=S.E.P. | n2=en:acute non-infective transverse myelitis | rel=r_associated | relid=0 | w=80
  29. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute otitis media/myringitis
    n1=S.E.P. | n2=en:acute otitis media/myringitis | rel=r_associated | relid=0 | w=80
  30. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute polyneuropathies
    n1=S.E.P. | n2=en:acute polyneuropathies | rel=r_associated | relid=0 | w=80
  31. S.E.P. -- r_associated #0: 80 / 0.34 -> en:acute tonsillitis
    n1=S.E.P. | n2=en:acute tonsillitis | rel=r_associated | relid=0 | w=80
  32. S.E.P. -- r_associated #0: 80 / 0.34 -> en:adrenoleukodystrophy
    n1=S.E.P. | n2=en:adrenoleukodystrophy | rel=r_associated | relid=0 | w=80
  33. S.E.P. -- r_associated #0: 80 / 0.34 -> en:adverse effect medical agent proper dose
    n1=S.E.P. | n2=en:adverse effect medical agent proper dose | rel=r_associated | relid=0 | w=80
  34. S.E.P. -- r_associated #0: 80 / 0.34 -> en:adverse effect of physical agent
    n1=S.E.P. | n2=en:adverse effect of physical agent | rel=r_associated | relid=0 | w=80
  35. S.E.P. -- r_associated #0: 80 / 0.34 -> en:affective psychosis
    n1=S.E.P. | n2=en:affective psychosis | rel=r_associated | relid=0 | w=80
  36. S.E.P. -- r_associated #0: 80 / 0.34 -> en:alcoholic polyneuropathy
    n1=S.E.P. | n2=en:alcoholic polyneuropathy | rel=r_associated | relid=0 | w=80
  37. S.E.P. -- r_associated #0: 80 / 0.34 -> en:alice in wonderland syndrome
    n1=S.E.P. | n2=en:alice in wonderland syndrome | rel=r_associated | relid=0 | w=80
  38. S.E.P. -- r_associated #0: 80 / 0.34 -> en:all other perinatal morbidity
    n1=S.E.P. | n2=en:all other perinatal morbidity | rel=r_associated | relid=0 | w=80
  39. S.E.P. -- r_associated #0: 80 / 0.34 -> en:allergic encephalitis
    n1=S.E.P. | n2=en:allergic encephalitis | rel=r_associated | relid=0 | w=80
  40. S.E.P. -- r_associated #0: 80 / 0.34 -> en:alzheimer's caregivers
    n1=S.E.P. | n2=en:alzheimer's caregivers | rel=r_associated | relid=0 | w=80
  41. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ambulation difficulty
    n1=S.E.P. | n2=en:ambulation difficulty | rel=r_associated | relid=0 | w=80
  42. S.E.P. -- r_associated #0: 80 / 0.34 -> en:amebic infection of central nervous system
    n1=S.E.P. | n2=en:amebic infection of central nervous system | rel=r_associated | relid=0 | w=80
  43. S.E.P. -- r_associated #0: 80 / 0.34 -> en:amputees
    n1=S.E.P. | n2=en:amputees | rel=r_associated | relid=0 | w=80
  44. S.E.P. -- r_associated #0: 80 / 0.34 -> en:amyloid neuropathy
    n1=S.E.P. | n2=en:amyloid neuropathy | rel=r_associated | relid=0 | w=80
  45. S.E.P. -- r_associated #0: 80 / 0.34 -> en:amyotrophic lateral sclerosis
    n1=S.E.P. | n2=en:amyotrophic lateral sclerosis | rel=r_associated | relid=0 | w=80
  46. S.E.P. -- r_associated #0: 80 / 0.34 -> en:anal fissure/perianal abscess
    n1=S.E.P. | n2=en:anal fissure/perianal abscess | rel=r_associated | relid=0 | w=80
  47. S.E.P. -- r_associated #0: 80 / 0.34 -> en:anatomic structures
    n1=S.E.P. | n2=en:anatomic structures | rel=r_associated | relid=0 | w=80
  48. S.E.P. -- r_associated #0: 80 / 0.34 -> en:angina
    n1=S.E.P. | n2=en:angina | rel=r_associated | relid=0 | w=80
  49. S.E.P. -- r_associated #0: 80 / 0.34 -> en:angiofollicular lymphoid hyperplasia
    n1=S.E.P. | n2=en:angiofollicular lymphoid hyperplasia | rel=r_associated | relid=0 | w=80
  50. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ankle injuries and disorders
    n1=S.E.P. | n2=en:ankle injuries and disorders | rel=r_associated | relid=0 | w=80
  51. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ankylosing spondylitis
    n1=S.E.P. | n2=en:ankylosing spondylitis | rel=r_associated | relid=0 | w=80
  52. S.E.P. -- r_associated #0: 80 / 0.34 -> en:anti-myelin-associated glycoprotein associated polyneuropathy
    n1=S.E.P. | n2=en:anti-myelin-associated glycoprotein associated polyneuropathy | rel=r_associated | relid=0 | w=80
  53. S.E.P. -- r_associated #0: 80 / 0.34 -> en:anti-neutrophil cytoplasmic antibody-associated vasculitis
    n1=S.E.P. | n2=en:anti-neutrophil cytoplasmic antibody-associated vasculitis | rel=r_associated | relid=0 | w=80
  54. S.E.P. -- r_associated #0: 80 / 0.34 -> en:antiphospholipid syndrome
    n1=S.E.P. | n2=en:antiphospholipid syndrome | rel=r_associated | relid=0 | w=80
  55. S.E.P. -- r_associated #0: 80 / 0.34 -> en:antisynthetase syndrome
    n1=S.E.P. | n2=en:antisynthetase syndrome | rel=r_associated | relid=0 | w=80
  56. S.E.P. -- r_associated #0: 80 / 0.34 -> en:anxiety disorder/anxiety state
    n1=S.E.P. | n2=en:anxiety disorder/anxiety state | rel=r_associated | relid=0 | w=80
  57. S.E.P. -- r_associated #0: 80 / 0.34 -> en:aphasia
    n1=S.E.P. | n2=en:aphasia | rel=r_associated | relid=0 | w=80
  58. S.E.P. -- r_associated #0: 80 / 0.34 -> en:appendicitis
    n1=S.E.P. | n2=en:appendicitis | rel=r_associated | relid=0 | w=80
  59. S.E.P. -- r_associated #0: 80 / 0.34 -> en:arm injuries
    n1=S.E.P. | n2=en:arm injuries | rel=r_associated | relid=0 | w=80
  60. S.E.P. -- r_associated #0: 80 / 0.34 -> en:arnold-chiari malformation
    n1=S.E.P. | n2=en:arnold-chiari malformation | rel=r_associated | relid=0 | w=80
  61. S.E.P. -- r_associated #0: 80 / 0.34 -> en:arrhythmia
    n1=S.E.P. | n2=en:arrhythmia | rel=r_associated | relid=0 | w=80
  62. S.E.P. -- r_associated #0: 80 / 0.34 -> en:arthritis
    n1=S.E.P. | n2=en:arthritis | rel=r_associated | relid=0 | w=80
  63. S.E.P. -- r_associated #0: 80 / 0.34 -> en:arthroplasty of the knee
    n1=S.E.P. | n2=en:arthroplasty of the knee | rel=r_associated | relid=0 | w=80
  64. S.E.P. -- r_associated #0: 80 / 0.34 -> en:aspects of mortality statistics
    n1=S.E.P. | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=80
  65. S.E.P. -- r_associated #0: 80 / 0.34 -> en:aspects of radionuclide imaging
    n1=S.E.P. | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=80
  66. S.E.P. -- r_associated #0: 80 / 0.34 -> en:asthma
    n1=S.E.P. | n2=en:asthma | rel=r_associated | relid=0 | w=80
  67. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ataxia telangiectasia syndrome
    n1=S.E.P. | n2=en:ataxia telangiectasia syndrome | rel=r_associated | relid=0 | w=80
  68. S.E.P. -- r_associated #0: 80 / 0.34 -> en:atherosclerosis excluding heart/brain
    n1=S.E.P. | n2=en:atherosclerosis excluding heart/brain | rel=r_associated | relid=0 | w=80
  69. S.E.P. -- r_associated #0: 80 / 0.34 -> en:atopic conjunctivitis
    n1=S.E.P. | n2=en:atopic conjunctivitis | rel=r_associated | relid=0 | w=80
  70. S.E.P. -- r_associated #0: 80 / 0.34 -> en:atopic dermatitis/eczema
    n1=S.E.P. | n2=en:atopic dermatitis/eczema | rel=r_associated | relid=0 | w=80
  71. S.E.P. -- r_associated #0: 80 / 0.34 -> en:attention deficit hyperactivity disorder
    n1=S.E.P. | n2=en:attention deficit hyperactivity disorder | rel=r_associated | relid=0 | w=80
  72. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune antibody positivity
    n1=S.E.P. | n2=en:autoimmune antibody positivity | rel=r_associated | relid=0 | w=80
  73. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune cholangitis
    n1=S.E.P. | n2=en:autoimmune cholangitis | rel=r_associated | relid=0 | w=80
  74. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune demyelinating disease
    n1=S.E.P. | n2=en:autoimmune demyelinating disease | rel=r_associated | relid=0 | w=80
  75. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune disease
    n1=S.E.P. | n2=en:autoimmune disease | rel=r_associated | relid=0 | w=80
  76. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune disease, nec in mdr
    n1=S.E.P. | n2=en:autoimmune disease, nec in mdr | rel=r_associated | relid=0 | w=80
  77. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune disorder of inner ear
    n1=S.E.P. | n2=en:autoimmune disorder of inner ear | rel=r_associated | relid=0 | w=80
  78. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune disorders nec
    n1=S.E.P. | n2=en:autoimmune disorders nec | rel=r_associated | relid=0 | w=80
  79. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune encephalitis
    n1=S.E.P. | n2=en:autoimmune encephalitis | rel=r_associated | relid=0 | w=80
  80. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune enteropathy
    n1=S.E.P. | n2=en:autoimmune enteropathy | rel=r_associated | relid=0 | w=80
  81. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune hematologic disorder
    n1=S.E.P. | n2=en:autoimmune hematologic disorder | rel=r_associated | relid=0 | w=80
  82. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune hemolytic anemia
    n1=S.E.P. | n2=en:autoimmune hemolytic anemia | rel=r_associated | relid=0 | w=80
  83. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune hepatitis
    n1=S.E.P. | n2=en:autoimmune hepatitis | rel=r_associated | relid=0 | w=80
  84. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune inflammation of skeletal muscle
    n1=S.E.P. | n2=en:autoimmune inflammation of skeletal muscle | rel=r_associated | relid=0 | w=80
  85. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune leukopenia
    n1=S.E.P. | n2=en:autoimmune leukopenia | rel=r_associated | relid=0 | w=80
  86. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune lymphoproliferative syndrome
    n1=S.E.P. | n2=en:autoimmune lymphoproliferative syndrome | rel=r_associated | relid=0 | w=80
  87. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune necrotizing myopathy
    n1=S.E.P. | n2=en:autoimmune necrotizing myopathy | rel=r_associated | relid=0 | w=80
  88. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune neonatal thrombocytopenia
    n1=S.E.P. | n2=en:autoimmune neonatal thrombocytopenia | rel=r_associated | relid=0 | w=80
  89. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune nervous system disorder
    n1=S.E.P. | n2=en:autoimmune nervous system disorder | rel=r_associated | relid=0 | w=80
  90. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune neuropathy
    n1=S.E.P. | n2=en:autoimmune neuropathy | rel=r_associated | relid=0 | w=80
  91. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune neutropenia
    n1=S.E.P. | n2=en:autoimmune neutropenia | rel=r_associated | relid=0 | w=80
  92. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune pancreatitis
    n1=S.E.P. | n2=en:autoimmune pancreatitis | rel=r_associated | relid=0 | w=80
  93. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune pancytopenia
    n1=S.E.P. | n2=en:autoimmune pancytopenia | rel=r_associated | relid=0 | w=80
  94. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune skin disease
    n1=S.E.P. | n2=en:autoimmune skin disease | rel=r_associated | relid=0 | w=80
  95. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune thyroiditis
    n1=S.E.P. | n2=en:autoimmune thyroiditis | rel=r_associated | relid=0 | w=80
  96. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autoimmune vasculitis
    n1=S.E.P. | n2=en:autoimmune vasculitis | rel=r_associated | relid=0 | w=80
  97. S.E.P. -- r_associated #0: 80 / 0.34 -> en:autosomal dominant optic atrophy and peripheral neuropathy syndrome
    n1=S.E.P. | n2=en:autosomal dominant optic atrophy and peripheral neuropathy syndrome | rel=r_associated | relid=0 | w=80
  98. S.E.P. -- r_associated #0: 80 / 0.34 -> en:babinski sign
    n1=S.E.P. | n2=en:babinski sign | rel=r_associated | relid=0 | w=80
  99. S.E.P. -- r_associated #0: 80 / 0.34 -> en:back pain
    n1=S.E.P. | n2=en:back pain | rel=r_associated | relid=0 | w=80
  100. S.E.P. -- r_associated #0: 80 / 0.34 -> en:behavioral/psychiatric manifestations
    n1=S.E.P. | n2=en:behavioral/psychiatric manifestations | rel=r_associated | relid=0 | w=80
  101. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign lymphoepithelial lesion of the salivary gland
    n1=S.E.P. | n2=en:benign lymphoepithelial lesion of the salivary gland | rel=r_associated | relid=0 | w=80
  102. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign neoplasm of male genital organ
    n1=S.E.P. | n2=en:benign neoplasm of male genital organ | rel=r_associated | relid=0 | w=80
  103. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign obstetric neoplasm
    n1=S.E.P. | n2=en:benign obstetric neoplasm | rel=r_associated | relid=0 | w=80
  104. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign prostatic hyperplasia
    n1=S.E.P. | n2=en:benign prostatic hyperplasia | rel=r_associated | relid=0 | w=80
  105. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign respiratory neoplasm
    n1=S.E.P. | n2=en:benign respiratory neoplasm | rel=r_associated | relid=0 | w=80
  106. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign thyroid gland neoplasm
    n1=S.E.P. | n2=en:benign thyroid gland neoplasm | rel=r_associated | relid=0 | w=80
  107. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign urinary system neoplasm
    n1=S.E.P. | n2=en:benign urinary system neoplasm | rel=r_associated | relid=0 | w=80
  108. S.E.P. -- r_associated #0: 80 / 0.34 -> en:benign/unspecified neoplasms
    n1=S.E.P. | n2=en:benign/unspecified neoplasms | rel=r_associated | relid=0 | w=80
  109. S.E.P. -- r_associated #0: 80 / 0.34 -> en:blastomyces infection of central nervous system
    n1=S.E.P. | n2=en:blastomyces infection of central nervous system | rel=r_associated | relid=0 | w=80
  110. S.E.P. -- r_associated #0: 80 / 0.34 -> en:blepharitis/stye/chalazion
    n1=S.E.P. | n2=en:blepharitis/stye/chalazion | rel=r_associated | relid=0 | w=80
  111. S.E.P. -- r_associated #0: 80 / 0.34 -> en:blepharospasm
    n1=S.E.P. | n2=en:blepharospasm | rel=r_associated | relid=0 | w=80
  112. S.E.P. -- r_associated #0: 80 / 0.34 -> en:blindness all degrees/types
    n1=S.E.P. | n2=en:blindness all degrees/types | rel=r_associated | relid=0 | w=80
  113. S.E.P. -- r_associated #0: 80 / 0.34 -> en:blocked lacrimal duct of infant
    n1=S.E.P. | n2=en:blocked lacrimal duct of infant | rel=r_associated | relid=0 | w=80
  114. S.E.P. -- r_associated #0: 80 / 0.34 -> en:body mass index 30+ - obesity
    n1=S.E.P. | n2=en:body mass index 30+ - obesity | rel=r_associated | relid=0 | w=80
  115. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bone diseases
    n1=S.E.P. | n2=en:bone diseases | rel=r_associated | relid=0 | w=80
  116. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bone graft - material
    n1=S.E.P. | n2=en:bone graft - material | rel=r_associated | relid=0 | w=80
  117. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bone infection
    n1=S.E.P. | n2=en:bone infection | rel=r_associated | relid=0 | w=80
  118. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bone mineral density
    n1=S.E.P. | n2=en:bone mineral density | rel=r_associated | relid=0 | w=80
  119. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bone necrosis
    n1=S.E.P. | n2=en:bone necrosis | rel=r_associated | relid=0 | w=80
  120. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bone paget disease
    n1=S.E.P. | n2=en:bone paget disease | rel=r_associated | relid=0 | w=80
  121. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bones, joints and muscles
    n1=S.E.P. | n2=en:bones, joints and muscles | rel=r_associated | relid=0 | w=80
  122. S.E.P. -- r_associated #0: 80 / 0.34 -> en:brachial plexopathy
    n1=S.E.P. | n2=en:brachial plexopathy | rel=r_associated | relid=0 | w=80
  123. S.E.P. -- r_associated #0: 80 / 0.34 -> en:brachial plexus injury
    n1=S.E.P. | n2=en:brachial plexus injury | rel=r_associated | relid=0 | w=80
  124. S.E.P. -- r_associated #0: 80 / 0.34 -> en:brain aneurysm
    n1=S.E.P. | n2=en:brain aneurysm | rel=r_associated | relid=0 | w=80
  125. S.E.P. -- r_associated #0: 80 / 0.34 -> en:brain edema
    n1=S.E.P. | n2=en:brain edema | rel=r_associated | relid=0 | w=80
  126. S.E.P. -- r_associated #0: 80 / 0.34 -> en:brain injury
    n1=S.E.P. | n2=en:brain injury | rel=r_associated | relid=0 | w=80
  127. S.E.P. -- r_associated #0: 80 / 0.34 -> en:brain stem disorder
    n1=S.E.P. | n2=en:brain stem disorder | rel=r_associated | relid=0 | w=80
  128. S.E.P. -- r_associated #0: 80 / 0.34 -> en:breast disorder in pregnancy/puerperium other
    n1=S.E.P. | n2=en:breast disorder in pregnancy/puerperium other | rel=r_associated | relid=0 | w=80
  129. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bruns nystagmus
    n1=S.E.P. | n2=en:bruns nystagmus | rel=r_associated | relid=0 | w=80
  130. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bullous pemphigoid
    n1=S.E.P. | n2=en:bullous pemphigoid | rel=r_associated | relid=0 | w=80
  131. S.E.P. -- r_associated #0: 80 / 0.34 -> en:bursitis
    n1=S.E.P. | n2=en:bursitis | rel=r_associated | relid=0 | w=80
  132. S.E.P. -- r_associated #0: 80 / 0.34 -> en:carcinomatosis (unknown primary site)
    n1=S.E.P. | n2=en:carcinomatosis (unknown primary site) | rel=r_associated | relid=0 | w=80
  133. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cardiovascular neoplasm
    n1=S.E.P. | n2=en:cardiovascular neoplasm | rel=r_associated | relid=0 | w=80
  134. S.E.P. -- r_associated #0: 80 / 0.34 -> en:carpal tunnel syndrome
    n1=S.E.P. | n2=en:carpal tunnel syndrome | rel=r_associated | relid=0 | w=80
  135. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cataplexy
    n1=S.E.P. | n2=en:cataplexy | rel=r_associated | relid=0 | w=80
  136. S.E.P. -- r_associated #0: 80 / 0.34 -> en:celiac plexus syndrome
    n1=S.E.P. | n2=en:celiac plexus syndrome | rel=r_associated | relid=0 | w=80
  137. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous disorder associated with aids
    n1=S.E.P. | n2=en:central nervous disorder associated with aids | rel=r_associated | relid=0 | w=80
  138. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system
    n1=S.E.P. | n2=en:central nervous system | rel=r_associated | relid=0 | w=80
  139. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system complication
    n1=S.E.P. | n2=en:central nervous system complication | rel=r_associated | relid=0 | w=80
  140. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system cyst
    n1=S.E.P. | n2=en:central nervous system cyst | rel=r_associated | relid=0 | w=80
  141. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system demyelinating disease associated with aids
    n1=S.E.P. | n2=en:central nervous system demyelinating disease associated with aids | rel=r_associated | relid=0 | w=80
  142. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system depression (disorder)
    n1=S.E.P. | n2=en:central nervous system depression (disorder) | rel=r_associated | relid=0 | w=80
  143. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system disorder
    n1=S.E.P. | n2=en:central nervous system disorder | rel=r_associated | relid=0 | w=80
  144. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system dysfunction in newborn
    n1=S.E.P. | n2=en:central nervous system dysfunction in newborn | rel=r_associated | relid=0 | w=80
  145. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system hamartoma
    n1=S.E.P. | n2=en:central nervous system hamartoma | rel=r_associated | relid=0 | w=80
  146. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system infectious disorder
    n1=S.E.P. | n2=en:central nervous system infectious disorder | rel=r_associated | relid=0 | w=80
  147. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system lupus
    n1=S.E.P. | n2=en:central nervous system lupus | rel=r_associated | relid=0 | w=80
  148. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system neoplasm
    n1=S.E.P. | n2=en:central nervous system neoplasm | rel=r_associated | relid=0 | w=80
  149. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system parasitic infections
    n1=S.E.P. | n2=en:central nervous system parasitic infections | rel=r_associated | relid=0 | w=80
  150. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central nervous system vasculitis
    n1=S.E.P. | n2=en:central nervous system vasculitis | rel=r_associated | relid=0 | w=80
  151. S.E.P. -- r_associated #0: 80 / 0.34 -> en:central pontine myelinolysis
    n1=S.E.P. | n2=en:central pontine myelinolysis | rel=r_associated | relid=0 | w=80
  152. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cerebellar diseases
    n1=S.E.P. | n2=en:cerebellar diseases | rel=r_associated | relid=0 | w=80
  153. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cerebral atrophy
    n1=S.E.P. | n2=en:cerebral atrophy | rel=r_associated | relid=0 | w=80
  154. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cerebral palsy
    n1=S.E.P. | n2=en:cerebral palsy | rel=r_associated | relid=0 | w=80
  155. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cerebrospinal fluid leakage
    n1=S.E.P. | n2=en:cerebrospinal fluid leakage | rel=r_associated | relid=0 | w=80
  156. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cerebrovascular accident
    n1=S.E.P. | n2=en:cerebrovascular accident | rel=r_associated | relid=0 | w=80
  157. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cerebrovascular and spinal vascular disorders
    n1=S.E.P. | n2=en:cerebrovascular and spinal vascular disorders | rel=r_associated | relid=0 | w=80
  158. S.E.P. -- r_associated #0: 80 / 0.34 -> en:charcot-marie-tooth disease
    n1=S.E.P. | n2=en:charcot-marie-tooth disease | rel=r_associated | relid=0 | w=80
  159. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chemically induced
    n1=S.E.P. | n2=en:chemically induced | rel=r_associated | relid=0 | w=80
  160. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chicken pox
    n1=S.E.P. | n2=en:chicken pox | rel=r_associated | relid=0 | w=80
  161. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cholecystitis with cholelithiasis
    n1=S.E.P. | n2=en:cholecystitis with cholelithiasis | rel=r_associated | relid=0 | w=80
  162. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic bronchitis/bronchiectasis
    n1=S.E.P. | n2=en:chronic bronchitis/bronchiectasis | rel=r_associated | relid=0 | w=80
  163. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic enteritis/ulcerative colitis
    n1=S.E.P. | n2=en:chronic enteritis/ulcerative colitis | rel=r_associated | relid=0 | w=80
  164. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic fatigue syndrome
    n1=S.E.P. | n2=en:chronic fatigue syndrome | rel=r_associated | relid=0 | w=80
  165. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic inflammatory demyelinating polyneuropathy
    n1=S.E.P. | n2=en:chronic inflammatory demyelinating polyneuropathy | rel=r_associated | relid=0 | w=80
  166. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic inflammatory demyelinating polyradiculoneuropathy with central nervous system demyelination
    n1=S.E.P. | n2=en:chronic inflammatory demyelinating polyradiculoneuropathy with central nervous system demyelination | rel=r_associated | relid=0 | w=80
  167. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic internal knee derangement
    n1=S.E.P. | n2=en:chronic internal knee derangement | rel=r_associated | relid=0 | w=80
  168. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
    n1=S.E.P. | n2=en:chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids | rel=r_associated | relid=0 | w=80
  169. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic otitis other infection ear
    n1=S.E.P. | n2=en:chronic otitis other infection ear | rel=r_associated | relid=0 | w=80
  170. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic pain
    n1=S.E.P. | n2=en:chronic pain | rel=r_associated | relid=0 | w=80
  171. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic polyneuropathy
    n1=S.E.P. | n2=en:chronic polyneuropathy | rel=r_associated | relid=0 | w=80
  172. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic skin ulcer
    n1=S.E.P. | n2=en:chronic skin ulcer | rel=r_associated | relid=0 | w=80
  173. S.E.P. -- r_associated #0: 80 / 0.34 -> en:chronic/non specific lymphadenitis
    n1=S.E.P. | n2=en:chronic/non specific lymphadenitis | rel=r_associated | relid=0 | w=80
  174. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cirrhosis/other liver disease
    n1=S.E.P. | n2=en:cirrhosis/other liver disease | rel=r_associated | relid=0 | w=80
  175. S.E.P. -- r_associated #0: 80 / 0.34 -> en:clinician-diagnosed illness:find:pt:^patient:nom:phenx
    n1=S.E.P. | n2=en:clinician-diagnosed illness:find:pt:^patient:nom:phenx | rel=r_associated | relid=0 | w=80
  176. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cluster headache
    n1=S.E.P. | n2=en:cluster headache | rel=r_associated | relid=0 | w=80
  177. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cns inflammation or infection
    n1=S.E.P. | n2=en:cns inflammation or infection | rel=r_associated | relid=0 | w=80
  178. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cns stimulation (finding)
    n1=S.E.P. | n2=en:cns stimulation (finding) | rel=r_associated | relid=0 | w=80
  179. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cochlear nerve diseases
    n1=S.E.P. | n2=en:cochlear nerve diseases | rel=r_associated | relid=0 | w=80
  180. S.E.P. -- r_associated #0: 80 / 0.34 -> en:complicated delivery deadborn
    n1=S.E.P. | n2=en:complicated delivery deadborn | rel=r_associated | relid=0 | w=80
  181. S.E.P. -- r_associated #0: 80 / 0.34 -> en:complicated delivery liveborn
    n1=S.E.P. | n2=en:complicated delivery liveborn | rel=r_associated | relid=0 | w=80
  182. S.E.P. -- r_associated #0: 80 / 0.34 -> en:complication aspects
    n1=S.E.P. | n2=en:complication aspects | rel=r_associated | relid=0 | w=80
  183. S.E.P. -- r_associated #0: 80 / 0.34 -> en:complication of surgical and medical care, unspecified
    n1=S.E.P. | n2=en:complication of surgical and medical care, unspecified | rel=r_associated | relid=0 | w=80
  184. S.E.P. -- r_associated #0: 80 / 0.34 -> en:concussion
    n1=S.E.P. | n2=en:concussion | rel=r_associated | relid=0 | w=80
  185. S.E.P. -- r_associated #0: 80 / 0.34 -> en:condyloma acuminatum
    n1=S.E.P. | n2=en:condyloma acuminatum | rel=r_associated | relid=0 | w=80
  186. S.E.P. -- r_associated #0: 80 / 0.34 -> en:condylomata acuminata in women
    n1=S.E.P. | n2=en:condylomata acuminata in women | rel=r_associated | relid=0 | w=80
  187. S.E.P. -- r_associated #0: 80 / 0.34 -> en:confirmation of pregnancy
    n1=S.E.P. | n2=en:confirmation of pregnancy | rel=r_associated | relid=0 | w=80
  188. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital abnormality
    n1=S.E.P. | n2=en:congenital abnormality | rel=r_associated | relid=0 | w=80
  189. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital anomaly of brain
    n1=S.E.P. | n2=en:congenital anomaly of brain | rel=r_associated | relid=0 | w=80
  190. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital anomaly of central nervous system
    n1=S.E.P. | n2=en:congenital anomaly of central nervous system | rel=r_associated | relid=0 | w=80
  191. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital anomaly of female genital system
    n1=S.E.P. | n2=en:congenital anomaly of female genital system | rel=r_associated | relid=0 | w=80
  192. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital anomaly of male genital system
    n1=S.E.P. | n2=en:congenital anomaly of male genital system | rel=r_associated | relid=0 | w=80
  193. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital anomaly of peripheral nerve
    n1=S.E.P. | n2=en:congenital anomaly of peripheral nerve | rel=r_associated | relid=0 | w=80
  194. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital anomaly of the peripheral nervous system
    n1=S.E.P. | n2=en:congenital anomaly of the peripheral nervous system | rel=r_associated | relid=0 | w=80
  195. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital cardiovascular abnormality
    n1=S.E.P. | n2=en:congenital cardiovascular abnormality | rel=r_associated | relid=0 | w=80
  196. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital ear anomaly nos (disorder)
    n1=S.E.P. | n2=en:congenital ear anomaly nos (disorder) | rel=r_associated | relid=0 | w=80
  197. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital ischemic atrophy of central nervous system structure
    n1=S.E.P. | n2=en:congenital ischemic atrophy of central nervous system structure | rel=r_associated | relid=0 | w=80
  198. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital mesh qualifier
    n1=S.E.P. | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=80
  199. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital pain insensitivity
    n1=S.E.P. | n2=en:congenital pain insensitivity | rel=r_associated | relid=0 | w=80
  200. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital peripheral neuropathy
    n1=S.E.P. | n2=en:congenital peripheral neuropathy | rel=r_associated | relid=0 | w=80
  201. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital respiratory system disorder
    n1=S.E.P. | n2=en:congenital respiratory system disorder | rel=r_associated | relid=0 | w=80
  202. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital spastic foot
    n1=S.E.P. | n2=en:congenital spastic foot | rel=r_associated | relid=0 | w=80
  203. S.E.P. -- r_associated #0: 80 / 0.34 -> en:congenital urinary system abnormality
    n1=S.E.P. | n2=en:congenital urinary system abnormality | rel=r_associated | relid=0 | w=80
  204. S.E.P. -- r_associated #0: 80 / 0.34 -> en:connective and soft tissue injury
    n1=S.E.P. | n2=en:connective and soft tissue injury | rel=r_associated | relid=0 | w=80
  205. S.E.P. -- r_associated #0: 80 / 0.34 -> en:connective tissue disorder
    n1=S.E.P. | n2=en:connective tissue disorder | rel=r_associated | relid=0 | w=80
  206. S.E.P. -- r_associated #0: 80 / 0.34 -> en:contact dermatitis and other eczema
    n1=S.E.P. | n2=en:contact dermatitis and other eczema | rel=r_associated | relid=0 | w=80
  207. S.E.P. -- r_associated #0: 80 / 0.34 -> en:contracting cord sign
    n1=S.E.P. | n2=en:contracting cord sign | rel=r_associated | relid=0 | w=80
  208. S.E.P. -- r_associated #0: 80 / 0.34 -> en:contusion/hemorrhage eye
    n1=S.E.P. | n2=en:contusion/hemorrhage eye | rel=r_associated | relid=0 | w=80
  209. S.E.P. -- r_associated #0: 80 / 0.34 -> en:convulsive seizures
    n1=S.E.P. | n2=en:convulsive seizures | rel=r_associated | relid=0 | w=80
  210. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cop 1 (polymer)
    n1=S.E.P. | n2=en:cop 1 (polymer) | rel=r_associated | relid=0 | w=80
  211. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cor pulmonale
    n1=S.E.P. | n2=en:cor pulmonale | rel=r_associated | relid=0 | w=80
  212. S.E.P. -- r_associated #0: 80 / 0.34 -> en:craniofacial abnormalities
    n1=S.E.P. | n2=en:craniofacial abnormalities | rel=r_associated | relid=0 | w=80
  213. S.E.P. -- r_associated #0: 80 / 0.34 -> en:creutzfeldt-jakob disease
    n1=S.E.P. | n2=en:creutzfeldt-jakob disease | rel=r_associated | relid=0 | w=80
  214. S.E.P. -- r_associated #0: 80 / 0.34 -> en:crohn disease
    n1=S.E.P. | n2=en:crohn disease | rel=r_associated | relid=0 | w=80
  215. S.E.P. -- r_associated #0: 80 / 0.34 -> en:crohn disease-associated dysplasia
    n1=S.E.P. | n2=en:crohn disease-associated dysplasia | rel=r_associated | relid=0 | w=80
  216. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cryptococcus infection of the central nervous system
    n1=S.E.P. | n2=en:cryptococcus infection of the central nervous system | rel=r_associated | relid=0 | w=80
  217. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ctla4 haploinsufficiency
    n1=S.E.P. | n2=en:ctla4 haploinsufficiency | rel=r_associated | relid=0 | w=80
  218. S.E.P. -- r_associated #0: 80 / 0.34 -> en:cytomegaloviral infection
    n1=S.E.P. | n2=en:cytomegaloviral infection | rel=r_associated | relid=0 | w=80
  219. S.E.P. -- r_associated #0: 80 / 0.34 -> en:de barsy syndrome
    n1=S.E.P. | n2=en:de barsy syndrome | rel=r_associated | relid=0 | w=80
  220. S.E.P. -- r_associated #0: 80 / 0.34 -> en:deafness
    n1=S.E.P. | n2=en:deafness | rel=r_associated | relid=0 | w=80
  221. S.E.P. -- r_associated #0: 80 / 0.34 -> en:death
    n1=S.E.P. | n2=en:death | rel=r_associated | relid=0 | w=80
  222. S.E.P. -- r_associated #0: 80 / 0.34 -> en:decreased libido
    n1=S.E.P. | n2=en:decreased libido | rel=r_associated | relid=0 | w=80
  223. S.E.P. -- r_associated #0: 80 / 0.34 -> en:degenerative nerve diseases
    n1=S.E.P. | n2=en:degenerative nerve diseases | rel=r_associated | relid=0 | w=80
  224. S.E.P. -- r_associated #0: 80 / 0.34 -> en:delirium
    n1=S.E.P. | n2=en:delirium | rel=r_associated | relid=0 | w=80
  225. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dementia
    n1=S.E.P. | n2=en:dementia | rel=r_associated | relid=0 | w=80
  226. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dementia associated with multiple sclerosis
    n1=S.E.P. | n2=en:dementia associated with multiple sclerosis | rel=r_associated | relid=0 | w=80
  227. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelinating autoimmune diseases, cns
    n1=S.E.P. | n2=en:demyelinating autoimmune diseases, cns | rel=r_associated | relid=0 | w=80
  228. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelinating disease (excl multiple sclerosis)
    n1=S.E.P. | n2=en:demyelinating disease (excl multiple sclerosis) | rel=r_associated | relid=0 | w=80
  229. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelinating disease of central nervous system co-occurrent with human immunodeficiency virus infection
    n1=S.E.P. | n2=en:demyelinating disease of central nervous system co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=80
  230. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelinating disorder
    n1=S.E.P. | n2=en:demyelinating disorder | rel=r_associated | relid=0 | w=80
  231. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelinating disorder of central nervous system
    n1=S.E.P. | n2=en:demyelinating disorder of central nervous system | rel=r_associated | relid=0 | w=80
  232. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelinating polyneuropathy
    n1=S.E.P. | n2=en:demyelinating polyneuropathy | rel=r_associated | relid=0 | w=80
  233. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelination
    n1=S.E.P. | n2=en:demyelination | rel=r_associated | relid=0 | w=80
  234. S.E.P. -- r_associated #0: 80 / 0.34 -> en:demyelination of spinal cord
    n1=S.E.P. | n2=en:demyelination of spinal cord | rel=r_associated | relid=0 | w=80
  235. S.E.P. -- r_associated #0: 80 / 0.34 -> en:depressive disorder
    n1=S.E.P. | n2=en:depressive disorder | rel=r_associated | relid=0 | w=80
  236. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dermatitis herpetiformis
    n1=S.E.P. | n2=en:dermatitis herpetiformis | rel=r_associated | relid=0 | w=80
  237. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dermatomyositis
    n1=S.E.P. | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=80
  238. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dermatophytosis
    n1=S.E.P. | n2=en:dermatophytosis | rel=r_associated | relid=0 | w=80
  239. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diabetic foot
    n1=S.E.P. | n2=en:diabetic foot | rel=r_associated | relid=0 | w=80
  240. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diabetic nerve problems
    n1=S.E.P. | n2=en:diabetic nerve problems | rel=r_associated | relid=0 | w=80
  241. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diabetic neuropathy
    n1=S.E.P. | n2=en:diabetic neuropathy | rel=r_associated | relid=0 | w=80
  242. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diagnosis/diseases component
    n1=S.E.P. | n2=en:diagnosis/diseases component | rel=r_associated | relid=0 | w=80
  243. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diaper dermatitis
    n1=S.E.P. | n2=en:diaper dermatitis | rel=r_associated | relid=0 | w=80
  244. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dietary calcium
    n1=S.E.P. | n2=en:dietary calcium | rel=r_associated | relid=0 | w=80
  245. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diffuse cerebral sclerosis of schilder
    n1=S.E.P. | n2=en:diffuse cerebral sclerosis of schilder | rel=r_associated | relid=0 | w=80
  246. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disease of teeth/gums
    n1=S.E.P. | n2=en:disease of teeth/gums | rel=r_associated | relid=0 | w=80
  247. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disk, herniated
    n1=S.E.P. | n2=en:disk, herniated | rel=r_associated | relid=0 | w=80
  248. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dislocation
    n1=S.E.P. | n2=en:dislocation | rel=r_associated | relid=0 | w=80
  249. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorder of central nervous system co-occurrent and due to acute lymphoid leukemia
    n1=S.E.P. | n2=en:disorder of central nervous system co-occurrent and due to acute lymphoid leukemia | rel=r_associated | relid=0 | w=80
  250. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorder of nerve root and/or plexus
    n1=S.E.P. | n2=en:disorder of nerve root and/or plexus | rel=r_associated | relid=0 | w=80
  251. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorder of peripheral nerve graft
    n1=S.E.P. | n2=en:disorder of peripheral nerve graft | rel=r_associated | relid=0 | w=80
  252. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorder of peripheral nervous system co-occurrent with human immunodeficiency virus infection
    n1=S.E.P. | n2=en:disorder of peripheral nervous system co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=80
  253. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorders of cerebrospinal fluid and intracranial pressure
    n1=S.E.P. | n2=en:disorders of cerebrospinal fluid and intracranial pressure | rel=r_associated | relid=0 | w=80
  254. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorders of meninges, not elsewhere classified in icd10cm
    n1=S.E.P. | n2=en:disorders of meninges, not elsewhere classified in icd10cm | rel=r_associated | relid=0 | w=80
  255. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disorders of other cranial nerves
    n1=S.E.P. | n2=en:disorders of other cranial nerves | rel=r_associated | relid=0 | w=80
  256. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disseminated multiple sclerosis
    n1=S.E.P. | n2=en:disseminated multiple sclerosis | rel=r_associated | relid=0 | w=80
  257. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disseminated or multiple sclerosis, brain stem
    n1=S.E.P. | n2=en:disseminated or multiple sclerosis, brain stem | rel=r_associated | relid=0 | w=80
  258. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disseminated or multiple sclerosis, generalized
    n1=S.E.P. | n2=en:disseminated or multiple sclerosis, generalized | rel=r_associated | relid=0 | w=80
  259. S.E.P. -- r_associated #0: 80 / 0.34 -> en:disturbances of smell and taste
    n1=S.E.P. | n2=en:disturbances of smell and taste | rel=r_associated | relid=0 | w=80
  260. S.E.P. -- r_associated #0: 80 / 0.34 -> en:diverticulosis
    n1=S.E.P. | n2=en:diverticulosis | rel=r_associated | relid=0 | w=80
  261. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dizziness and vertigo
    n1=S.E.P. | n2=en:dizziness and vertigo | rel=r_associated | relid=0 | w=80
  262. S.E.P. -- r_associated #0: 80 / 0.34 -> en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx
    n1=S.E.P. | n2=en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx | rel=r_associated | relid=0 | w=80
  263. S.E.P. -- r_associated #0: 80 / 0.34 -> en:duodenal ulcer
    n1=S.E.P. | n2=en:duodenal ulcer | rel=r_associated | relid=0 | w=80
  264. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dwarfism
    n1=S.E.P. | n2=en:dwarfism | rel=r_associated | relid=0 | w=80
  265. S.E.P. -- r_associated #0: 80 / 0.34 -> en:dysarthria
    n1=S.E.P. | n2=en:dysarthria | rel=r_associated | relid=0 | w=80
  266. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ear neoplasm
    n1=S.E.P. | n2=en:ear neoplasm | rel=r_associated | relid=0 | w=80
  267. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ectopic pregnancy
    n1=S.E.P. | n2=en:ectopic pregnancy | rel=r_associated | relid=0 | w=80
  268. S.E.P. -- r_associated #0: 80 / 0.34 -> en:eeg shows generalized and focal spike and wave complexes
    n1=S.E.P. | n2=en:eeg shows generalized and focal spike and wave complexes | rel=r_associated | relid=0 | w=80
  269. S.E.P. -- r_associated #0: 80 / 0.34 -> en:eeg with photoparoxysmal response
    n1=S.E.P. | n2=en:eeg with photoparoxysmal response | rel=r_associated | relid=0 | w=80
  270. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ehlers-danlos syndrome
    n1=S.E.P. | n2=en:ehlers-danlos syndrome | rel=r_associated | relid=0 | w=80
  271. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ehrlichia infection of the central nervous system
    n1=S.E.P. | n2=en:ehrlichia infection of the central nervous system | rel=r_associated | relid=0 | w=80
  272. S.E.P. -- r_associated #0: 80 / 0.34 -> en:elbow injuries and disorders
    n1=S.E.P. | n2=en:elbow injuries and disorders | rel=r_associated | relid=0 | w=80
  273. S.E.P. -- r_associated #0: 80 / 0.34 -> en:electrophysiologic studies indicate cortical origin
    n1=S.E.P. | n2=en:electrophysiologic studies indicate cortical origin | rel=r_associated | relid=0 | w=80
  274. S.E.P. -- r_associated #0: 80 / 0.34 -> en:embryologic
    n1=S.E.P. | n2=en:embryologic | rel=r_associated | relid=0 | w=80
  275. S.E.P. -- r_associated #0: 80 / 0.34 -> en:encephalitis
    n1=S.E.P. | n2=en:encephalitis | rel=r_associated | relid=0 | w=80
  276. S.E.P. -- r_associated #0: 80 / 0.34 -> en:encephalomyelitis
    n1=S.E.P. | n2=en:encephalomyelitis | rel=r_associated | relid=0 | w=80
  277. S.E.P. -- r_associated #0: 80 / 0.34 -> en:endocrine infection
    n1=S.E.P. | n2=en:endocrine infection | rel=r_associated | relid=0 | w=80
  278. S.E.P. -- r_associated #0: 80 / 0.34 -> en:endometrial hyperplasia without atypia
    n1=S.E.P. | n2=en:endometrial hyperplasia without atypia | rel=r_associated | relid=0 | w=80
  279. S.E.P. -- r_associated #0: 80 / 0.34 -> en:enhancement of the c-reflex
    n1=S.E.P. | n2=en:enhancement of the c-reflex | rel=r_associated | relid=0 | w=80
  280. S.E.P. -- r_associated #0: 80 / 0.34 -> en:enterovirus infection of the central nervous system
    n1=S.E.P. | n2=en:enterovirus infection of the central nervous system | rel=r_associated | relid=0 | w=80
  281. S.E.P. -- r_associated #0: 80 / 0.34 -> en:entrapment neuropathy
    n1=S.E.P. | n2=en:entrapment neuropathy | rel=r_associated | relid=0 | w=80
  282. S.E.P. -- r_associated #0: 80 / 0.34 -> en:enzymology
    n1=S.E.P. | n2=en:enzymology | rel=r_associated | relid=0 | w=80
  283. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ependymal cyst of spinal nerve
    n1=S.E.P. | n2=en:ependymal cyst of spinal nerve | rel=r_associated | relid=0 | w=80
  284. S.E.P. -- r_associated #0: 80 / 0.34 -> en:epidemiologic
    n1=S.E.P. | n2=en:epidemiologic | rel=r_associated | relid=0 | w=80
  285. S.E.P. -- r_associated #0: 80 / 0.34 -> en:epididymo-orchitis
    n1=S.E.P. | n2=en:epididymo-orchitis | rel=r_associated | relid=0 | w=80
  286. S.E.P. -- r_associated #0: 80 / 0.34 -> en:epilepsy and recurrent seizures
    n1=S.E.P. | n2=en:epilepsy and recurrent seizures | rel=r_associated | relid=0 | w=80
  287. S.E.P. -- r_associated #0: 80 / 0.34 -> en:episodic peripheral neuropathy
    n1=S.E.P. | n2=en:episodic peripheral neuropathy | rel=r_associated | relid=0 | w=80
  288. S.E.P. -- r_associated #0: 80 / 0.34 -> en:epstein-barr virus infection
    n1=S.E.P. | n2=en:epstein-barr virus infection | rel=r_associated | relid=0 | w=80
  289. S.E.P. -- r_associated #0: 80 / 0.34 -> en:erdheim-chester disease
    n1=S.E.P. | n2=en:erdheim-chester disease | rel=r_associated | relid=0 | w=80
  290. S.E.P. -- r_associated #0: 80 / 0.34 -> en:escherichia coli infection of the central nervous system
    n1=S.E.P. | n2=en:escherichia coli infection of the central nervous system | rel=r_associated | relid=0 | w=80
  291. S.E.P. -- r_associated #0: 80 / 0.34 -> en:esophageal stricture
    n1=S.E.P. | n2=en:esophageal stricture | rel=r_associated | relid=0 | w=80
  292. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ethnologic
    n1=S.E.P. | n2=en:ethnologic | rel=r_associated | relid=0 | w=80
  293. S.E.P. -- r_associated #0: 80 / 0.34 -> en:etiology aspects
    n1=S.E.P. | n2=en:etiology aspects | rel=r_associated | relid=0 | w=80
  294. S.E.P. -- r_associated #0: 80 / 0.34 -> en:evans syndrome
    n1=S.E.P. | n2=en:evans syndrome | rel=r_associated | relid=0 | w=80
  295. S.E.P. -- r_associated #0: 80 / 0.34 -> en:exophthalmos
    n1=S.E.P. | n2=en:exophthalmos | rel=r_associated | relid=0 | w=80
  296. S.E.P. -- r_associated #0: 80 / 0.34 -> en:experimental allergic encephalomyelitis
    n1=S.E.P. | n2=en:experimental allergic encephalomyelitis | rel=r_associated | relid=0 | w=80
  297. S.E.P. -- r_associated #0: 80 / 0.34 -> en:extrapontine myelinolyses
    n1=S.E.P. | n2=en:extrapontine myelinolyses | rel=r_associated | relid=0 | w=80
  298. S.E.P. -- r_associated #0: 80 / 0.34 -> en:facial nerve disorder
    n1=S.E.P. | n2=en:facial nerve disorder | rel=r_associated | relid=0 | w=80
  299. S.E.P. -- r_associated #0: 80 / 0.34 -> en:facial nerve palsy
    n1=S.E.P. | n2=en:facial nerve palsy | rel=r_associated | relid=0 | w=80
  300. S.E.P. -- r_associated #0: 80 / 0.34 -> en:facial pain
    n1=S.E.P. | n2=en:facial pain | rel=r_associated | relid=0 | w=80
  301. S.E.P. -- r_associated #0: 80 / 0.34 -> en:facial paralysis
    n1=S.E.P. | n2=en:facial paralysis | rel=r_associated | relid=0 | w=80
  302. S.E.P. -- r_associated #0: 80 / 0.34 -> en:familial periodic paralysis
    n1=S.E.P. | n2=en:familial periodic paralysis | rel=r_associated | relid=0 | w=80
  303. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fear of cancer neurological system
    n1=S.E.P. | n2=en:fear of cancer neurological system | rel=r_associated | relid=0 | w=80
  304. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fear of other neurological disease
    n1=S.E.P. | n2=en:fear of other neurological disease | rel=r_associated | relid=0 | w=80
  305. S.E.P. -- r_associated #0: 80 / 0.34 -> en:female genital injuries
    n1=S.E.P. | n2=en:female genital injuries | rel=r_associated | relid=0 | w=80
  306. S.E.P. -- r_associated #0: 80 / 0.34 -> en:femur fracture
    n1=S.E.P. | n2=en:femur fracture | rel=r_associated | relid=0 | w=80
  307. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fetus with central nervous system malformation
    n1=S.E.P. | n2=en:fetus with central nervous system malformation | rel=r_associated | relid=0 | w=80
  308. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fh: multiple sclerosis
    n1=S.E.P. | n2=en:fh: multiple sclerosis | rel=r_associated | relid=0 | w=80
  309. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fibroid/myoma (uterus/cervix)
    n1=S.E.P. | n2=en:fibroid/myoma (uterus/cervix) | rel=r_associated | relid=0 | w=80
  310. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fibromyalgia
    n1=S.E.P. | n2=en:fibromyalgia | rel=r_associated | relid=0 | w=80
  311. S.E.P. -- r_associated #0: 80 / 0.34 -> en:finger injury
    n1=S.E.P. | n2=en:finger injury | rel=r_associated | relid=0 | w=80
  312. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fisher syndrome
    n1=S.E.P. | n2=en:fisher syndrome | rel=r_associated | relid=0 | w=80
  313. S.E.P. -- r_associated #0: 80 / 0.34 -> en:foot injuries and disorders
    n1=S.E.P. | n2=en:foot injuries and disorders | rel=r_associated | relid=0 | w=80
  314. S.E.P. -- r_associated #0: 80 / 0.34 -> en:foreign body in auditory canal
    n1=S.E.P. | n2=en:foreign body in auditory canal | rel=r_associated | relid=0 | w=80
  315. S.E.P. -- r_associated #0: 80 / 0.34 -> en:foreign body nose/larynx/bronchus
    n1=S.E.P. | n2=en:foreign body nose/larynx/bronchus | rel=r_associated | relid=0 | w=80
  316. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fracture
    n1=S.E.P. | n2=en:fracture | rel=r_associated | relid=0 | w=80
  317. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fracture hand/foot bones
    n1=S.E.P. | n2=en:fracture hand/foot bones | rel=r_associated | relid=0 | w=80
  318. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fracture of radius and ulna
    n1=S.E.P. | n2=en:fracture of radius and ulna | rel=r_associated | relid=0 | w=80
  319. S.E.P. -- r_associated #0: 80 / 0.34 -> en:fracture other
    n1=S.E.P. | n2=en:fracture other | rel=r_associated | relid=0 | w=80
  320. S.E.P. -- r_associated #0: 80 / 0.34 -> en:friedreich ataxia
    n1=S.E.P. | n2=en:friedreich ataxia | rel=r_associated | relid=0 | w=80
  321. S.E.P. -- r_associated #0: 80 / 0.34 -> en:gait disturbance
    n1=S.E.P. | n2=en:gait disturbance | rel=r_associated | relid=0 | w=80
  322. S.E.P. -- r_associated #0: 80 / 0.34 -> en:gastroenteritis presumed infectious
    n1=S.E.P. | n2=en:gastroenteritis presumed infectious | rel=r_associated | relid=0 | w=80
  323. S.E.P. -- r_associated #0: 80 / 0.34 -> en:generalized tonic-clonic seizures (gtcs), infrequent
    n1=S.E.P. | n2=en:generalized tonic-clonic seizures (gtcs), infrequent | rel=r_associated | relid=0 | w=80
  324. S.E.P. -- r_associated #0: 80 / 0.34 -> en:genetic aspects
    n1=S.E.P. | n2=en:genetic aspects | rel=r_associated | relid=0 | w=80
  325. S.E.P. -- r_associated #0: 80 / 0.34 -> en:genetic brain disorders
    n1=S.E.P. | n2=en:genetic brain disorders | rel=r_associated | relid=0 | w=80
  326. S.E.P. -- r_associated #0: 80 / 0.34 -> en:genital herpes in men
    n1=S.E.P. | n2=en:genital herpes in men | rel=r_associated | relid=0 | w=80
  327. S.E.P. -- r_associated #0: 80 / 0.34 -> en:genital herpes in women
    n1=S.E.P. | n2=en:genital herpes in women | rel=r_associated | relid=0 | w=80
  328. S.E.P. -- r_associated #0: 80 / 0.34 -> en:giant axonal neuropathy
    n1=S.E.P. | n2=en:giant axonal neuropathy | rel=r_associated | relid=0 | w=80
  329. S.E.P. -- r_associated #0: 80 / 0.34 -> en:giant somatosensory evoked potentials
    n1=S.E.P. | n2=en:giant somatosensory evoked potentials | rel=r_associated | relid=0 | w=80
  330. S.E.P. -- r_associated #0: 80 / 0.34 -> en:glaucoma
    n1=S.E.P. | n2=en:glaucoma | rel=r_associated | relid=0 | w=80
  331. S.E.P. -- r_associated #0: 80 / 0.34 -> en:glomerulonephritis
    n1=S.E.P. | n2=en:glomerulonephritis | rel=r_associated | relid=0 | w=80
  332. S.E.P. -- r_associated #0: 80 / 0.34 -> en:glomerulonephritis/nephrosis
    n1=S.E.P. | n2=en:glomerulonephritis/nephrosis | rel=r_associated | relid=0 | w=80
  333. S.E.P. -- r_associated #0: 80 / 0.34 -> en:glossopharyngeal nerve disorder
    n1=S.E.P. | n2=en:glossopharyngeal nerve disorder | rel=r_associated | relid=0 | w=80
  334. S.E.P. -- r_associated #0: 80 / 0.34 -> en:glycosuria, renal
    n1=S.E.P. | n2=en:glycosuria, renal | rel=r_associated | relid=0 | w=80
  335. S.E.P. -- r_associated #0: 80 / 0.34 -> en:goiter
    n1=S.E.P. | n2=en:goiter | rel=r_associated | relid=0 | w=80
  336. S.E.P. -- r_associated #0: 80 / 0.34 -> en:gonorrhea female
    n1=S.E.P. | n2=en:gonorrhea female | rel=r_associated | relid=0 | w=80
  337. S.E.P. -- r_associated #0: 80 / 0.34 -> en:gout
    n1=S.E.P. | n2=en:gout | rel=r_associated | relid=0 | w=80
  338. S.E.P. -- r_associated #0: 80 / 0.34 -> en:grand mal epilepsy
    n1=S.E.P. | n2=en:grand mal epilepsy | rel=r_associated | relid=0 | w=80
  339. S.E.P. -- r_associated #0: 80 / 0.34 -> en:graves disease
    n1=S.E.P. | n2=en:graves disease | rel=r_associated | relid=0 | w=80
  340. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hand injuries and disorders
    n1=S.E.P. | n2=en:hand injuries and disorders | rel=r_associated | relid=0 | w=80
  341. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hand-arm vibration syndrome
    n1=S.E.P. | n2=en:hand-arm vibration syndrome | rel=r_associated | relid=0 | w=80
  342. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hashimoto thyroiditis
    n1=S.E.P. | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=80
  343. S.E.P. -- r_associated #0: 80 / 0.34 -> en:headache
    n1=S.E.P. | n2=en:headache | rel=r_associated | relid=0 | w=80
  344. S.E.P. -- r_associated #0: 80 / 0.34 -> en:heart failure
    n1=S.E.P. | n2=en:heart failure | rel=r_associated | relid=0 | w=80
  345. S.E.P. -- r_associated #0: 80 / 0.34 -> en:heart murmur
    n1=S.E.P. | n2=en:heart murmur | rel=r_associated | relid=0 | w=80
  346. S.E.P. -- r_associated #0: 80 / 0.34 -> en:helicobacter pylori infection
    n1=S.E.P. | n2=en:helicobacter pylori infection | rel=r_associated | relid=0 | w=80
  347. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hemiparesis
    n1=S.E.P. | n2=en:hemiparesis | rel=r_associated | relid=0 | w=80
  348. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hemiplegia
    n1=S.E.P. | n2=en:hemiplegia | rel=r_associated | relid=0 | w=80
  349. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hemiplegia/hemiparesis
    n1=S.E.P. | n2=en:hemiplegia/hemiparesis | rel=r_associated | relid=0 | w=80
  350. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hemophagocytic lymphohistiocytosis
    n1=S.E.P. | n2=en:hemophagocytic lymphohistiocytosis | rel=r_associated | relid=0 | w=80
  351. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hemorrhagic cerebrovascular accident
    n1=S.E.P. | n2=en:hemorrhagic cerebrovascular accident | rel=r_associated | relid=0 | w=80
  352. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hemorrhoid
    n1=S.E.P. | n2=en:hemorrhoid | rel=r_associated | relid=0 | w=80
  353. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hepatic autoimmune disorders
    n1=S.E.P. | n2=en:hepatic autoimmune disorders | rel=r_associated | relid=0 | w=80
  354. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hepatitis b infection
    n1=S.E.P. | n2=en:hepatitis b infection | rel=r_associated | relid=0 | w=80
  355. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hepatolenticular degeneration
    n1=S.E.P. | n2=en:hepatolenticular degeneration | rel=r_associated | relid=0 | w=80
  356. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hepatomegaly
    n1=S.E.P. | n2=en:hepatomegaly | rel=r_associated | relid=0 | w=80
  357. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary and idiopathic peripheral neuropathy
    n1=S.E.P. | n2=en:hereditary and idiopathic peripheral neuropathy | rel=r_associated | relid=0 | w=80
  358. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary and idiopathic peripheral neuropathy, other
    n1=S.E.P. | n2=en:hereditary and idiopathic peripheral neuropathy, other | rel=r_associated | relid=0 | w=80
  359. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary degenerative disease of central nervous system
    n1=S.E.P. | n2=en:hereditary degenerative disease of central nervous system | rel=r_associated | relid=0 | w=80
  360. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary hemolytic anemia
    n1=S.E.P. | n2=en:hereditary hemolytic anemia | rel=r_associated | relid=0 | w=80
  361. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary neuraxial edema
    n1=S.E.P. | n2=en:hereditary neuraxial edema | rel=r_associated | relid=0 | w=80
  362. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary peripheral nervous system disorder
    n1=S.E.P. | n2=en:hereditary peripheral nervous system disorder | rel=r_associated | relid=0 | w=80
  363. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hereditary peripheral neuropathy
    n1=S.E.P. | n2=en:hereditary peripheral neuropathy | rel=r_associated | relid=0 | w=80
  364. S.E.P. -- r_associated #0: 80 / 0.34 -> en:herpes simplex infections
    n1=S.E.P. | n2=en:herpes simplex infections | rel=r_associated | relid=0 | w=80
  365. S.E.P. -- r_associated #0: 80 / 0.34 -> en:herpes virus infection of the central nervous system
    n1=S.E.P. | n2=en:herpes virus infection of the central nervous system | rel=r_associated | relid=0 | w=80
  366. S.E.P. -- r_associated #0: 80 / 0.34 -> en:herpes zoster
    n1=S.E.P. | n2=en:herpes zoster | rel=r_associated | relid=0 | w=80
  367. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hiatal hernia
    n1=S.E.P. | n2=en:hiatal hernia | rel=r_associated | relid=0 | w=80
  368. S.E.P. -- r_associated #0: 80 / 0.34 -> en:high risk pregnancy
    n1=S.E.P. | n2=en:high risk pregnancy | rel=r_associated | relid=0 | w=80
  369. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hip injuries and disorders
    n1=S.E.P. | n2=en:hip injuries and disorders | rel=r_associated | relid=0 | w=80
  370. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hip osteoarthritis
    n1=S.E.P. | n2=en:hip osteoarthritis | rel=r_associated | relid=0 | w=80
  371. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hip replacement arthroplasty (procedure)
    n1=S.E.P. | n2=en:hip replacement arthroplasty (procedure) | rel=r_associated | relid=0 | w=80
  372. S.E.P. -- r_associated #0: 80 / 0.34 -> en:histoplasma infection of central nervous system
    n1=S.E.P. | n2=en:histoplasma infection of central nervous system | rel=r_associated | relid=0 | w=80
  373. S.E.P. -- r_associated #0: 80 / 0.34 -> en:historical aspects qualifier
    n1=S.E.P. | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=80
  374. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hiv infection
    n1=S.E.P. | n2=en:hiv infection | rel=r_associated | relid=0 | w=80
  375. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hiv/aids
    n1=S.E.P. | n2=en:hiv/aids | rel=r_associated | relid=0 | w=80
  376. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hodgkin lymphoma
    n1=S.E.P. | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=80
  377. S.E.P. -- r_associated #0: 80 / 0.34 -> en:htlv-1 infection
    n1=S.E.P. | n2=en:htlv-1 infection | rel=r_associated | relid=0 | w=80
  378. S.E.P. -- r_associated #0: 80 / 0.34 -> en:human papillomavirus infection
    n1=S.E.P. | n2=en:human papillomavirus infection | rel=r_associated | relid=0 | w=80
  379. S.E.P. -- r_associated #0: 80 / 0.34 -> en:huntington's disease
    n1=S.E.P. | n2=en:huntington's disease | rel=r_associated | relid=0 | w=80
  380. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hurler syndrome
    n1=S.E.P. | n2=en:hurler syndrome | rel=r_associated | relid=0 | w=80
  381. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hydrocephalus
    n1=S.E.P. | n2=en:hydrocephalus | rel=r_associated | relid=0 | w=80
  382. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hyperalgesia
    n1=S.E.P. | n2=en:hyperalgesia | rel=r_associated | relid=0 | w=80
  383. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hyperesthesia
    n1=S.E.P. | n2=en:hyperesthesia | rel=r_associated | relid=0 | w=80
  384. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hyperparathyroidism
    n1=S.E.P. | n2=en:hyperparathyroidism | rel=r_associated | relid=0 | w=80
  385. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypertension
    n1=S.E.P. | n2=en:hypertension | rel=r_associated | relid=0 | w=80
  386. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypertension with involvement target organs
    n1=S.E.P. | n2=en:hypertension with involvement target organs | rel=r_associated | relid=0 | w=80
  387. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypertrophic interstitial neuropathy
    n1=S.E.P. | n2=en:hypertrophic interstitial neuropathy | rel=r_associated | relid=0 | w=80
  388. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hyperventilation
    n1=S.E.P. | n2=en:hyperventilation | rel=r_associated | relid=0 | w=80
  389. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypoalgesia
    n1=S.E.P. | n2=en:hypoalgesia | rel=r_associated | relid=0 | w=80
  390. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypoesthesia
    n1=S.E.P. | n2=en:hypoesthesia | rel=r_associated | relid=0 | w=80
  391. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypoglossal nerve disorder
    n1=S.E.P. | n2=en:hypoglossal nerve disorder | rel=r_associated | relid=0 | w=80
  392. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hypoglycemia
    n1=S.E.P. | n2=en:hypoglycemia | rel=r_associated | relid=0 | w=80
  393. S.E.P. -- r_associated #0: 80 / 0.34 -> en:hysterical/hypochondriacal disease
    n1=S.E.P. | n2=en:hysterical/hypochondriacal disease | rel=r_associated | relid=0 | w=80
  394. S.E.P. -- r_associated #0: 80 / 0.34 -> en:idiopathic peripheral neuropathy
    n1=S.E.P. | n2=en:idiopathic peripheral neuropathy | rel=r_associated | relid=0 | w=80
  395. S.E.P. -- r_associated #0: 80 / 0.34 -> en:idiopathic thrombocytopenic purpura
    n1=S.E.P. | n2=en:idiopathic thrombocytopenic purpura | rel=r_associated | relid=0 | w=80
  396. S.E.P. -- r_associated #0: 80 / 0.34 -> en:iga nephropathy
    n1=S.E.P. | n2=en:iga nephropathy | rel=r_associated | relid=0 | w=80
  397. S.E.P. -- r_associated #0: 80 / 0.34 -> en:il17a gene
    n1=S.E.P. | n2=en:il17a gene | rel=r_associated | relid=0 | w=80
  398. S.E.P. -- r_associated #0: 80 / 0.34 -> en:immune system disorder
    n1=S.E.P. | n2=en:immune system disorder | rel=r_associated | relid=0 | w=80
  399. S.E.P. -- r_associated #0: 80 / 0.34 -> en:immunology aspects
    n1=S.E.P. | n2=en:immunology aspects | rel=r_associated | relid=0 | w=80
  400. S.E.P. -- r_associated #0: 80 / 0.34 -> en:in cerebrospinal fluid
    n1=S.E.P. | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=80
  401. S.E.P. -- r_associated #0: 80 / 0.34 -> en:in urine
    n1=S.E.P. | n2=en:in urine | rel=r_associated | relid=0 | w=80
  402. S.E.P. -- r_associated #0: 80 / 0.34 -> en:increase in blood pressure
    n1=S.E.P. | n2=en:increase in blood pressure | rel=r_associated | relid=0 | w=80
  403. S.E.P. -- r_associated #0: 80 / 0.34 -> en:increased libido
    n1=S.E.P. | n2=en:increased libido | rel=r_associated | relid=0 | w=80
  404. S.E.P. -- r_associated #0: 80 / 0.34 -> en:indolent systemic mastocytosis
    n1=S.E.P. | n2=en:indolent systemic mastocytosis | rel=r_associated | relid=0 | w=80
  405. S.E.P. -- r_associated #0: 80 / 0.34 -> en:induced abortion finding
    n1=S.E.P. | n2=en:induced abortion finding | rel=r_associated | relid=0 | w=80
  406. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infantile cerebral palsy
    n1=S.E.P. | n2=en:infantile cerebral palsy | rel=r_associated | relid=0 | w=80
  407. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infantile neuroaxonal dystrophy
    n1=S.E.P. | n2=en:infantile neuroaxonal dystrophy | rel=r_associated | relid=0 | w=80
  408. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infections of musculoskeletal system
    n1=S.E.P. | n2=en:infections of musculoskeletal system | rel=r_associated | relid=0 | w=80
  409. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infectious conjunctivitis
    n1=S.E.P. | n2=en:infectious conjunctivitis | rel=r_associated | relid=0 | w=80
  410. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infectious diarrhea/dysentery
    n1=S.E.P. | n2=en:infectious diarrhea/dysentery | rel=r_associated | relid=0 | w=80
  411. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infectious mononucleosis
    n1=S.E.P. | n2=en:infectious mononucleosis | rel=r_associated | relid=0 | w=80
  412. S.E.P. -- r_associated #0: 80 / 0.34 -> en:infective arthritis
    n1=S.E.P. | n2=en:infective arthritis | rel=r_associated | relid=0 | w=80
  413. S.E.P. -- r_associated #0: 80 / 0.34 -> en:inflammatory and toxic neuropathy
    n1=S.E.P. | n2=en:inflammatory and toxic neuropathy | rel=r_associated | relid=0 | w=80
  414. S.E.P. -- r_associated #0: 80 / 0.34 -> en:inflammatory disease of the central nervous system
    n1=S.E.P. | n2=en:inflammatory disease of the central nervous system | rel=r_associated | relid=0 | w=80
  415. S.E.P. -- r_associated #0: 80 / 0.34 -> en:influenza of the central nervous system
    n1=S.E.P. | n2=en:influenza of the central nervous system | rel=r_associated | relid=0 | w=80
  416. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ingrown toenail/other disease of nail
    n1=S.E.P. | n2=en:ingrown toenail/other disease of nail | rel=r_associated | relid=0 | w=80
  417. S.E.P. -- r_associated #0: 80 / 0.34 -> en:inguinal hernia
    n1=S.E.P. | n2=en:inguinal hernia | rel=r_associated | relid=0 | w=80
  418. S.E.P. -- r_associated #0: 80 / 0.34 -> en:inherited neuropathy
    n1=S.E.P. | n2=en:inherited neuropathy | rel=r_associated | relid=0 | w=80
  419. S.E.P. -- r_associated #0: 80 / 0.34 -> en:injection neuropathy
    n1=S.E.P. | n2=en:injection neuropathy | rel=r_associated | relid=0 | w=80
  420. S.E.P. -- r_associated #0: 80 / 0.34 -> en:injuries complicating pregnancy
    n1=S.E.P. | n2=en:injuries complicating pregnancy | rel=r_associated | relid=0 | w=80
  421. S.E.P. -- r_associated #0: 80 / 0.34 -> en:injury of central nervous system
    n1=S.E.P. | n2=en:injury of central nervous system | rel=r_associated | relid=0 | w=80
  422. S.E.P. -- r_associated #0: 80 / 0.34 -> en:insulin resistance - type b
    n1=S.E.P. | n2=en:insulin resistance - type b | rel=r_associated | relid=0 | w=80
  423. S.E.P. -- r_associated #0: 80 / 0.34 -> en:intercostal neuropathy
    n1=S.E.P. | n2=en:intercostal neuropathy | rel=r_associated | relid=0 | w=80
  424. S.E.P. -- r_associated #0: 80 / 0.34 -> en:intracranial hemorrhage
    n1=S.E.P. | n2=en:intracranial hemorrhage | rel=r_associated | relid=0 | w=80
  425. S.E.P. -- r_associated #0: 80 / 0.34 -> en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers
    n1=S.E.P. | n2=en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers | rel=r_associated | relid=0 | w=80
  426. S.E.P. -- r_associated #0: 80 / 0.34 -> en:iron-deficiency anemia
    n1=S.E.P. | n2=en:iron-deficiency anemia | rel=r_associated | relid=0 | w=80
  427. S.E.P. -- r_associated #0: 80 / 0.34 -> en:irritable bowel syndrome
    n1=S.E.P. | n2=en:irritable bowel syndrome | rel=r_associated | relid=0 | w=80
  428. S.E.P. -- r_associated #0: 80 / 0.34 -> en:isaacs syndrome
    n1=S.E.P. | n2=en:isaacs syndrome | rel=r_associated | relid=0 | w=80
  429. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ischemic cerebrovascular accident
    n1=S.E.P. | n2=en:ischemic cerebrovascular accident | rel=r_associated | relid=0 | w=80
  430. S.E.P. -- r_associated #0: 80 / 0.34 -> en:jerk-locked premyoclonus spikes
    n1=S.E.P. | n2=en:jerk-locked premyoclonus spikes | rel=r_associated | relid=0 | w=80
  431. S.E.P. -- r_associated #0: 80 / 0.34 -> en:juvenile arthritis
    n1=S.E.P. | n2=en:juvenile arthritis | rel=r_associated | relid=0 | w=80
  432. S.E.P. -- r_associated #0: 80 / 0.34 -> en:knee injuries and disorders
    n1=S.E.P. | n2=en:knee injuries and disorders | rel=r_associated | relid=0 | w=80
  433. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lambert eaton myasthenic syndrome
    n1=S.E.P. | n2=en:lambert eaton myasthenic syndrome | rel=r_associated | relid=0 | w=80
  434. S.E.P. -- r_associated #0: 80 / 0.34 -> en:late effects of central nervous system tuberculosis
    n1=S.E.P. | n2=en:late effects of central nervous system tuberculosis | rel=r_associated | relid=0 | w=80
  435. S.E.P. -- r_associated #0: 80 / 0.34 -> en:late effects of poliomyelitis
    n1=S.E.P. | n2=en:late effects of poliomyelitis | rel=r_associated | relid=0 | w=80
  436. S.E.P. -- r_associated #0: 80 / 0.34 -> en:late secondary abnormalities of the central nervous system
    n1=S.E.P. | n2=en:late secondary abnormalities of the central nervous system | rel=r_associated | relid=0 | w=80
  437. S.E.P. -- r_associated #0: 80 / 0.34 -> en:learning difficulties (classic feature)
    n1=S.E.P. | n2=en:learning difficulties (classic feature) | rel=r_associated | relid=0 | w=80
  438. S.E.P. -- r_associated #0: 80 / 0.34 -> en:leg cramp
    n1=S.E.P. | n2=en:leg cramp | rel=r_associated | relid=0 | w=80
  439. S.E.P. -- r_associated #0: 80 / 0.34 -> en:leg injuries and disorders
    n1=S.E.P. | n2=en:leg injuries and disorders | rel=r_associated | relid=0 | w=80
  440. S.E.P. -- r_associated #0: 80 / 0.34 -> en:leprosy neuropathy
    n1=S.E.P. | n2=en:leprosy neuropathy | rel=r_associated | relid=0 | w=80
  441. S.E.P. -- r_associated #0: 80 / 0.34 -> en:leukemia
    n1=S.E.P. | n2=en:leukemia | rel=r_associated | relid=0 | w=80
  442. S.E.P. -- r_associated #0: 80 / 0.34 -> en:leukodystrophy
    n1=S.E.P. | n2=en:leukodystrophy | rel=r_associated | relid=0 | w=80
  443. S.E.P. -- r_associated #0: 80 / 0.34 -> en:leukoencephalomyelitis
    n1=S.E.P. | n2=en:leukoencephalomyelitis | rel=r_associated | relid=0 | w=80
  444. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lewy body dementia
    n1=S.E.P. | n2=en:lewy body dementia | rel=r_associated | relid=0 | w=80
  445. S.E.P. -- r_associated #0: 80 / 0.34 -> en:limbic encephalitis
    n1=S.E.P. | n2=en:limbic encephalitis | rel=r_associated | relid=0 | w=80
  446. S.E.P. -- r_associated #0: 80 / 0.34 -> en:limited neurologic function
    n1=S.E.P. | n2=en:limited neurologic function | rel=r_associated | relid=0 | w=80
  447. S.E.P. -- r_associated #0: 80 / 0.34 -> en:linear iga bullous dermatosis
    n1=S.E.P. | n2=en:linear iga bullous dermatosis | rel=r_associated | relid=0 | w=80
  448. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lipid metabolism disorder
    n1=S.E.P. | n2=en:lipid metabolism disorder | rel=r_associated | relid=0 | w=80
  449. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lipoma
    n1=S.E.P. | n2=en:lipoma | rel=r_associated | relid=0 | w=80
  450. S.E.P. -- r_associated #0: 80 / 0.34 -> en:listeria infection of the central nervous system
    n1=S.E.P. | n2=en:listeria infection of the central nervous system | rel=r_associated | relid=0 | w=80
  451. S.E.P. -- r_associated #0: 80 / 0.34 -> en:localized scleroderma
    n1=S.E.P. | n2=en:localized scleroderma | rel=r_associated | relid=0 | w=80
  452. S.E.P. -- r_associated #0: 80 / 0.34 -> en:long thoracic nerve lesion
    n1=S.E.P. | n2=en:long thoracic nerve lesion | rel=r_associated | relid=0 | w=80
  453. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lumbar disc lesion/radiation
    n1=S.E.P. | n2=en:lumbar disc lesion/radiation | rel=r_associated | relid=0 | w=80
  454. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lupus erythematosus
    n1=S.E.P. | n2=en:lupus erythematosus | rel=r_associated | relid=0 | w=80
  455. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lupus erythematosus and associated conditions
    n1=S.E.P. | n2=en:lupus erythematosus and associated conditions | rel=r_associated | relid=0 | w=80
  456. S.E.P. -- r_associated #0: 80 / 0.34 -> en:lymphangioleiomyomatosis
    n1=S.E.P. | n2=en:lymphangioleiomyomatosis | rel=r_associated | relid=0 | w=80
  457. S.E.P. -- r_associated #0: 80 / 0.34 -> en:macular degeneration
    n1=S.E.P. | n2=en:macular degeneration | rel=r_associated | relid=0 | w=80
  458. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malaria
    n1=S.E.P. | n2=en:malaria | rel=r_associated | relid=0 | w=80
  459. S.E.P. -- r_associated #0: 80 / 0.34 -> en:male genital injuries
    n1=S.E.P. | n2=en:male genital injuries | rel=r_associated | relid=0 | w=80
  460. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant bladder neoplasm
    n1=S.E.P. | n2=en:malignant bladder neoplasm | rel=r_associated | relid=0 | w=80
  461. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant bone neoplasm
    n1=S.E.P. | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=80
  462. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant cervical neoplasm
    n1=S.E.P. | n2=en:malignant cervical neoplasm | rel=r_associated | relid=0 | w=80
  463. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant gastric neoplasm
    n1=S.E.P. | n2=en:malignant gastric neoplasm | rel=r_associated | relid=0 | w=80
  464. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant kidney neoplasm
    n1=S.E.P. | n2=en:malignant kidney neoplasm | rel=r_associated | relid=0 | w=80
  465. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant neoplasm of colon with rectum
    n1=S.E.P. | n2=en:malignant neoplasm of colon with rectum | rel=r_associated | relid=0 | w=80
  466. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant neoplasm of female breast
    n1=S.E.P. | n2=en:malignant neoplasm of female breast | rel=r_associated | relid=0 | w=80
  467. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant neoplasm other/unspecified
    n1=S.E.P. | n2=en:malignant neoplasm other/unspecified | rel=r_associated | relid=0 | w=80
  468. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant neoplasm: bronchus or lung, unspecified
    n1=S.E.P. | n2=en:malignant neoplasm: bronchus or lung, unspecified | rel=r_associated | relid=0 | w=80
  469. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant nervous system neoplasm
    n1=S.E.P. | n2=en:malignant nervous system neoplasm | rel=r_associated | relid=0 | w=80
  470. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant pancreatic neoplasm
    n1=S.E.P. | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=80
  471. S.E.P. -- r_associated #0: 80 / 0.34 -> en:malignant prostate neoplasm
    n1=S.E.P. | n2=en:malignant prostate neoplasm | rel=r_associated | relid=0 | w=80
  472. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mandibular injuries
    n1=S.E.P. | n2=en:mandibular injuries | rel=r_associated | relid=0 | w=80
  473. S.E.P. -- r_associated #0: 80 / 0.34 -> en:marburg's variant multiple sclerosis
    n1=S.E.P. | n2=en:marburg's variant multiple sclerosis | rel=r_associated | relid=0 | w=80
  474. S.E.P. -- r_associated #0: 80 / 0.34 -> en:marchiafava-bignami disease
    n1=S.E.P. | n2=en:marchiafava-bignami disease | rel=r_associated | relid=0 | w=80
  475. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mastitis, postpartum
    n1=S.E.P. | n2=en:mastitis, postpartum | rel=r_associated | relid=0 | w=80
  476. S.E.P. -- r_associated #0: 80 / 0.34 -> en:measles of the central nervous system
    n1=S.E.P. | n2=en:measles of the central nervous system | rel=r_associated | relid=0 | w=80
  477. S.E.P. -- r_associated #0: 80 / 0.34 -> en:membranous glomerulonephritis
    n1=S.E.P. | n2=en:membranous glomerulonephritis | rel=r_associated | relid=0 | w=80
  478. S.E.P. -- r_associated #0: 80 / 0.34 -> en:memory
    n1=S.E.P. | n2=en:memory | rel=r_associated | relid=0 | w=80
  479. S.E.P. -- r_associated #0: 80 / 0.34 -> en:meningeal disorder
    n1=S.E.P. | n2=en:meningeal disorder | rel=r_associated | relid=0 | w=80
  480. S.E.P. -- r_associated #0: 80 / 0.34 -> en:meningitis
    n1=S.E.P. | n2=en:meningitis | rel=r_associated | relid=0 | w=80
  481. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mental retardation
    n1=S.E.P. | n2=en:mental retardation | rel=r_associated | relid=0 | w=80
  482. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mental retardation (classic feature)
    n1=S.E.P. | n2=en:mental retardation (classic feature) | rel=r_associated | relid=0 | w=80
  483. S.E.P. -- r_associated #0: 80 / 0.34 -> en:metabolic aspects
    n1=S.E.P. | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=80
  484. S.E.P. -- r_associated #0: 80 / 0.34 -> en:microbiological
    n1=S.E.P. | n2=en:microbiological | rel=r_associated | relid=0 | w=80
  485. S.E.P. -- r_associated #0: 80 / 0.34 -> en:migraine
    n1=S.E.P. | n2=en:migraine | rel=r_associated | relid=0 | w=80
  486. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mikulicz disease
    n1=S.E.P. | n2=en:mikulicz disease | rel=r_associated | relid=0 | w=80
  487. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mitoxantrone
    n1=S.E.P. | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=80
  488. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mitoxantrone hydrochloride
    n1=S.E.P. | n2=en:mitoxantrone hydrochloride | rel=r_associated | relid=0 | w=80
  489. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mixed connective tissue disease
    n1=S.E.P. | n2=en:mixed connective tissue disease | rel=r_associated | relid=0 | w=80
  490. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mixed demyelinating and axonal polyneuropathy
    n1=S.E.P. | n2=en:mixed demyelinating and axonal polyneuropathy | rel=r_associated | relid=0 | w=80
  491. S.E.P. -- r_associated #0: 80 / 0.34 -> en:molluscum contagiosum
    n1=S.E.P. | n2=en:molluscum contagiosum | rel=r_associated | relid=0 | w=80
  492. S.E.P. -- r_associated #0: 80 / 0.34 -> en:moniliasis genital female
    n1=S.E.P. | n2=en:moniliasis genital female | rel=r_associated | relid=0 | w=80
  493. S.E.P. -- r_associated #0: 80 / 0.34 -> en:moniliasis/candida (excluding x72 y75)
    n1=S.E.P. | n2=en:moniliasis/candida (excluding x72 y75) | rel=r_associated | relid=0 | w=80
  494. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mononeuritis of upper limb and mononeuritis multiplex
    n1=S.E.P. | n2=en:mononeuritis of upper limb and mononeuritis multiplex | rel=r_associated | relid=0 | w=80
  495. S.E.P. -- r_associated #0: 80 / 0.34 -> en:mononeuropathies
    n1=S.E.P. | n2=en:mononeuropathies | rel=r_associated | relid=0 | w=80
  496. S.E.P. -- r_associated #0: 80 / 0.34 -> en:monoplegias
    n1=S.E.P. | n2=en:monoplegias | rel=r_associated | relid=0 | w=80
  497. S.E.P. -- r_associated #0: 80 / 0.34 -> en:motor neuron disease
    n1=S.E.P. | n2=en:motor neuron disease | rel=r_associated | relid=0 | w=80
  498. S.E.P. -- r_associated #0: 80 / 0.34 -> en:movements ('tremors') characterized by 8 to 10-hz discharges
    n1=S.E.P. | n2=en:movements ('tremors') characterized by 8 to 10-hz discharges | rel=r_associated | relid=0 | w=80
  499. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ms aggravated
    n1=S.E.P. | n2=en:ms aggravated | rel=r_associated | relid=0 | w=80
  500. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ms gene
    n1=S.E.P. | n2=en:ms gene | rel=r_associated | relid=0 | w=80
  501. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis acute and progressive
    n1=S.E.P. | n2=en:multiple sclerosis acute and progressive | rel=r_associated | relid=0 | w=80
  502. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis brain lesion
    n1=S.E.P. | n2=en:multiple sclerosis brain lesion | rel=r_associated | relid=0 | w=80
  503. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis of the brainstem
    n1=S.E.P. | n2=en:multiple sclerosis of the brainstem | rel=r_associated | relid=0 | w=80
  504. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis of the spinal cord
    n1=S.E.P. | n2=en:multiple sclerosis of the spinal cord | rel=r_associated | relid=0 | w=80
  505. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis plaque
    n1=S.E.P. | n2=en:multiple sclerosis plaque | rel=r_associated | relid=0 | w=80
  506. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis relapse
    n1=S.E.P. | n2=en:multiple sclerosis relapse | rel=r_associated | relid=0 | w=80
  507. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis spinal cord lesion
    n1=S.E.P. | n2=en:multiple sclerosis spinal cord lesion | rel=r_associated | relid=0 | w=80
  508. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis, chronic progressive
    n1=S.E.P. | n2=en:multiple sclerosis, chronic progressive | rel=r_associated | relid=0 | w=80
  509. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple sclerosis:find:pt:^patient:ord:mds
    n1=S.E.P. | n2=en:multiple sclerosis:find:pt:^patient:ord:mds | rel=r_associated | relid=0 | w=80
  510. S.E.P. -- r_associated #0: 80 / 0.34 -> en:multiple trauma/internal injury
    n1=S.E.P. | n2=en:multiple trauma/internal injury | rel=r_associated | relid=0 | w=80
  511. S.E.P. -- r_associated #0: 80 / 0.34 -> en:muscle cramp
    n1=S.E.P. | n2=en:muscle cramp | rel=r_associated | relid=0 | w=80
  512. S.E.P. -- r_associated #0: 80 / 0.34 -> en:muscular autoimmune disorders
    n1=S.E.P. | n2=en:muscular autoimmune disorders | rel=r_associated | relid=0 | w=80
  513. S.E.P. -- r_associated #0: 80 / 0.34 -> en:muscular dystrophies and other myopathies
    n1=S.E.P. | n2=en:muscular dystrophies and other myopathies | rel=r_associated | relid=0 | w=80
  514. S.E.P. -- r_associated #0: 80 / 0.34 -> en:muscular dystrophy
    n1=S.E.P. | n2=en:muscular dystrophy | rel=r_associated | relid=0 | w=80
  515. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myasthenia gravis
    n1=S.E.P. | n2=en:myasthenia gravis | rel=r_associated | relid=0 | w=80
  516. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myelin-oligodendrocyte glycoprotein
    n1=S.E.P. | n2=en:myelin-oligodendrocyte glycoprotein | rel=r_associated | relid=0 | w=80
  517. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myelinopathy
    n1=S.E.P. | n2=en:myelinopathy | rel=r_associated | relid=0 | w=80
  518. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myelitis
    n1=S.E.P. | n2=en:myelitis | rel=r_associated | relid=0 | w=80
  519. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myelitis, transverse
    n1=S.E.P. | n2=en:myelitis, transverse | rel=r_associated | relid=0 | w=80
  520. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myopathy
    n1=S.E.P. | n2=en:myopathy | rel=r_associated | relid=0 | w=80
  521. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myositis
    n1=S.E.P. | n2=en:myositis | rel=r_associated | relid=0 | w=80
  522. S.E.P. -- r_associated #0: 80 / 0.34 -> en:myxedema
    n1=S.E.P. | n2=en:myxedema | rel=r_associated | relid=0 | w=80
  523. S.E.P. -- r_associated #0: 80 / 0.34 -> en:narcolepsy
    n1=S.E.P. | n2=en:narcolepsy | rel=r_associated | relid=0 | w=80
  524. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neoplasm
    n1=S.E.P. | n2=en:neoplasm | rel=r_associated | relid=0 | w=80
  525. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nerve compression syndrome
    n1=S.E.P. | n2=en:nerve compression syndrome | rel=r_associated | relid=0 | w=80
  526. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nerve root and plexus disorders
    n1=S.E.P. | n2=en:nerve root and plexus disorders | rel=r_associated | relid=0 | w=80
  527. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nervous system autoimmune disease, experimental
    n1=S.E.P. | n2=en:nervous system autoimmune disease, experimental | rel=r_associated | relid=0 | w=80
  528. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nervous system disorder
    n1=S.E.P. | n2=en:nervous system disorder | rel=r_associated | relid=0 | w=80
  529. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nervous system disorders, general and nec
    n1=S.E.P. | n2=en:nervous system disorders, general and nec | rel=r_associated | relid=0 | w=80
  530. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neural tube defect
    n1=S.E.P. | n2=en:neural tube defect | rel=r_associated | relid=0 | w=80
  531. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuralgic amyotrophy
    n1=S.E.P. | n2=en:neuralgic amyotrophy | rel=r_associated | relid=0 | w=80
  532. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neurasthenia/surmenage
    n1=S.E.P. | n2=en:neurasthenia/surmenage | rel=r_associated | relid=0 | w=80
  533. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuritis
    n1=S.E.P. | n2=en:neuritis | rel=r_associated | relid=0 | w=80
  534. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neurodevelopmental disorder
    n1=S.E.P. | n2=en:neurodevelopmental disorder | rel=r_associated | relid=0 | w=80
  535. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neurofibromatosis
    n1=S.E.P. | n2=en:neurofibromatosis | rel=r_associated | relid=0 | w=80
  536. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neurologic
    n1=S.E.P. | n2=en:neurologic | rel=r_associated | relid=0 | w=80
  537. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuromyelitis optica
    n1=S.E.P. | n2=en:neuromyelitis optica | rel=r_associated | relid=0 | w=80
  538. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuronal intestinal pseudoobstruction
    n1=S.E.P. | n2=en:neuronal intestinal pseudoobstruction | rel=r_associated | relid=0 | w=80
  539. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuronitis
    n1=S.E.P. | n2=en:neuronitis | rel=r_associated | relid=0 | w=80
  540. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuropathy
    n1=S.E.P. | n2=en:neuropathy | rel=r_associated | relid=0 | w=80
  541. S.E.P. -- r_associated #0: 80 / 0.34 -> en:neuropathy of lower limb
    n1=S.E.P. | n2=en:neuropathy of lower limb | rel=r_associated | relid=0 | w=80
  542. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nevus/mole
    n1=S.E.P. | n2=en:nevus/mole | rel=r_associated | relid=0 | w=80
  543. S.E.P. -- r_associated #0: 80 / 0.34 -> en:no disease
    n1=S.E.P. | n2=en:no disease | rel=r_associated | relid=0 | w=80
  544. S.E.P. -- r_associated #0: 80 / 0.34 -> en:no neurologic abnormalities
    n1=S.E.P. | n2=en:no neurologic abnormalities | rel=r_associated | relid=0 | w=80
  545. S.E.P. -- r_associated #0: 80 / 0.34 -> en:non-gonococcal urethritis
    n1=S.E.P. | n2=en:non-gonococcal urethritis | rel=r_associated | relid=0 | w=80
  546. S.E.P. -- r_associated #0: 80 / 0.34 -> en:non-neoplastic brain disorder
    n1=S.E.P. | n2=en:non-neoplastic brain disorder | rel=r_associated | relid=0 | w=80
  547. S.E.P. -- r_associated #0: 80 / 0.34 -> en:non-neoplastic peripheral nervous system disorder
    n1=S.E.P. | n2=en:non-neoplastic peripheral nervous system disorder | rel=r_associated | relid=0 | w=80
  548. S.E.P. -- r_associated #0: 80 / 0.34 -> en:normal delivery liveborn
    n1=S.E.P. | n2=en:normal delivery liveborn | rel=r_associated | relid=0 | w=80
  549. S.E.P. -- r_associated #0: 80 / 0.34 -> en:normal early motor milestones
    n1=S.E.P. | n2=en:normal early motor milestones | rel=r_associated | relid=0 | w=80
  550. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nursing therapy
    n1=S.E.P. | n2=en:nursing therapy | rel=r_associated | relid=0 | w=80
  551. S.E.P. -- r_associated #0: 80 / 0.34 -> en:nutritional management
    n1=S.E.P. | n2=en:nutritional management | rel=r_associated | relid=0 | w=80
  552. S.E.P. -- r_associated #0: 80 / 0.34 -> en:obtundation
    n1=S.E.P. | n2=en:obtundation | rel=r_associated | relid=0 | w=80
  553. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ocular foreign body
    n1=S.E.P. | n2=en:ocular foreign body | rel=r_associated | relid=0 | w=80
  554. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ocular motility disorders
    n1=S.E.P. | n2=en:ocular motility disorders | rel=r_associated | relid=0 | w=80
  555. S.E.P. -- r_associated #0: 80 / 0.34 -> en:oculogyric crisis
    n1=S.E.P. | n2=en:oculogyric crisis | rel=r_associated | relid=0 | w=80
  556. S.E.P. -- r_associated #0: 80 / 0.34 -> en:oculovestibuloauditory syndrome
    n1=S.E.P. | n2=en:oculovestibuloauditory syndrome | rel=r_associated | relid=0 | w=80
  557. S.E.P. -- r_associated #0: 80 / 0.34 -> en:oncocytic neoplasm
    n1=S.E.P. | n2=en:oncocytic neoplasm | rel=r_associated | relid=0 | w=80
  558. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ophthalmia, sympathetic
    n1=S.E.P. | n2=en:ophthalmia, sympathetic | rel=r_associated | relid=0 | w=80
  559. S.E.P. -- r_associated #0: 80 / 0.34 -> en:optic neuropathy
    n1=S.E.P. | n2=en:optic neuropathy | rel=r_associated | relid=0 | w=80
  560. S.E.P. -- r_associated #0: 80 / 0.34 -> en:opticospinal multiple sclerosis
    n1=S.E.P. | n2=en:opticospinal multiple sclerosis | rel=r_associated | relid=0 | w=80
  561. S.E.P. -- r_associated #0: 80 / 0.34 -> en:orthostatic proteinuria
    n1=S.E.P. | n2=en:orthostatic proteinuria | rel=r_associated | relid=0 | w=80
  562. S.E.P. -- r_associated #0: 80 / 0.34 -> en:osgood-schlatter's disease
    n1=S.E.P. | n2=en:osgood-schlatter's disease | rel=r_associated | relid=0 | w=80
  563. S.E.P. -- r_associated #0: 80 / 0.34 -> en:osteoarthritis
    n1=S.E.P. | n2=en:osteoarthritis | rel=r_associated | relid=0 | w=80
  564. S.E.P. -- r_associated #0: 80 / 0.34 -> en:osteoarthritis, spine
    n1=S.E.P. | n2=en:osteoarthritis, spine | rel=r_associated | relid=0 | w=80
  565. S.E.P. -- r_associated #0: 80 / 0.34 -> en:osteogenesis imperfecta
    n1=S.E.P. | n2=en:osteogenesis imperfecta | rel=r_associated | relid=0 | w=80
  566. S.E.P. -- r_associated #0: 80 / 0.34 -> en:osteoporosis
    n1=S.E.P. | n2=en:osteoporosis | rel=r_associated | relid=0 | w=80
  567. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other abdominal hernia
    n1=S.E.P. | n2=en:other abdominal hernia | rel=r_associated | relid=0 | w=80
  568. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other acute disseminated demyelination
    n1=S.E.P. | n2=en:other acute disseminated demyelination | rel=r_associated | relid=0 | w=80
  569. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other anaemias
    n1=S.E.P. | n2=en:other anaemias | rel=r_associated | relid=0 | w=80
  570. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other arterial obstructive/peripheral vascular disease
    n1=S.E.P. | n2=en:other arterial obstructive/peripheral vascular disease | rel=r_associated | relid=0 | w=80
  571. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other auditory injuries
    n1=S.E.P. | n2=en:other auditory injuries | rel=r_associated | relid=0 | w=80
  572. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other benign neoplasm female genital
    n1=S.E.P. | n2=en:other benign neoplasm female genital | rel=r_associated | relid=0 | w=80
  573. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other benign neoplasm of skin, unspecified
    n1=S.E.P. | n2=en:other benign neoplasm of skin, unspecified | rel=r_associated | relid=0 | w=80
  574. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other central nervous system demyelinating diseases
    n1=S.E.P. | n2=en:other central nervous system demyelinating diseases | rel=r_associated | relid=0 | w=80
  575. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other complications of the puerperium
    n1=S.E.P. | n2=en:other complications of the puerperium | rel=r_associated | relid=0 | w=80
  576. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other conditions of brain
    n1=S.E.P. | n2=en:other conditions of brain | rel=r_associated | relid=0 | w=80
  577. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other congenital malformations of eye
    n1=S.E.P. | n2=en:other congenital malformations of eye | rel=r_associated | relid=0 | w=80
  578. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other dermatologic congenital anomalies
    n1=S.E.P. | n2=en:other dermatologic congenital anomalies | rel=r_associated | relid=0 | w=80
  579. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disease blood/lymph/spleen
    n1=S.E.P. | n2=en:other disease blood/lymph/spleen | rel=r_associated | relid=0 | w=80
  580. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disease male genital including breast
    n1=S.E.P. | n2=en:other disease male genital including breast | rel=r_associated | relid=0 | w=80
  581. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disease of neurological system
    n1=S.E.P. | n2=en:other disease of neurological system | rel=r_associated | relid=0 | w=80
  582. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other diseases female genital system
    n1=S.E.P. | n2=en:other diseases female genital system | rel=r_associated | relid=0 | w=80
  583. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other diseases of digestive system
    n1=S.E.P. | n2=en:other diseases of digestive system | rel=r_associated | relid=0 | w=80
  584. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other diseases of ear/mastoid
    n1=S.E.P. | n2=en:other diseases of ear/mastoid | rel=r_associated | relid=0 | w=80
  585. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disorders of central nervous system
    n1=S.E.P. | n2=en:other disorders of central nervous system | rel=r_associated | relid=0 | w=80
  586. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disorders of eye
    n1=S.E.P. | n2=en:other disorders of eye | rel=r_associated | relid=0 | w=80
  587. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disorders of the skin and subcutaneous tissue
    n1=S.E.P. | n2=en:other disorders of the skin and subcutaneous tissue | rel=r_associated | relid=0 | w=80
  588. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other disorders of urinary system
    n1=S.E.P. | n2=en:other disorders of urinary system | rel=r_associated | relid=0 | w=80
  589. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other female genital malignant neoplasms
    n1=S.E.P. | n2=en:other female genital malignant neoplasms | rel=r_associated | relid=0 | w=80
  590. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other forms of chronic ischaemic heart disease
    n1=S.E.P. | n2=en:other forms of chronic ischaemic heart disease | rel=r_associated | relid=0 | w=80
  591. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other forms of heart disease
    n1=S.E.P. | n2=en:other forms of heart disease | rel=r_associated | relid=0 | w=80
  592. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other general/unspecified diseases
    n1=S.E.P. | n2=en:other general/unspecified diseases | rel=r_associated | relid=0 | w=80
  593. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other head injury without skull fracture
    n1=S.E.P. | n2=en:other head injury without skull fracture | rel=r_associated | relid=0 | w=80
  594. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other hematologic congenital anomalies
    n1=S.E.P. | n2=en:other hematologic congenital anomalies | rel=r_associated | relid=0 | w=80
  595. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other hematologic injuries
    n1=S.E.P. | n2=en:other hematologic injuries | rel=r_associated | relid=0 | w=80
  596. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other hematologic malignant neoplasms
    n1=S.E.P. | n2=en:other hematologic malignant neoplasms | rel=r_associated | relid=0 | w=80
  597. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other infection neurological system
    n1=S.E.P. | n2=en:other infection neurological system | rel=r_associated | relid=0 | w=80
  598. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other infection/inflammation of eye (excluding herpes)
    n1=S.E.P. | n2=en:other infection/inflammation of eye (excluding herpes) | rel=r_associated | relid=0 | w=80
  599. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other infectious diseases
    n1=S.E.P. | n2=en:other infectious diseases | rel=r_associated | relid=0 | w=80
  600. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other infectious skin disease
    n1=S.E.P. | n2=en:other infectious skin disease | rel=r_associated | relid=0 | w=80
  601. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other inflammatory and toxic neuropathy
    n1=S.E.P. | n2=en:other inflammatory and toxic neuropathy | rel=r_associated | relid=0 | w=80
  602. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other male genital malignant neoplasm
    n1=S.E.P. | n2=en:other male genital malignant neoplasm | rel=r_associated | relid=0 | w=80
  603. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other malignant neoplasm urinary tract
    n1=S.E.P. | n2=en:other malignant neoplasm urinary tract | rel=r_associated | relid=0 | w=80
  604. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other mental/psychological disorders
    n1=S.E.P. | n2=en:other mental/psychological disorders | rel=r_associated | relid=0 | w=80
  605. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other musculoskeletal disorder
    n1=S.E.P. | n2=en:other musculoskeletal disorder | rel=r_associated | relid=0 | w=80
  606. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other neurologic injuries
    n1=S.E.P. | n2=en:other neurologic injuries | rel=r_associated | relid=0 | w=80
  607. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other neurotic disorders
    n1=S.E.P. | n2=en:other neurotic disorders | rel=r_associated | relid=0 | w=80
  608. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other non-obstetrical conditions
    n1=S.E.P. | n2=en:other non-obstetrical conditions | rel=r_associated | relid=0 | w=80
  609. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other ocular injuries
    n1=S.E.P. | n2=en:other ocular injuries | rel=r_associated | relid=0 | w=80
  610. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other organic psychosis
    n1=S.E.P. | n2=en:other organic psychosis | rel=r_associated | relid=0 | w=80
  611. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other paralytic syndromes
    n1=S.E.P. | n2=en:other paralytic syndromes | rel=r_associated | relid=0 | w=80
  612. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other peptic ulcers
    n1=S.E.P. | n2=en:other peptic ulcers | rel=r_associated | relid=0 | w=80
  613. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other peripheral neuritis
    n1=S.E.P. | n2=en:other peripheral neuritis | rel=r_associated | relid=0 | w=80
  614. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other respiratory injuries
    n1=S.E.P. | n2=en:other respiratory injuries | rel=r_associated | relid=0 | w=80
  615. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other respiratory system diseases
    n1=S.E.P. | n2=en:other respiratory system diseases | rel=r_associated | relid=0 | w=80
  616. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other sensation disturbance/abnormal involuntary movement
    n1=S.E.P. | n2=en:other sensation disturbance/abnormal involuntary movement | rel=r_associated | relid=0 | w=80
  617. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other specified idiopathic peripheral neuropathy
    n1=S.E.P. | n2=en:other specified idiopathic peripheral neuropathy | rel=r_associated | relid=0 | w=80
  618. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other symptom/complaint neurological system
    n1=S.E.P. | n2=en:other symptom/complaint neurological system | rel=r_associated | relid=0 | w=80
  619. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other/unspecified neoplasm female genital
    n1=S.E.P. | n2=en:other/unspecified neoplasm female genital | rel=r_associated | relid=0 | w=80
  620. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other/unspecified neoplasm skin
    n1=S.E.P. | n2=en:other/unspecified neoplasm skin | rel=r_associated | relid=0 | w=80
  621. S.E.P. -- r_associated #0: 80 / 0.34 -> en:other/unspecified neoplasms
    n1=S.E.P. | n2=en:other/unspecified neoplasms | rel=r_associated | relid=0 | w=80
  622. S.E.P. -- r_associated #0: 80 / 0.34 -> en:otitis externa
    n1=S.E.P. | n2=en:otitis externa | rel=r_associated | relid=0 | w=80
  623. S.E.P. -- r_associated #0: 80 / 0.34 -> en:overlap syndrome
    n1=S.E.P. | n2=en:overlap syndrome | rel=r_associated | relid=0 | w=80
  624. S.E.P. -- r_associated #0: 80 / 0.34 -> en:overweight
    n1=S.E.P. | n2=en:overweight | rel=r_associated | relid=0 | w=80
  625. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pain
    n1=S.E.P. | n2=en:pain | rel=r_associated | relid=0 | w=80
  626. S.E.P. -- r_associated #0: 80 / 0.34 -> en:paralysis
    n1=S.E.P. | n2=en:paralysis | rel=r_associated | relid=0 | w=80
  627. S.E.P. -- r_associated #0: 80 / 0.34 -> en:paralysis/weakness (excluding a04)
    n1=S.E.P. | n2=en:paralysis/weakness (excluding a04) | rel=r_associated | relid=0 | w=80
  628. S.E.P. -- r_associated #0: 80 / 0.34 -> en:paraneoplastic polyneuropathy
    n1=S.E.P. | n2=en:paraneoplastic polyneuropathy | rel=r_associated | relid=0 | w=80
  629. S.E.P. -- r_associated #0: 80 / 0.34 -> en:paraplegia
    n1=S.E.P. | n2=en:paraplegia | rel=r_associated | relid=0 | w=80
  630. S.E.P. -- r_associated #0: 80 / 0.34 -> en:parasitology
    n1=S.E.P. | n2=en:parasitology | rel=r_associated | relid=0 | w=80
  631. S.E.P. -- r_associated #0: 80 / 0.34 -> en:parkinson's disease
    n1=S.E.P. | n2=en:parkinson's disease | rel=r_associated | relid=0 | w=80
  632. S.E.P. -- r_associated #0: 80 / 0.34 -> en:parkinsonism
    n1=S.E.P. | n2=en:parkinsonism | rel=r_associated | relid=0 | w=80
  633. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pathological aspects
    n1=S.E.P. | n2=en:pathological aspects | rel=r_associated | relid=0 | w=80
  634. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pediatric adverse events terminology
    n1=S.E.P. | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=80
  635. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections
    n1=S.E.P. | n2=en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections | rel=r_associated | relid=0 | w=80
  636. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pediatric terminology
    n1=S.E.P. | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=80
  637. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pediculosis/other skin infestation
    n1=S.E.P. | n2=en:pediculosis/other skin infestation | rel=r_associated | relid=0 | w=80
  638. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pelvic inflammatory disease
    n1=S.E.P. | n2=en:pelvic inflammatory disease | rel=r_associated | relid=0 | w=80
  639. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pemphigus
    n1=S.E.P. | n2=en:pemphigus | rel=r_associated | relid=0 | w=80
  640. S.E.P. -- r_associated #0: 80 / 0.34 -> en:perinatal mortality
    n1=S.E.P. | n2=en:perinatal mortality | rel=r_associated | relid=0 | w=80
  641. S.E.P. -- r_associated #0: 80 / 0.34 -> en:perinatal subependymal hemorrhage
    n1=S.E.P. | n2=en:perinatal subependymal hemorrhage | rel=r_associated | relid=0 | w=80
  642. S.E.P. -- r_associated #0: 80 / 0.34 -> en:perineural cyst
    n1=S.E.P. | n2=en:perineural cyst | rel=r_associated | relid=0 | w=80
  643. S.E.P. -- r_associated #0: 80 / 0.34 -> en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome
    n1=S.E.P. | n2=en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome | rel=r_associated | relid=0 | w=80
  644. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral axonal neuropathy
    n1=S.E.P. | n2=en:peripheral axonal neuropathy | rel=r_associated | relid=0 | w=80
  645. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral motor neuropathy
    n1=S.E.P. | n2=en:peripheral motor neuropathy | rel=r_associated | relid=0 | w=80
  646. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral nerve decompression injury
    n1=S.E.P. | n2=en:peripheral nerve decompression injury | rel=r_associated | relid=0 | w=80
  647. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral nerve injury
    n1=S.E.P. | n2=en:peripheral nerve injury | rel=r_associated | relid=0 | w=80
  648. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral nervous system
    n1=S.E.P. | n2=en:peripheral nervous system | rel=r_associated | relid=0 | w=80
  649. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral nervous system disorder
    n1=S.E.P. | n2=en:peripheral nervous system disorder | rel=r_associated | relid=0 | w=80
  650. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral nervous system infectious disorder
    n1=S.E.P. | n2=en:peripheral nervous system infectious disorder | rel=r_associated | relid=0 | w=80
  651. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuralgia
    n1=S.E.P. | n2=en:peripheral neuralgia | rel=r_associated | relid=0 | w=80
  652. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuritis in pregnancy
    n1=S.E.P. | n2=en:peripheral neuritis in pregnancy | rel=r_associated | relid=0 | w=80
  653. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuritis in pregnancy, delivered, with mention of postpartum complication
    n1=S.E.P. | n2=en:peripheral neuritis in pregnancy, delivered, with mention of postpartum complication | rel=r_associated | relid=0 | w=80
  654. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuritis in pregnancy, delivered, with or without mention of antepartum condition
    n1=S.E.P. | n2=en:peripheral neuritis in pregnancy, delivered, with or without mention of antepartum condition | rel=r_associated | relid=0 | w=80
  655. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuritis in pregnancy, postpartum condition or complication
    n1=S.E.P. | n2=en:peripheral neuritis in pregnancy, postpartum condition or complication | rel=r_associated | relid=0 | w=80
  656. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuritis in pregnancy, unspecified as to episode of care or not applicable
    n1=S.E.P. | n2=en:peripheral neuritis in pregnancy, unspecified as to episode of care or not applicable | rel=r_associated | relid=0 | w=80
  657. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuropathies nec
    n1=S.E.P. | n2=en:peripheral neuropathies nec | rel=r_associated | relid=0 | w=80
  658. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuropathy - hereditary or idiopathic
    n1=S.E.P. | n2=en:peripheral neuropathy - hereditary or idiopathic | rel=r_associated | relid=0 | w=80
  659. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuropathy aggravated
    n1=S.E.P. | n2=en:peripheral neuropathy aggravated | rel=r_associated | relid=0 | w=80
  660. S.E.P. -- r_associated #0: 80 / 0.34 -> en:peripheral neuropathy due to metabolic disorder
    n1=S.E.P. | n2=en:peripheral neuropathy due to metabolic disorder | rel=r_associated | relid=0 | w=80
  661. S.E.P. -- r_associated #0: 80 / 0.34 -> en:phantom pain
    n1=S.E.P. | n2=en:phantom pain | rel=r_associated | relid=0 | w=80
  662. S.E.P. -- r_associated #0: 80 / 0.34 -> en:phlebitis and thrombophlebitis
    n1=S.E.P. | n2=en:phlebitis and thrombophlebitis | rel=r_associated | relid=0 | w=80
  663. S.E.P. -- r_associated #0: 80 / 0.34 -> en:physiopathological
    n1=S.E.P. | n2=en:physiopathological | rel=r_associated | relid=0 | w=80
  664. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pilonidal cyst/fistula
    n1=S.E.P. | n2=en:pilonidal cyst/fistula | rel=r_associated | relid=0 | w=80
  665. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pituitary gland disorder
    n1=S.E.P. | n2=en:pituitary gland disorder | rel=r_associated | relid=0 | w=80
  666. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pityriasis rosea
    n1=S.E.P. | n2=en:pityriasis rosea | rel=r_associated | relid=0 | w=80
  667. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pleural effusion
    n1=S.E.P. | n2=en:pleural effusion | rel=r_associated | relid=0 | w=80
  668. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pleurisy with pleural effusion
    n1=S.E.P. | n2=en:pleurisy with pleural effusion | rel=r_associated | relid=0 | w=80
  669. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pneumonia
    n1=S.E.P. | n2=en:pneumonia | rel=r_associated | relid=0 | w=80
  670. S.E.P. -- r_associated #0: 80 / 0.34 -> en:poems syndrome
    n1=S.E.P. | n2=en:poems syndrome | rel=r_associated | relid=0 | w=80
  671. S.E.P. -- r_associated #0: 80 / 0.34 -> en:polio and post-polio syndrome
    n1=S.E.P. | n2=en:polio and post-polio syndrome | rel=r_associated | relid=0 | w=80
  672. S.E.P. -- r_associated #0: 80 / 0.34 -> en:poliomyelitis/other enterovirus
    n1=S.E.P. | n2=en:poliomyelitis/other enterovirus | rel=r_associated | relid=0 | w=80
  673. S.E.P. -- r_associated #0: 80 / 0.34 -> en:polymyalgia rheumatica
    n1=S.E.P. | n2=en:polymyalgia rheumatica | rel=r_associated | relid=0 | w=80
  674. S.E.P. -- r_associated #0: 80 / 0.34 -> en:polyneuropathies, motor
    n1=S.E.P. | n2=en:polyneuropathies, motor | rel=r_associated | relid=0 | w=80
  675. S.E.P. -- r_associated #0: 80 / 0.34 -> en:polyneuropathy
    n1=S.E.P. | n2=en:polyneuropathy | rel=r_associated | relid=0 | w=80
  676. S.E.P. -- r_associated #0: 80 / 0.34 -> en:polyradiculoneuropathy
    n1=S.E.P. | n2=en:polyradiculoneuropathy | rel=r_associated | relid=0 | w=80
  677. S.E.P. -- r_associated #0: 80 / 0.34 -> en:polyradiculopathy
    n1=S.E.P. | n2=en:polyradiculopathy | rel=r_associated | relid=0 | w=80
  678. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pregnancy complications, infectious
    n1=S.E.P. | n2=en:pregnancy complications, infectious | rel=r_associated | relid=0 | w=80
  679. S.E.P. -- r_associated #0: 80 / 0.34 -> en:presbycusis
    n1=S.E.P. | n2=en:presbycusis | rel=r_associated | relid=0 | w=80
  680. S.E.P. -- r_associated #0: 80 / 0.34 -> en:primary health condition:find:pt:^patient:nom
    n1=S.E.P. | n2=en:primary health condition:find:pt:^patient:nom | rel=r_associated | relid=0 | w=80
  681. S.E.P. -- r_associated #0: 80 / 0.34 -> en:primary progressive multiple sclerosis
    n1=S.E.P. | n2=en:primary progressive multiple sclerosis | rel=r_associated | relid=0 | w=80
  682. S.E.P. -- r_associated #0: 80 / 0.34 -> en:primary sclerosing cholangitis
    n1=S.E.P. | n2=en:primary sclerosing cholangitis | rel=r_associated | relid=0 | w=80
  683. S.E.P. -- r_associated #0: 80 / 0.34 -> en:progressive multifocal leukoencephalopathy
    n1=S.E.P. | n2=en:progressive multifocal leukoencephalopathy | rel=r_associated | relid=0 | w=80
  684. S.E.P. -- r_associated #0: 80 / 0.34 -> en:progressive multiple sclerosis
    n1=S.E.P. | n2=en:progressive multiple sclerosis | rel=r_associated | relid=0 | w=80
  685. S.E.P. -- r_associated #0: 80 / 0.34 -> en:progressive peripheral neuropathy
    n1=S.E.P. | n2=en:progressive peripheral neuropathy | rel=r_associated | relid=0 | w=80
  686. S.E.P. -- r_associated #0: 80 / 0.34 -> en:progressive supranuclear palsy
    n1=S.E.P. | n2=en:progressive supranuclear palsy | rel=r_associated | relid=0 | w=80
  687. S.E.P. -- r_associated #0: 80 / 0.34 -> en:prostatitis/seminal vesiculitis
    n1=S.E.P. | n2=en:prostatitis/seminal vesiculitis | rel=r_associated | relid=0 | w=80
  688. S.E.P. -- r_associated #0: 80 / 0.34 -> en:psychology qualifier
    n1=S.E.P. | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=80
  689. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ptprc gene
    n1=S.E.P. | n2=en:ptprc gene | rel=r_associated | relid=0 | w=80
  690. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ptprc wt allele
    n1=S.E.P. | n2=en:ptprc wt allele | rel=r_associated | relid=0 | w=80
  691. S.E.P. -- r_associated #0: 80 / 0.34 -> en:puerperal infection/sepsis
    n1=S.E.P. | n2=en:puerperal infection/sepsis | rel=r_associated | relid=0 | w=80
  692. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pulmonary alveolar proteinosis, acquired
    n1=S.E.P. | n2=en:pulmonary alveolar proteinosis, acquired | rel=r_associated | relid=0 | w=80
  693. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pulmonary embolism
    n1=S.E.P. | n2=en:pulmonary embolism | rel=r_associated | relid=0 | w=80
  694. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pulmonary tuberculosis
    n1=S.E.P. | n2=en:pulmonary tuberculosis | rel=r_associated | relid=0 | w=80
  695. S.E.P. -- r_associated #0: 80 / 0.34 -> en:purpura/coagulation defects/abnormal platelets
    n1=S.E.P. | n2=en:purpura/coagulation defects/abnormal platelets | rel=r_associated | relid=0 | w=80
  696. S.E.P. -- r_associated #0: 80 / 0.34 -> en:pyelonephritis/pyelitis acute
    n1=S.E.P. | n2=en:pyelonephritis/pyelitis acute | rel=r_associated | relid=0 | w=80
  697. S.E.P. -- r_associated #0: 80 / 0.34 -> en:quadriplegia
    n1=S.E.P. | n2=en:quadriplegia | rel=r_associated | relid=0 | w=80
  698. S.E.P. -- r_associated #0: 80 / 0.34 -> en:radiation-induced myelopathy
    n1=S.E.P. | n2=en:radiation-induced myelopathy | rel=r_associated | relid=0 | w=80
  699. S.E.P. -- r_associated #0: 80 / 0.34 -> en:radiculopathy
    n1=S.E.P. | n2=en:radiculopathy | rel=r_associated | relid=0 | w=80
  700. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rasmussen subacute encephalitis
    n1=S.E.P. | n2=en:rasmussen subacute encephalitis | rel=r_associated | relid=0 | w=80
  701. S.E.P. -- r_associated #0: 80 / 0.34 -> en:receptor-type tyrosine-protein phosphatase c
    n1=S.E.P. | n2=en:receptor-type tyrosine-protein phosphatase c | rel=r_associated | relid=0 | w=80
  702. S.E.P. -- r_associated #0: 80 / 0.34 -> en:redundant prepuce and phimosis
    n1=S.E.P. | n2=en:redundant prepuce and phimosis | rel=r_associated | relid=0 | w=80
  703. S.E.P. -- r_associated #0: 80 / 0.34 -> en:refractive error
    n1=S.E.P. | n2=en:refractive error | rel=r_associated | relid=0 | w=80
  704. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rehabilitation aspects
    n1=S.E.P. | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=80
  705. S.E.P. -- r_associated #0: 80 / 0.34 -> en:reiter syndrome
    n1=S.E.P. | n2=en:reiter syndrome | rel=r_associated | relid=0 | w=80
  706. S.E.P. -- r_associated #0: 80 / 0.34 -> en:restless leg syndrome
    n1=S.E.P. | n2=en:restless leg syndrome | rel=r_associated | relid=0 | w=80
  707. S.E.P. -- r_associated #0: 80 / 0.34 -> en:retinal detachment
    n1=S.E.P. | n2=en:retinal detachment | rel=r_associated | relid=0 | w=80
  708. S.E.P. -- r_associated #0: 80 / 0.34 -> en:retinopathy
    n1=S.E.P. | n2=en:retinopathy | rel=r_associated | relid=0 | w=80
  709. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rett syndrome
    n1=S.E.P. | n2=en:rett syndrome | rel=r_associated | relid=0 | w=80
  710. S.E.P. -- r_associated #0: 80 / 0.34 -> en:reye syndrome
    n1=S.E.P. | n2=en:reye syndrome | rel=r_associated | relid=0 | w=80
  711. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rheumatic heart disease
    n1=S.E.P. | n2=en:rheumatic heart disease | rel=r_associated | relid=0 | w=80
  712. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rheumatoid arthritis
    n1=S.E.P. | n2=en:rheumatoid arthritis | rel=r_associated | relid=0 | w=80
  713. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rheumatoid arthritis and associated conditions
    n1=S.E.P. | n2=en:rheumatoid arthritis and associated conditions | rel=r_associated | relid=0 | w=80
  714. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rhinitis seasonal
    n1=S.E.P. | n2=en:rhinitis seasonal | rel=r_associated | relid=0 | w=80
  715. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rickets
    n1=S.E.P. | n2=en:rickets | rel=r_associated | relid=0 | w=80
  716. S.E.P. -- r_associated #0: 80 / 0.34 -> en:roentgenographic
    n1=S.E.P. | n2=en:roentgenographic | rel=r_associated | relid=0 | w=80
  717. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rotator cuff injuries
    n1=S.E.P. | n2=en:rotator cuff injuries | rel=r_associated | relid=0 | w=80
  718. S.E.P. -- r_associated #0: 80 / 0.34 -> en:rubella infection
    n1=S.E.P. | n2=en:rubella infection | rel=r_associated | relid=0 | w=80
  719. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sarcoidosis
    n1=S.E.P. | n2=en:sarcoidosis | rel=r_associated | relid=0 | w=80
  720. S.E.P. -- r_associated #0: 80 / 0.34 -> en:scabies and other acariases
    n1=S.E.P. | n2=en:scabies and other acariases | rel=r_associated | relid=0 | w=80
  721. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sciatica
    n1=S.E.P. | n2=en:sciatica | rel=r_associated | relid=0 | w=80
  722. S.E.P. -- r_associated #0: 80 / 0.34 -> en:science of ergonomics
    n1=S.E.P. | n2=en:science of ergonomics | rel=r_associated | relid=0 | w=80
  723. S.E.P. -- r_associated #0: 80 / 0.34 -> en:scleroderma
    n1=S.E.P. | n2=en:scleroderma | rel=r_associated | relid=0 | w=80
  724. S.E.P. -- r_associated #0: 80 / 0.34 -> en:scleroderma and associated disorders
    n1=S.E.P. | n2=en:scleroderma and associated disorders | rel=r_associated | relid=0 | w=80
  725. S.E.P. -- r_associated #0: 80 / 0.34 -> en:seborrheic dermatitis
    n1=S.E.P. | n2=en:seborrheic dermatitis | rel=r_associated | relid=0 | w=80
  726. S.E.P. -- r_associated #0: 80 / 0.34 -> en:secondary cerebellar degeneration
    n1=S.E.P. | n2=en:secondary cerebellar degeneration | rel=r_associated | relid=0 | w=80
  727. S.E.P. -- r_associated #0: 80 / 0.34 -> en:secondary parkinsonism
    n1=S.E.P. | n2=en:secondary parkinsonism | rel=r_associated | relid=0 | w=80
  728. S.E.P. -- r_associated #0: 80 / 0.34 -> en:secondary peripheral neuropathy
    n1=S.E.P. | n2=en:secondary peripheral neuropathy | rel=r_associated | relid=0 | w=80
  729. S.E.P. -- r_associated #0: 80 / 0.34 -> en:secondary progressive multiple sclerosis
    n1=S.E.P. | n2=en:secondary progressive multiple sclerosis | rel=r_associated | relid=0 | w=80
  730. S.E.P. -- r_associated #0: 80 / 0.34 -> en:seizure
    n1=S.E.P. | n2=en:seizure | rel=r_associated | relid=0 | w=80
  731. S.E.P. -- r_associated #0: 80 / 0.34 -> en:seizure disorder
    n1=S.E.P. | n2=en:seizure disorder | rel=r_associated | relid=0 | w=80
  732. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sensorimotor neuropathy
    n1=S.E.P. | n2=en:sensorimotor neuropathy | rel=r_associated | relid=0 | w=80
  733. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sensorimotor polyneuropathy affecting arms more than legs
    n1=S.E.P. | n2=en:sensorimotor polyneuropathy affecting arms more than legs | rel=r_associated | relid=0 | w=80
  734. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sensory disorder
    n1=S.E.P. | n2=en:sensory disorder | rel=r_associated | relid=0 | w=80
  735. S.E.P. -- r_associated #0: 80 / 0.34 -> en:seropositive rheumatoid arthritis
    n1=S.E.P. | n2=en:seropositive rheumatoid arthritis | rel=r_associated | relid=0 | w=80
  736. S.E.P. -- r_associated #0: 80 / 0.34 -> en:shoulder injuries and disorders
    n1=S.E.P. | n2=en:shoulder injuries and disorders | rel=r_associated | relid=0 | w=80
  737. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sinusitis acute/chronic
    n1=S.E.P. | n2=en:sinusitis acute/chronic | rel=r_associated | relid=0 | w=80
  738. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sjogren syndrome
    n1=S.E.P. | n2=en:sjogren syndrome | rel=r_associated | relid=0 | w=80
  739. S.E.P. -- r_associated #0: 80 / 0.34 -> en:skin autoimmune disorders nec
    n1=S.E.P. | n2=en:skin autoimmune disorders nec | rel=r_associated | relid=0 | w=80
  740. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sleep apnea
    n1=S.E.P. | n2=en:sleep apnea | rel=r_associated | relid=0 | w=80
  741. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sleep disorder
    n1=S.E.P. | n2=en:sleep disorder | rel=r_associated | relid=0 | w=80
  742. S.E.P. -- r_associated #0: 80 / 0.34 -> en:slow viral central nervous system infection
    n1=S.E.P. | n2=en:slow viral central nervous system infection | rel=r_associated | relid=0 | w=80
  743. S.E.P. -- r_associated #0: 80 / 0.34 -> en:small fiber neuropathy
    n1=S.E.P. | n2=en:small fiber neuropathy | rel=r_associated | relid=0 | w=80
  744. S.E.P. -- r_associated #0: 80 / 0.34 -> en:speech and communication disorders
    n1=S.E.P. | n2=en:speech and communication disorders | rel=r_associated | relid=0 | w=80
  745. S.E.P. -- r_associated #0: 80 / 0.34 -> en:speech and language problems in children
    n1=S.E.P. | n2=en:speech and language problems in children | rel=r_associated | relid=0 | w=80
  746. S.E.P. -- r_associated #0: 80 / 0.34 -> en:spina bifida
    n1=S.E.P. | n2=en:spina bifida | rel=r_associated | relid=0 | w=80
  747. S.E.P. -- r_associated #0: 80 / 0.34 -> en:spinal cord disorder
    n1=S.E.P. | n2=en:spinal cord disorder | rel=r_associated | relid=0 | w=80
  748. S.E.P. -- r_associated #0: 80 / 0.34 -> en:spinal cord injury
    n1=S.E.P. | n2=en:spinal cord injury | rel=r_associated | relid=0 | w=80
  749. S.E.P. -- r_associated #0: 80 / 0.34 -> en:spinal muscular atrophy
    n1=S.E.P. | n2=en:spinal muscular atrophy | rel=r_associated | relid=0 | w=80
  750. S.E.P. -- r_associated #0: 80 / 0.34 -> en:spinal stenosis
    n1=S.E.P. | n2=en:spinal stenosis | rel=r_associated | relid=0 | w=80
  751. S.E.P. -- r_associated #0: 80 / 0.34 -> en:spine injuries and disorders
    n1=S.E.P. | n2=en:spine injuries and disorders | rel=r_associated | relid=0 | w=80
  752. S.E.P. -- r_associated #0: 80 / 0.34 -> en:splenic rupture
    n1=S.E.P. | n2=en:splenic rupture | rel=r_associated | relid=0 | w=80
  753. S.E.P. -- r_associated #0: 80 / 0.34 -> en:splenomegaly
    n1=S.E.P. | n2=en:splenomegaly | rel=r_associated | relid=0 | w=80
  754. S.E.P. -- r_associated #0: 80 / 0.34 -> en:sprains and strains
    n1=S.E.P. | n2=en:sprains and strains | rel=r_associated | relid=0 | w=80
  755. S.E.P. -- r_associated #0: 80 / 0.34 -> en:stiff person syndrome
    n1=S.E.P. | n2=en:stiff person syndrome | rel=r_associated | relid=0 | w=80
  756. S.E.P. -- r_associated #0: 80 / 0.34 -> en:strabismus
    n1=S.E.P. | n2=en:strabismus | rel=r_associated | relid=0 | w=80
  757. S.E.P. -- r_associated #0: 80 / 0.34 -> en:strachan's syndrome
    n1=S.E.P. | n2=en:strachan's syndrome | rel=r_associated | relid=0 | w=80
  758. S.E.P. -- r_associated #0: 80 / 0.34 -> en:strep throat/scarlet fever
    n1=S.E.P. | n2=en:strep throat/scarlet fever | rel=r_associated | relid=0 | w=80
  759. S.E.P. -- r_associated #0: 80 / 0.34 -> en:stroke rehabilitation
    n1=S.E.P. | n2=en:stroke rehabilitation | rel=r_associated | relid=0 | w=80
  760. S.E.P. -- r_associated #0: 80 / 0.34 -> en:stump hallucination
    n1=S.E.P. | n2=en:stump hallucination | rel=r_associated | relid=0 | w=80
  761. S.E.P. -- r_associated #0: 80 / 0.34 -> en:stutter
    n1=S.E.P. | n2=en:stutter | rel=r_associated | relid=0 | w=80
  762. S.E.P. -- r_associated #0: 80 / 0.34 -> en:suicide attempt
    n1=S.E.P. | n2=en:suicide attempt | rel=r_associated | relid=0 | w=80
  763. S.E.P. -- r_associated #0: 80 / 0.34 -> en:surgical aspects
    n1=S.E.P. | n2=en:surgical aspects | rel=r_associated | relid=0 | w=80
  764. S.E.P. -- r_associated #0: 80 / 0.34 -> en:susac syndrome
    n1=S.E.P. | n2=en:susac syndrome | rel=r_associated | relid=0 | w=80
  765. S.E.P. -- r_associated #0: 80 / 0.34 -> en:suspected multiple sclerosis
    n1=S.E.P. | n2=en:suspected multiple sclerosis | rel=r_associated | relid=0 | w=80
  766. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syncope
    n1=S.E.P. | n2=en:syncope | rel=r_associated | relid=0 | w=80
  767. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syndrome ms-like
    n1=S.E.P. | n2=en:syndrome ms-like | rel=r_associated | relid=0 | w=80
  768. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syndrome screaming
    n1=S.E.P. | n2=en:syndrome screaming | rel=r_associated | relid=0 | w=80
  769. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syndromes, narcolepsy-cataplexy
    n1=S.E.P. | n2=en:syndromes, narcolepsy-cataplexy | rel=r_associated | relid=0 | w=80
  770. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syphilis female
    n1=S.E.P. | n2=en:syphilis female | rel=r_associated | relid=0 | w=80
  771. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syphilis male
    n1=S.E.P. | n2=en:syphilis male | rel=r_associated | relid=0 | w=80
  772. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syringomyelia
    n1=S.E.P. | n2=en:syringomyelia | rel=r_associated | relid=0 | w=80
  773. S.E.P. -- r_associated #0: 80 / 0.34 -> en:syringomyelia-like syndrome
    n1=S.E.P. | n2=en:syringomyelia-like syndrome | rel=r_associated | relid=0 | w=80
  774. S.E.P. -- r_associated #0: 80 / 0.34 -> en:systemic lupus erythematosus
    n1=S.E.P. | n2=en:systemic lupus erythematosus | rel=r_associated | relid=0 | w=80
  775. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tailbone disorders
    n1=S.E.P. | n2=en:tailbone disorders | rel=r_associated | relid=0 | w=80
  776. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tap2 gene
    n1=S.E.P. | n2=en:tap2 gene | rel=r_associated | relid=0 | w=80
  777. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tap2 wt allele
    n1=S.E.P. | n2=en:tap2 wt allele | rel=r_associated | relid=0 | w=80
  778. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tay-sachs disease
    n1=S.E.P. | n2=en:tay-sachs disease | rel=r_associated | relid=0 | w=80
  779. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tension headache
    n1=S.E.P. | n2=en:tension headache | rel=r_associated | relid=0 | w=80
  780. S.E.P. -- r_associated #0: 80 / 0.34 -> en:testicular hydrocele
    n1=S.E.P. | n2=en:testicular hydrocele | rel=r_associated | relid=0 | w=80
  781. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tetanus
    n1=S.E.P. | n2=en:tetanus | rel=r_associated | relid=0 | w=80
  782. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tetany
    n1=S.E.P. | n2=en:tetany | rel=r_associated | relid=0 | w=80
  783. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thalassemia major
    n1=S.E.P. | n2=en:thalassemia major | rel=r_associated | relid=0 | w=80
  784. S.E.P. -- r_associated #0: 80 / 0.34 -> en:therapeutic aspects
    n1=S.E.P. | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=80
  785. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thoracic outlet syndrome
    n1=S.E.P. | n2=en:thoracic outlet syndrome | rel=r_associated | relid=0 | w=80
  786. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thoracoabdominal neuropathy
    n1=S.E.P. | n2=en:thoracoabdominal neuropathy | rel=r_associated | relid=0 | w=80
  787. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thrombocytopenic purpura
    n1=S.E.P. | n2=en:thrombocytopenic purpura | rel=r_associated | relid=0 | w=80
  788. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thymus disorder
    n1=S.E.P. | n2=en:thymus disorder | rel=r_associated | relid=0 | w=80
  789. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thyroglossal duct cyst
    n1=S.E.P. | n2=en:thyroglossal duct cyst | rel=r_associated | relid=0 | w=80
  790. S.E.P. -- r_associated #0: 80 / 0.34 -> en:thyrotoxicosis [hyperthyroidism]
    n1=S.E.P. | n2=en:thyrotoxicosis [hyperthyroidism] | rel=r_associated | relid=0 | w=80
  791. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tingling fingers/feet/toes
    n1=S.E.P. | n2=en:tingling fingers/feet/toes | rel=r_associated | relid=0 | w=80
  792. S.E.P. -- r_associated #0: 80 / 0.34 -> en:toe injuries and disorders
    n1=S.E.P. | n2=en:toe injuries and disorders | rel=r_associated | relid=0 | w=80
  793. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tourette syndrome
    n1=S.E.P. | n2=en:tourette syndrome | rel=r_associated | relid=0 | w=80
  794. S.E.P. -- r_associated #0: 80 / 0.34 -> en:toxemia of pregnancy
    n1=S.E.P. | n2=en:toxemia of pregnancy | rel=r_associated | relid=0 | w=80
  795. S.E.P. -- r_associated #0: 80 / 0.34 -> en:toxic oil syndrome
    n1=S.E.P. | n2=en:toxic oil syndrome | rel=r_associated | relid=0 | w=80
  796. S.E.P. -- r_associated #0: 80 / 0.34 -> en:toxoplasmosis
    n1=S.E.P. | n2=en:toxoplasmosis | rel=r_associated | relid=0 | w=80
  797. S.E.P. -- r_associated #0: 80 / 0.34 -> en:trachoma
    n1=S.E.P. | n2=en:trachoma | rel=r_associated | relid=0 | w=80
  798. S.E.P. -- r_associated #0: 80 / 0.34 -> en:transient cerebral ischemia
    n1=S.E.P. | n2=en:transient cerebral ischemia | rel=r_associated | relid=0 | w=80
  799. S.E.P. -- r_associated #0: 80 / 0.34 -> en:transient ischemic attack
    n1=S.E.P. | n2=en:transient ischemic attack | rel=r_associated | relid=0 | w=80
  800. S.E.P. -- r_associated #0: 80 / 0.34 -> en:trauma/injury problem
    n1=S.E.P. | n2=en:trauma/injury problem | rel=r_associated | relid=0 | w=80
  801. S.E.P. -- r_associated #0: 80 / 0.34 -> en:traumatic encephalopathy
    n1=S.E.P. | n2=en:traumatic encephalopathy | rel=r_associated | relid=0 | w=80
  802. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tremor
    n1=S.E.P. | n2=en:tremor | rel=r_associated | relid=0 | w=80
  803. S.E.P. -- r_associated #0: 80 / 0.34 -> en:trigeminal nerve disorder
    n1=S.E.P. | n2=en:trigeminal nerve disorder | rel=r_associated | relid=0 | w=80
  804. S.E.P. -- r_associated #0: 80 / 0.34 -> en:trigeminal neuralgia
    n1=S.E.P. | n2=en:trigeminal neuralgia | rel=r_associated | relid=0 | w=80
  805. S.E.P. -- r_associated #0: 80 / 0.34 -> en:trochlear nerve disorder
    n1=S.E.P. | n2=en:trochlear nerve disorder | rel=r_associated | relid=0 | w=80
  806. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tuberous sclerosis
    n1=S.E.P. | n2=en:tuberous sclerosis | rel=r_associated | relid=0 | w=80
  807. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tumefactive multiple sclerosis
    n1=S.E.P. | n2=en:tumefactive multiple sclerosis | rel=r_associated | relid=0 | w=80
  808. S.E.P. -- r_associated #0: 80 / 0.34 -> en:twitching
    n1=S.E.P. | n2=en:twitching | rel=r_associated | relid=0 | w=80
  809. S.E.P. -- r_associated #0: 80 / 0.34 -> en:tympanic membrane perforation
    n1=S.E.P. | n2=en:tympanic membrane perforation | rel=r_associated | relid=0 | w=80
  810. S.E.P. -- r_associated #0: 80 / 0.34 -> en:type 1 diabetes mellitus
    n1=S.E.P. | n2=en:type 1 diabetes mellitus | rel=r_associated | relid=0 | w=80
  811. S.E.P. -- r_associated #0: 80 / 0.34 -> en:type iii hypersensitivity
    n1=S.E.P. | n2=en:type iii hypersensitivity | rel=r_associated | relid=0 | w=80
  812. S.E.P. -- r_associated #0: 80 / 0.34 -> en:uhthoff's phenomenon
    n1=S.E.P. | n2=en:uhthoff's phenomenon | rel=r_associated | relid=0 | w=80
  813. S.E.P. -- r_associated #0: 80 / 0.34 -> en:ulcerative colitis-associated low-grade dysplasia
    n1=S.E.P. | n2=en:ulcerative colitis-associated low-grade dysplasia | rel=r_associated | relid=0 | w=80
  814. S.E.P. -- r_associated #0: 80 / 0.34 -> en:undescended testes
    n1=S.E.P. | n2=en:undescended testes | rel=r_associated | relid=0 | w=80
  815. S.E.P. -- r_associated #0: 80 / 0.34 -> en:undifferentiated connective tissue disease
    n1=S.E.P. | n2=en:undifferentiated connective tissue disease | rel=r_associated | relid=0 | w=80
  816. S.E.P. -- r_associated #0: 80 / 0.34 -> en:unexplained abnormal blood test
    n1=S.E.P. | n2=en:unexplained abnormal blood test | rel=r_associated | relid=0 | w=80
  817. S.E.P. -- r_associated #0: 80 / 0.34 -> en:unspecified neoplasms
    n1=S.E.P. | n2=en:unspecified neoplasms | rel=r_associated | relid=0 | w=80
  818. S.E.P. -- r_associated #0: 80 / 0.34 -> en:upper motor neuron disease
    n1=S.E.P. | n2=en:upper motor neuron disease | rel=r_associated | relid=0 | w=80
  819. S.E.P. -- r_associated #0: 80 / 0.34 -> en:urinary stone
    n1=S.E.P. | n2=en:urinary stone | rel=r_associated | relid=0 | w=80
  820. S.E.P. -- r_associated #0: 80 / 0.34 -> en:urogenital trichomoniasis proven
    n1=S.E.P. | n2=en:urogenital trichomoniasis proven | rel=r_associated | relid=0 | w=80
  821. S.E.P. -- r_associated #0: 80 / 0.34 -> en:urologic injuries
    n1=S.E.P. | n2=en:urologic injuries | rel=r_associated | relid=0 | w=80
  822. S.E.P. -- r_associated #0: 80 / 0.34 -> en:use of ultrasonography
    n1=S.E.P. | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=80
  823. S.E.P. -- r_associated #0: 80 / 0.34 -> en:uterovaginal prolapse
    n1=S.E.P. | n2=en:uterovaginal prolapse | rel=r_associated | relid=0 | w=80
  824. S.E.P. -- r_associated #0: 80 / 0.34 -> en:vaginitis/vulvitis nos
    n1=S.E.P. | n2=en:vaginitis/vulvitis nos | rel=r_associated | relid=0 | w=80
  825. S.E.P. -- r_associated #0: 80 / 0.34 -> en:vagus nerve disorder
    n1=S.E.P. | n2=en:vagus nerve disorder | rel=r_associated | relid=0 | w=80
  826. S.E.P. -- r_associated #0: 80 / 0.34 -> en:vanishing white matter disease
    n1=S.E.P. | n2=en:vanishing white matter disease | rel=r_associated | relid=0 | w=80
  827. S.E.P. -- r_associated #0: 80 / 0.34 -> en:viral hepatitis
    n1=S.E.P. | n2=en:viral hepatitis | rel=r_associated | relid=0 | w=80
  828. S.E.P. -- r_associated #0: 80 / 0.34 -> en:viruses
    n1=S.E.P. | n2=en:viruses | rel=r_associated | relid=0 | w=80
  829. S.E.P. -- r_associated #0: 80 / 0.34 -> en:vitamin deficiency/other nutritional/disease
    n1=S.E.P. | n2=en:vitamin deficiency/other nutritional/disease | rel=r_associated | relid=0 | w=80
  830. S.E.P. -- r_associated #0: 80 / 0.34 -> en:voice disorder
    n1=S.E.P. | n2=en:voice disorder | rel=r_associated | relid=0 | w=80
  831. S.E.P. -- r_associated #0: 80 / 0.34 -> en:west nile viral infection
    n1=S.E.P. | n2=en:west nile viral infection | rel=r_associated | relid=0 | w=80
  832. S.E.P. -- r_associated #0: 80 / 0.34 -> en:white blood cell abnormality
    n1=S.E.P. | n2=en:white blood cell abnormality | rel=r_associated | relid=0 | w=80
  833. S.E.P. -- r_associated #0: 80 / 0.34 -> encéphalomyélite myalgique bénigne
    n1=S.E.P. | n2=encéphalomyélite myalgique bénigne | rel=r_associated | relid=0 | w=80
  834. S.E.P. -- r_associated #0: 80 / 0.34 -> encéphalopathie
    n1=S.E.P. | n2=encéphalopathie | rel=r_associated | relid=0 | w=80
  835. S.E.P. -- r_associated #0: 80 / 0.34 -> encéphalopathie alcoolique
    n1=S.E.P. | n2=encéphalopathie alcoolique | rel=r_associated | relid=0 | w=80
  836. S.E.P. -- r_associated #0: 80 / 0.34 -> encéphalopathie toxique
    n1=S.E.P. | n2=encéphalopathie toxique | rel=r_associated | relid=0 | w=80
  837. S.E.P. -- r_associated #0: 80 / 0.34 -> fibre nerveuse
    n1=S.E.P. | n2=fibre nerveuse | rel=r_associated | relid=0 | w=80
  838. S.E.P. -- r_associated #0: 80 / 0.34 -> forme progressive primaire
    n1=S.E.P. | n2=forme progressive primaire | rel=r_associated | relid=0 | w=80
  839. S.E.P. -- r_associated #0: 80 / 0.34 -> forme progressive secondaire
    n1=S.E.P. | n2=forme progressive secondaire | rel=r_associated | relid=0 | w=80
  840. S.E.P. -- r_associated #0: 80 / 0.34 -> forme récurrente-rémittente
    n1=S.E.P. | n2=forme récurrente-rémittente | rel=r_associated | relid=0 | w=80
  841. S.E.P. -- r_associated #0: 80 / 0.34 -> handicap
    n1=S.E.P. | n2=handicap | rel=r_associated | relid=0 | w=80
  842. S.E.P. -- r_associated #0: 80 / 0.34 -> handicap moteur
    n1=S.E.P. | n2=handicap moteur | rel=r_associated | relid=0 | w=80
  843. S.E.P. -- r_associated #0: 80 / 0.34 -> hypersignal T2
    n1=S.E.P. | n2=hypersignal T2 | rel=r_associated | relid=0 | w=80
  844. S.E.P. -- r_associated #0: 80 / 0.34 -> incurable
    n1=S.E.P. | n2=incurable | rel=r_associated | relid=0 | w=80
  845. S.E.P. -- r_associated #0: 80 / 0.34 -> IRM
    n1=S.E.P. | n2=IRM | rel=r_associated | relid=0 | w=80
  846. S.E.P. -- r_associated #0: 80 / 0.34 -> lésion
    n1=S.E.P. | n2=lésion | rel=r_associated | relid=0 | w=80
  847. S.E.P. -- r_associated #0: 80 / 0.34 -> lésion
    (médecine)
    n1=S.E.P. | n2=lésion
    (médecine)
    | rel=r_associated | relid=0 | w=80
  848. S.E.P. -- r_associated #0: 80 / 0.34 -> leucomyélite ascendante aiguë
    n1=S.E.P. | n2=leucomyélite ascendante aiguë | rel=r_associated | relid=0 | w=80
  849. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie
    n1=S.E.P. | n2=maladie | rel=r_associated | relid=0 | w=80
  850. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie auto-immune
    n1=S.E.P. | n2=maladie auto-immune | rel=r_associated | relid=0 | w=80
  851. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie dégénérative
    n1=S.E.P. | n2=maladie dégénérative | rel=r_associated | relid=0 | w=80
  852. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie du système nerveux
    n1=S.E.P. | n2=maladie du système nerveux | rel=r_associated | relid=0 | w=80
  853. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie du système nerveux central
    n1=S.E.P. | n2=maladie du système nerveux central | rel=r_associated | relid=0 | w=80
  854. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie nerveuse
    n1=S.E.P. | n2=maladie nerveuse | rel=r_associated | relid=0 | w=80
  855. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie neuro-dégénérative
    n1=S.E.P. | n2=maladie neuro-dégénérative | rel=r_associated | relid=0 | w=80
  856. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie neurologique
    n1=S.E.P. | n2=maladie neurologique | rel=r_associated | relid=0 | w=80
  857. S.E.P. -- r_associated #0: 80 / 0.34 -> maladie
    (médecine)
    n1=S.E.P. | n2=maladie
    (médecine)
    | rel=r_associated | relid=0 | w=80
  858. S.E.P. -- r_associated #0: 80 / 0.34 -> maladies
    n1=S.E.P. | n2=maladies | rel=r_associated | relid=0 | w=80
  859. S.E.P. -- r_associated #0: 80 / 0.34 -> Médecine
    n1=S.E.P. | n2=Médecine | rel=r_associated | relid=0 | w=80
  860. S.E.P. -- r_associated #0: 80 / 0.34 -> méningo-encéphalite
    n1=S.E.P. | n2=méningo-encéphalite | rel=r_associated | relid=0 | w=80
  861. S.E.P. -- r_associated #0: 80 / 0.34 -> méningoencéphalite
    n1=S.E.P. | n2=méningoencéphalite | rel=r_associated | relid=0 | w=80
  862. S.E.P. -- r_associated #0: 80 / 0.34 -> méningomyélite
    n1=S.E.P. | n2=méningomyélite | rel=r_associated | relid=0 | w=80
  863. S.E.P. -- r_associated #0: 80 / 0.34 -> MS
    n1=S.E.P. | n2=MS | rel=r_associated | relid=0 | w=80
  864. S.E.P. -- r_associated #0: 80 / 0.34 -> myélite aiguë diffuse
    n1=S.E.P. | n2=myélite aiguë diffuse | rel=r_associated | relid=0 | w=80
  865. S.E.P. -- r_associated #0: 80 / 0.34 -> myélite ascendante aiguë
    n1=S.E.P. | n2=myélite ascendante aiguë | rel=r_associated | relid=0 | w=80
  866. S.E.P. -- r_associated #0: 80 / 0.34 -> myélite nécrosante subaigüe
    n1=S.E.P. | n2=myélite nécrosante subaigüe | rel=r_associated | relid=0 | w=80
  867. S.E.P. -- r_associated #0: 80 / 0.34 -> myélite transverse aiguë
    n1=S.E.P. | n2=myélite transverse aiguë | rel=r_associated | relid=0 | w=80
  868. S.E.P. -- r_associated #0: 80 / 0.34 -> myélite transverse aigüe
    n1=S.E.P. | n2=myélite transverse aigüe | rel=r_associated | relid=0 | w=80
  869. S.E.P. -- r_associated #0: 80 / 0.34 -> neurodégénérative
    n1=S.E.P. | n2=neurodégénérative | rel=r_associated | relid=0 | w=80
  870. S.E.P. -- r_associated #0: 80 / 0.34 -> neurologie
    n1=S.E.P. | n2=neurologie | rel=r_associated | relid=0 | w=80
  871. S.E.P. -- r_associated #0: 80 / 0.34 -> neuropathie
    n1=S.E.P. | n2=neuropathie | rel=r_associated | relid=0 | w=80
  872. S.E.P. -- r_associated #0: 80 / 0.34 -> nosologie
    n1=S.E.P. | n2=nosologie | rel=r_associated | relid=0 | w=80
  873. S.E.P. -- r_associated #0: 80 / 0.34 -> paralysie faciale
    n1=S.E.P. | n2=paralysie faciale | rel=r_associated | relid=0 | w=80
  874. S.E.P. -- r_associated #0: 80 / 0.34 -> plaque
    n1=S.E.P. | n2=plaque | rel=r_associated | relid=0 | w=80
  875. S.E.P. -- r_associated #0: 80 / 0.34 -> plaques
    n1=S.E.P. | n2=plaques | rel=r_associated | relid=0 | w=80
  876. S.E.P. -- r_associated #0: 80 / 0.34 -> poussée
    (médecine)
    n1=S.E.P. | n2=poussée
    (médecine)
    | rel=r_associated | relid=0 | w=80
  877. S.E.P. -- r_associated #0: 80 / 0.34 -> sciences
    n1=S.E.P. | n2=sciences | rel=r_associated | relid=0 | w=80
  878. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose
    n1=S.E.P. | n2=sclérose | rel=r_associated | relid=0 | w=80
  879. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose disséminée
    n1=S.E.P. | n2=sclérose disséminée | rel=r_associated | relid=0 | w=80
  880. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose en plaques de la moelle épinière
    n1=S.E.P. | n2=sclérose en plaques de la moelle épinière | rel=r_associated | relid=0 | w=80
  881. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose en plaques disséminée
    n1=S.E.P. | n2=sclérose en plaques disséminée | rel=r_associated | relid=0 | w=80
  882. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose en plaques du tronc cérébral
    n1=S.E.P. | n2=sclérose en plaques du tronc cérébral | rel=r_associated | relid=0 | w=80
  883. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose en plaques généralisée
    n1=S.E.P. | n2=sclérose en plaques généralisée | rel=r_associated | relid=0 | w=80
  884. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose multiloculaire
    n1=S.E.P. | n2=sclérose multiloculaire | rel=r_associated | relid=0 | w=80
  885. S.E.P. -- r_associated #0: 80 / 0.34 -> sclérose multiple
    n1=S.E.P. | n2=sclérose multiple | rel=r_associated | relid=0 | w=80
  886. S.E.P. -- r_associated #0: 80 / 0.34 -> sep
    n1=S.E.P. | n2=sep | rel=r_associated | relid=0 | w=80
  887. S.E.P. -- r_associated #0: 80 / 0.34 -> SEP
    n1=S.E.P. | n2=SEP | rel=r_associated | relid=0 | w=80
  888. S.E.P. -- r_associated #0: 80 / 0.34 -> SEP
    (sclérose en plaques)
    n1=S.E.P. | n2=SEP
    (sclérose en plaques)
    | rel=r_associated | relid=0 | w=80
  889. S.E.P. -- r_associated #0: 80 / 0.34 -> substance blanche
    n1=S.E.P. | n2=substance blanche | rel=r_associated | relid=0 | w=80
  890. S.E.P. -- r_associated #0: 80 / 0.34 -> système nerveux central
    n1=S.E.P. | n2=système nerveux central | rel=r_associated | relid=0 | w=80
  891. S.E.P. -- r_associated #0: 80 / 0.34 -> trouble de l'humeur
    n1=S.E.P. | n2=trouble de l'humeur | rel=r_associated | relid=0 | w=80
  892. S.E.P. -- r_associated #0: 80 / 0.34 -> trouble neurologique
    n1=S.E.P. | n2=trouble neurologique | rel=r_associated | relid=0 | w=80
  893. S.E.P. -- r_associated #0: 75 / 0.319 -> processus pathologique
    n1=S.E.P. | n2=processus pathologique | rel=r_associated | relid=0 | w=75
  894. S.E.P. -- r_associated #0: 70 / 0.298 -> maladie neurodégénérative
    n1=S.E.P. | n2=maladie neurodégénérative | rel=r_associated | relid=0 | w=70
  895. S.E.P. -- r_associated #0: 70 / 0.298 -> neurosciences
    n1=S.E.P. | n2=neurosciences | rel=r_associated | relid=0 | w=70
  896. S.E.P. -- r_associated #0: 65 / 0.277 -> en:multiple sclerosis
    n1=S.E.P. | n2=en:multiple sclerosis | rel=r_associated | relid=0 | w=65
  897. S.E.P. -- r_associated #0: 59 / 0.251 -> en:focal sclerosis
    n1=S.E.P. | n2=en:focal sclerosis | rel=r_associated | relid=0 | w=59
  898. S.E.P. -- r_associated #0: 55 / 0.234 -> médecine
    (science)
    n1=S.E.P. | n2=médecine
    (science)
    | rel=r_associated | relid=0 | w=55
  899. S.E.P. -- r_associated #0: 55 / 0.234 -> sclérose en plaque
    n1=S.E.P. | n2=sclérose en plaque | rel=r_associated | relid=0 | w=55
  900. S.E.P. -- r_associated #0: 54 / 0.23 -> en:disseminated sclerosis
    n1=S.E.P. | n2=en:disseminated sclerosis | rel=r_associated | relid=0 | w=54
  901. S.E.P. -- r_associated #0: 52 / 0.221 -> en:msc
    n1=S.E.P. | n2=en:msc | rel=r_associated | relid=0 | w=52
  902. S.E.P. -- r_associated #0: 51 / 0.217 -> rare
    n1=S.E.P. | n2=rare | rel=r_associated | relid=0 | w=51
  903. S.E.P. -- r_associated #0: 50 / 0.213 -> Sclérose
    n1=S.E.P. | n2=Sclérose | rel=r_associated | relid=0 | w=50
  904. S.E.P. -- r_associated #0: 49 / 0.209 -> en:mississippi
    n1=S.E.P. | n2=en:mississippi | rel=r_associated | relid=0 | w=49
  905. S.E.P. -- r_associated #0: 49 / 0.209 -> en:motor disability
    n1=S.E.P. | n2=en:motor disability | rel=r_associated | relid=0 | w=49
  906. S.E.P. -- r_associated #0: 49 / 0.209 -> en:MS
    n1=S.E.P. | n2=en:MS | rel=r_associated | relid=0 | w=49
  907. S.E.P. -- r_associated #0: 47 / 0.2 -> en:insular sclerosis
    n1=S.E.P. | n2=en:insular sclerosis | rel=r_associated | relid=0 | w=47
  908. S.E.P. -- r_associated #0: 47 / 0.2 -> en:sm
    n1=S.E.P. | n2=en:sm | rel=r_associated | relid=0 | w=47
  909. S.E.P. -- r_associated #0: 47 / 0.2 -> MatC
    n1=S.E.P. | n2=MatC | rel=r_associated | relid=0 | w=47
  910. S.E.P. -- r_associated #0: 47 / 0.2 -> sclérose combinée de la moelle (syndrome de)
    n1=S.E.P. | n2=sclérose combinée de la moelle (syndrome de) | rel=r_associated | relid=0 | w=47
  911. S.E.P. -- r_associated #0: 46 / 0.196 -> en:miss.
    n1=S.E.P. | n2=en:miss. | rel=r_associated | relid=0 | w=46
  912. S.E.P. -- r_associated #0: 45 / 0.191 -> en:abnormal urine test result
    n1=S.E.P. | n2=en:abnormal urine test result | rel=r_associated | relid=0 | w=45
  913. S.E.P. -- r_associated #0: 45 / 0.191 -> en:acquired deformity of limb
    n1=S.E.P. | n2=en:acquired deformity of limb | rel=r_associated | relid=0 | w=45
  914. S.E.P. -- r_associated #0: 45 / 0.191 -> en:acute disseminated encephalomyelitis
    n1=S.E.P. | n2=en:acute disseminated encephalomyelitis | rel=r_associated | relid=0 | w=45
  915. S.E.P. -- r_associated #0: 45 / 0.191 -> en:acute motor and sensory axonal neuropathy
    n1=S.E.P. | n2=en:acute motor and sensory axonal neuropathy | rel=r_associated | relid=0 | w=45
  916. S.E.P. -- r_associated #0: 45 / 0.191 -> en:adenomatous polyp
    n1=S.E.P. | n2=en:adenomatous polyp | rel=r_associated | relid=0 | w=45
  917. S.E.P. -- r_associated #0: 45 / 0.191 -> en:alzheimer's disease
    n1=S.E.P. | n2=en:alzheimer's disease | rel=r_associated | relid=0 | w=45
  918. S.E.P. -- r_associated #0: 45 / 0.191 -> en:anti-nmda receptor encephalitis
    n1=S.E.P. | n2=en:anti-nmda receptor encephalitis | rel=r_associated | relid=0 | w=45
  919. S.E.P. -- r_associated #0: 45 / 0.191 -> en:arteriovenous hemangioma
    n1=S.E.P. | n2=en:arteriovenous hemangioma | rel=r_associated | relid=0 | w=45
  920. S.E.P. -- r_associated #0: 45 / 0.191 -> en:autoimmune hypophysitis
    n1=S.E.P. | n2=en:autoimmune hypophysitis | rel=r_associated | relid=0 | w=45
  921. S.E.P. -- r_associated #0: 45 / 0.191 -> en:autoimmune liver disease
    n1=S.E.P. | n2=en:autoimmune liver disease | rel=r_associated | relid=0 | w=45
  922. S.E.P. -- r_associated #0: 45 / 0.191 -> en:autonomic dysfunction, variable
    n1=S.E.P. | n2=en:autonomic dysfunction, variable | rel=r_associated | relid=0 | w=45
  923. S.E.P. -- r_associated #0: 45 / 0.191 -> en:autonomic nervous system disorders
    n1=S.E.P. | n2=en:autonomic nervous system disorders | rel=r_associated | relid=0 | w=45
  924. S.E.P. -- r_associated #0: 45 / 0.191 -> en:band sensation
    n1=S.E.P. | n2=en:band sensation | rel=r_associated | relid=0 | w=45
  925. S.E.P. -- r_associated #0: 45 / 0.191 -> en:benign digestive system neoplasm
    n1=S.E.P. | n2=en:benign digestive system neoplasm | rel=r_associated | relid=0 | w=45
  926. S.E.P. -- r_associated #0: 45 / 0.191 -> en:binswanger's encephalopathy
    n1=S.E.P. | n2=en:binswanger's encephalopathy | rel=r_associated | relid=0 | w=45
  927. S.E.P. -- r_associated #0: 45 / 0.191 -> en:blau syndrome
    n1=S.E.P. | n2=en:blau syndrome | rel=r_associated | relid=0 | w=45
  928. S.E.P. -- r_associated #0: 45 / 0.191 -> en:brain and nerves
    n1=S.E.P. | n2=en:brain and nerves | rel=r_associated | relid=0 | w=45
  929. S.E.P. -- r_associated #0: 45 / 0.191 -> en:brain neoplasm
    n1=S.E.P. | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=45
  930. S.E.P. -- r_associated #0: 45 / 0.191 -> en:central pain syndrome
    n1=S.E.P. | n2=en:central pain syndrome | rel=r_associated | relid=0 | w=45
  931. S.E.P. -- r_associated #0: 45 / 0.191 -> en:cervical disorder
    n1=S.E.P. | n2=en:cervical disorder | rel=r_associated | relid=0 | w=45
  932. S.E.P. -- r_associated #0: 45 / 0.191 -> en:chemotherapy-induced peripheral neuropathy
    n1=S.E.P. | n2=en:chemotherapy-induced peripheral neuropathy | rel=r_associated | relid=0 | w=45
  933. S.E.P. -- r_associated #0: 45 / 0.191 -> en:childhood brain neoplasm
    n1=S.E.P. | n2=en:childhood brain neoplasm | rel=r_associated | relid=0 | w=45
  934. S.E.P. -- r_associated #0: 45 / 0.191 -> en:chronic sensorineural polyneuropathy
    n1=S.E.P. | n2=en:chronic sensorineural polyneuropathy | rel=r_associated | relid=0 | w=45
  935. S.E.P. -- r_associated #0: 45 / 0.191 -> en:clinically isolated syndrome
    n1=S.E.P. | n2=en:clinically isolated syndrome | rel=r_associated | relid=0 | w=45
  936. S.E.P. -- r_associated #0: 45 / 0.191 -> en:dementia senile/alzheimer
    n1=S.E.P. | n2=en:dementia senile/alzheimer | rel=r_associated | relid=0 | w=45
  937. S.E.P. -- r_associated #0: 45 / 0.191 -> en:diabetes mellitus
    n1=S.E.P. | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=45
  938. S.E.P. -- r_associated #0: 45 / 0.191 -> en:diagnosis aspect
    n1=S.E.P. | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=45
  939. S.E.P. -- r_associated #0: 45 / 0.191 -> en:disseminated or multiple sclerosis nos
    n1=S.E.P. | n2=en:disseminated or multiple sclerosis nos | rel=r_associated | relid=0 | w=45
  940. S.E.P. -- r_associated #0: 45 / 0.191 -> en:disseminated or multiple sclerosis, cord
    n1=S.E.P. | n2=en:disseminated or multiple sclerosis, cord | rel=r_associated | relid=0 | w=45
  941. S.E.P. -- r_associated #0: 45 / 0.191 -> en:dizziness adverse event
    n1=S.E.P. | n2=en:dizziness adverse event | rel=r_associated | relid=0 | w=45
  942. S.E.P. -- r_associated #0: 45 / 0.191 -> en:dystonia disorders
    n1=S.E.P. | n2=en:dystonia disorders | rel=r_associated | relid=0 | w=45
  943. S.E.P. -- r_associated #0: 45 / 0.191 -> en:effect prosthetic device
    n1=S.E.P. | n2=en:effect prosthetic device | rel=r_associated | relid=0 | w=45
  944. S.E.P. -- r_associated #0: 45 / 0.191 -> en:esophageal disorder
    n1=S.E.P. | n2=en:esophageal disorder | rel=r_associated | relid=0 | w=45
  945. S.E.P. -- r_associated #0: 45 / 0.191 -> en:excessive cerumen
    n1=S.E.P. | n2=en:excessive cerumen | rel=r_associated | relid=0 | w=45
  946. S.E.P. -- r_associated #0: 45 / 0.191 -> en:exposure as collected domain
    n1=S.E.P. | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=45
  947. S.E.P. -- r_associated #0: 45 / 0.191 -> en:f8 gene
    n1=S.E.P. | n2=en:f8 gene | rel=r_associated | relid=0 | w=45
  948. S.E.P. -- r_associated #0: 45 / 0.191 -> en:facial injuries and disorders
    n1=S.E.P. | n2=en:facial injuries and disorders | rel=r_associated | relid=0 | w=45
  949. S.E.P. -- r_associated #0: 45 / 0.191 -> en:foot health
    n1=S.E.P. | n2=en:foot health | rel=r_associated | relid=0 | w=45
  950. S.E.P. -- r_associated #0: 45 / 0.191 -> en:fracture of tibia and fibula
    n1=S.E.P. | n2=en:fracture of tibia and fibula | rel=r_associated | relid=0 | w=45
  951. S.E.P. -- r_associated #0: 45 / 0.191 -> en:ganglion joint/tendon
    n1=S.E.P. | n2=en:ganglion joint/tendon | rel=r_associated | relid=0 | w=45
  952. S.E.P. -- r_associated #0: 45 / 0.191 -> en:guillain-barre syndrome
    n1=S.E.P. | n2=en:guillain-barre syndrome | rel=r_associated | relid=0 | w=45
  953. S.E.P. -- r_associated #0: 45 / 0.191 -> en:headache, primary thunderclap
    n1=S.E.P. | n2=en:headache, primary thunderclap | rel=r_associated | relid=0 | w=45
  954. S.E.P. -- r_associated #0: 45 / 0.191 -> en:hepatitis c infection
    n1=S.E.P. | n2=en:hepatitis c infection | rel=r_associated | relid=0 | w=45
  955. S.E.P. -- r_associated #0: 45 / 0.191 -> en:high pressure neurological syndrome
    n1=S.E.P. | n2=en:high pressure neurological syndrome | rel=r_associated | relid=0 | w=45
  956. S.E.P. -- r_associated #0: 45 / 0.191 -> en:hypertrophy of tonsils and adenoids
    n1=S.E.P. | n2=en:hypertrophy of tonsils and adenoids | rel=r_associated | relid=0 | w=45
  957. S.E.P. -- r_associated #0: 45 / 0.191 -> en:hypospadias
    n1=S.E.P. | n2=en:hypospadias | rel=r_associated | relid=0 | w=45
  958. S.E.P. -- r_associated #0: 45 / 0.191 -> en:idiopathic neuropathy
    n1=S.E.P. | n2=en:idiopathic neuropathy | rel=r_associated | relid=0 | w=45
  959. S.E.P. -- r_associated #0: 45 / 0.191 -> en:impetigo
    n1=S.E.P. | n2=en:impetigo | rel=r_associated | relid=0 | w=45
  960. S.E.P. -- r_associated #0: 45 / 0.191 -> en:in blood
    n1=S.E.P. | n2=en:in blood | rel=r_associated | relid=0 | w=45
  961. S.E.P. -- r_associated #0: 45 / 0.191 -> en:infectious disease circulatory system
    n1=S.E.P. | n2=en:infectious disease circulatory system | rel=r_associated | relid=0 | w=45
  962. S.E.P. -- r_associated #0: 45 / 0.191 -> en:influenza (proven) without pneumonia
    n1=S.E.P. | n2=en:influenza (proven) without pneumonia | rel=r_associated | relid=0 | w=45
  963. S.E.P. -- r_associated #0: 45 / 0.191 -> en:insomnia
    n1=S.E.P. | n2=en:insomnia | rel=r_associated | relid=0 | w=45
  964. S.E.P. -- r_associated #0: 45 / 0.191 -> en:interleukin-17a
    n1=S.E.P. | n2=en:interleukin-17a | rel=r_associated | relid=0 | w=45
  965. S.E.P. -- r_associated #0: 45 / 0.191 -> en:intracranial hypertension
    n1=S.E.P. | n2=en:intracranial hypertension | rel=r_associated | relid=0 | w=45
  966. S.E.P. -- r_associated #0: 45 / 0.191 -> en:late effect of trauma
    n1=S.E.P. | n2=en:late effect of trauma | rel=r_associated | relid=0 | w=45
  967. S.E.P. -- r_associated #0: 45 / 0.191 -> en:lateral epicondylitis
    n1=S.E.P. | n2=en:lateral epicondylitis | rel=r_associated | relid=0 | w=45
  968. S.E.P. -- r_associated #0: 45 / 0.191 -> en:lymphatic diseases
    n1=S.E.P. | n2=en:lymphatic diseases | rel=r_associated | relid=0 | w=45
  969. S.E.P. -- r_associated #0: 45 / 0.191 -> en:malignant skin neoplasm
    n1=S.E.P. | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=45
  970. S.E.P. -- r_associated #0: 45 / 0.191 -> en:meningitis/encephalitis
    n1=S.E.P. | n2=en:meningitis/encephalitis | rel=r_associated | relid=0 | w=45
  971. S.E.P. -- r_associated #0: 45 / 0.191 -> en:mild cognitive disorder
    n1=S.E.P. | n2=en:mild cognitive disorder | rel=r_associated | relid=0 | w=45
  972. S.E.P. -- r_associated #0: 45 / 0.191 -> en:ms
    n1=S.E.P. | n2=en:ms | rel=r_associated | relid=0 | w=45
  973. S.E.P. -- r_associated #0: 45 / 0.191 -> en:multiple sclerosis, relapsing-remitting
    n1=S.E.P. | n2=en:multiple sclerosis, relapsing-remitting | rel=r_associated | relid=0 | w=45
  974. S.E.P. -- r_associated #0: 45 / 0.191 -> en:multiple sclerosis, susceptibility to
    n1=S.E.P. | n2=en:multiple sclerosis, susceptibility to | rel=r_associated | relid=0 | w=45
  975. S.E.P. -- r_associated #0: 45 / 0.191 -> en:neck injuries and disorders
    n1=S.E.P. | n2=en:neck injuries and disorders | rel=r_associated | relid=0 | w=45
  976. S.E.P. -- r_associated #0: 45 / 0.191 -> en:neoplasm of ocular adnexa
    n1=S.E.P. | n2=en:neoplasm of ocular adnexa | rel=r_associated | relid=0 | w=45
  977. S.E.P. -- r_associated #0: 45 / 0.191 -> en:neuralgia
    n1=S.E.P. | n2=en:neuralgia | rel=r_associated | relid=0 | w=45
  978. S.E.P. -- r_associated #0: 45 / 0.191 -> en:neuroblastoma
    n1=S.E.P. | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=45
  979. S.E.P. -- r_associated #0: 45 / 0.191 -> en:neuropathy of upper limb
    n1=S.E.P. | n2=en:neuropathy of upper limb | rel=r_associated | relid=0 | w=45
  980. S.E.P. -- r_associated #0: 45 / 0.191 -> en:non-rheum heart valve disease
    n1=S.E.P. | n2=en:non-rheum heart valve disease | rel=r_associated | relid=0 | w=45
  981. S.E.P. -- r_associated #0: 45 / 0.191 -> en:normal delivery deadborn
    n1=S.E.P. | n2=en:normal delivery deadborn | rel=r_associated | relid=0 | w=45
  982. S.E.P. -- r_associated #0: 45 / 0.191 -> en:oculomotor nerve disorder
    n1=S.E.P. | n2=en:oculomotor nerve disorder | rel=r_associated | relid=0 | w=45
  983. S.E.P. -- r_associated #0: 45 / 0.191 -> en:optic neuritis
    n1=S.E.P. | n2=en:optic neuritis | rel=r_associated | relid=0 | w=45
  984. S.E.P. -- r_associated #0: 45 / 0.191 -> en:osteoarthritis, knee
    n1=S.E.P. | n2=en:osteoarthritis, knee | rel=r_associated | relid=0 | w=45
  985. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other digestive system injuries
    n1=S.E.P. | n2=en:other digestive system injuries | rel=r_associated | relid=0 | w=45
  986. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other endocrine or metabolic congenital anomalies
    n1=S.E.P. | n2=en:other endocrine or metabolic congenital anomalies | rel=r_associated | relid=0 | w=45
  987. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other endocrine/metabolic nutritional disease
    n1=S.E.P. | n2=en:other endocrine/metabolic nutritional disease | rel=r_associated | relid=0 | w=45
  988. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other health condition:find:pt:^patient:nom
    n1=S.E.P. | n2=en:other health condition:find:pt:^patient:nom | rel=r_associated | relid=0 | w=45
  989. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other hematological abnormality
    n1=S.E.P. | n2=en:other hematological abnormality | rel=r_associated | relid=0 | w=45
  990. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other infections of respiratory system
    n1=S.E.P. | n2=en:other infections of respiratory system | rel=r_associated | relid=0 | w=45
  991. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other osteoarthritis
    n1=S.E.P. | n2=en:other osteoarthritis | rel=r_associated | relid=0 | w=45
  992. S.E.P. -- r_associated #0: 45 / 0.191 -> en:other psychoses
    n1=S.E.P. | n2=en:other psychoses | rel=r_associated | relid=0 | w=45
  993. S.E.P. -- r_associated #0: 45 / 0.191 -> en:otosclerosis
    n1=S.E.P. | n2=en:otosclerosis | rel=r_associated | relid=0 | w=45
  994. S.E.P. -- r_associated #0: 45 / 0.191 -> en:paralysis vocal cord
    n1=S.E.P. | n2=en:paralysis vocal cord | rel=r_associated | relid=0 | w=45
  995. S.E.P. -- r_associated #0: 45 / 0.191 -> en:peripheral nerve disorder associated with repair of hernia
    n1=S.E.P. | n2=en:peripheral nerve disorder associated with repair of hernia | rel=r_associated | relid=0 | w=45
  996. S.E.P. -- r_associated #0: 45 / 0.191 -> en:peripheral neuropathy caused by toxin
    n1=S.E.P. | n2=en:peripheral neuropathy caused by toxin | rel=r_associated | relid=0 | w=45
  997. S.E.P. -- r_associated #0: 45 / 0.191 -> en:pernicious/folate deficiency anemias
    n1=S.E.P. | n2=en:pernicious/folate deficiency anemias | rel=r_associated | relid=0 | w=45
  998. S.E.P. -- r_associated #0: 45 / 0.191 -> en:personality disorder
    n1=S.E.P. | n2=en:personality disorder | rel=r_associated | relid=0 | w=45
  999. S.E.P. -- r_associated #0: 45 / 0.191 -> en:pharmacotherapeutic
    n1=S.E.P. | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=45
  1000. S.E.P. -- r_associated #0: 45 / 0.191 -> en:phrenic nerve disorder
    n1=S.E.P. | n2=en:phrenic nerve disorder | rel=r_associated | relid=0 | w=45
  1001. S.E.P. -- r_associated #0: 45 / 0.191 -> en:pudendal nerve neuropathy
    n1=S.E.P. | n2=en:pudendal nerve neuropathy | rel=r_associated | relid=0 | w=45
  1002. S.E.P. -- r_associated #0: 45 / 0.191 -> en:rabies
    n1=S.E.P. | n2=en:rabies | rel=r_associated | relid=0 | w=45
  1003. S.E.P. -- r_associated #0: 45 / 0.191 -> en:remittent-progressive multiple sclerosis
    n1=S.E.P. | n2=en:remittent-progressive multiple sclerosis | rel=r_associated | relid=0 | w=45
  1004. S.E.P. -- r_associated #0: 45 / 0.191 -> en:schizophrenia
    n1=S.E.P. | n2=en:schizophrenia | rel=r_associated | relid=0 | w=45
  1005. S.E.P. -- r_associated #0: 45 / 0.191 -> en:scoliosis
    n1=S.E.P. | n2=en:scoliosis | rel=r_associated | relid=0 | w=45
  1006. S.E.P. -- r_associated #0: 45 / 0.191 -> en:shoulder syndrome
    n1=S.E.P. | n2=en:shoulder syndrome | rel=r_associated | relid=0 | w=45
  1007. S.E.P. -- r_associated #0: 45 / 0.191 -> en:spastic paralysis
    n1=S.E.P. | n2=en:spastic paralysis | rel=r_associated | relid=0 | w=45
  1008. S.E.P. -- r_associated #0: 45 / 0.191 -> en:speech abnormality if untreated
    n1=S.E.P. | n2=en:speech abnormality if untreated | rel=r_associated | relid=0 | w=45
  1009. S.E.P. -- r_associated #0: 45 / 0.191 -> en:spontaneous abortion
    n1=S.E.P. | n2=en:spontaneous abortion | rel=r_associated | relid=0 | w=45
  1010. S.E.P. -- r_associated #0: 45 / 0.191 -> en:sprain and strain of ankle
    n1=S.E.P. | n2=en:sprain and strain of ankle | rel=r_associated | relid=0 | w=45
  1011. S.E.P. -- r_associated #0: 45 / 0.191 -> en:stomach function disorder
    n1=S.E.P. | n2=en:stomach function disorder | rel=r_associated | relid=0 | w=45
  1012. S.E.P. -- r_associated #0: 45 / 0.191 -> en:swallowed foreign body in digestive system
    n1=S.E.P. | n2=en:swallowed foreign body in digestive system | rel=r_associated | relid=0 | w=45
  1013. S.E.P. -- r_associated #0: 45 / 0.191 -> en:systemic scleroderma
    n1=S.E.P. | n2=en:systemic scleroderma | rel=r_associated | relid=0 | w=45
  1014. S.E.P. -- r_associated #0: 45 / 0.191 -> en:tachycardia, paroxysmal
    n1=S.E.P. | n2=en:tachycardia, paroxysmal | rel=r_associated | relid=0 | w=45
  1015. S.E.P. -- r_associated #0: 45 / 0.191 -> en:tendonitis
    n1=S.E.P. | n2=en:tendonitis | rel=r_associated | relid=0 | w=45
  1016. S.E.P. -- r_associated #0: 45 / 0.191 -> en:thoracic injuries
    n1=S.E.P. | n2=en:thoracic injuries | rel=r_associated | relid=0 | w=45
  1017. S.E.P. -- r_associated #0: 45 / 0.191 -> en:unspecified hereditary and idiopathic peripheral neuropathy
    n1=S.E.P. | n2=en:unspecified hereditary and idiopathic peripheral neuropathy | rel=r_associated | relid=0 | w=45
  1018. S.E.P. -- r_associated #0: 45 / 0.191 -> en:unwanted pregnancy confirmed
    n1=S.E.P. | n2=en:unwanted pregnancy confirmed | rel=r_associated | relid=0 | w=45
  1019. S.E.P. -- r_associated #0: 45 / 0.191 -> en:urinary system neoplasm
    n1=S.E.P. | n2=en:urinary system neoplasm | rel=r_associated | relid=0 | w=45
  1020. S.E.P. -- r_associated #0: 45 / 0.191 -> en:urticaria
    n1=S.E.P. | n2=en:urticaria | rel=r_associated | relid=0 | w=45
  1021. S.E.P. -- r_associated #0: 45 / 0.191 -> en:vertiginous syndrome
    n1=S.E.P. | n2=en:vertiginous syndrome | rel=r_associated | relid=0 | w=45
  1022. S.E.P. -- r_associated #0: 45 / 0.191 -> en:veterinary aspects
    n1=S.E.P. | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=45
  1023. S.E.P. -- r_associated #0: 45 / 0.191 -> en:visual pathway disorder
    n1=S.E.P. | n2=en:visual pathway disorder | rel=r_associated | relid=0 | w=45
  1024. S.E.P. -- r_associated #0: 45 / 0.191 -> en:whooping cough due to unspecified organism
    n1=S.E.P. | n2=en:whooping cough due to unspecified organism | rel=r_associated | relid=0 | w=45
  1025. S.E.P. -- r_associated #0: 45 / 0.191 -> FLAIR
    n1=S.E.P. | n2=FLAIR | rel=r_associated | relid=0 | w=45
  1026. S.E.P. -- r_associated #0: 45 / 0.191 -> vessie désinhibée
    n1=S.E.P. | n2=vessie désinhibée | rel=r_associated | relid=0 | w=45
  1027. S.E.P. -- r_associated #0: 45 / 0.191 -> vessie neurologique
    n1=S.E.P. | n2=vessie neurologique | rel=r_associated | relid=0 | w=45
  1028. S.E.P. -- r_associated #0: 44 / 0.187 -> abr
    n1=S.E.P. | n2=abr | rel=r_associated | relid=0 | w=44
  1029. S.E.P. -- r_associated #0: 44 / 0.187 -> en:magnolia state
    n1=S.E.P. | n2=en:magnolia state | rel=r_associated | relid=0 | w=44
  1030. S.E.P. -- r_associated #0: 44 / 0.187 -> en:Magnolia State
    n1=S.E.P. | n2=en:Magnolia State | rel=r_associated | relid=0 | w=44
  1031. S.E.P. -- r_associated #0: 40 / 0.17 -> en:acrodynia
    n1=S.E.P. | n2=en:acrodynia | rel=r_associated | relid=0 | w=40
  1032. S.E.P. -- r_associated #0: 40 / 0.17 -> en:addison's disease
    n1=S.E.P. | n2=en:addison's disease | rel=r_associated | relid=0 | w=40
  1033. S.E.P. -- r_associated #0: 40 / 0.17 -> en:allergic arthritis
    n1=S.E.P. | n2=en:allergic arthritis | rel=r_associated | relid=0 | w=40
  1034. S.E.P. -- r_associated #0: 40 / 0.17 -> en:anti-glomerular basement membrane disease
    n1=S.E.P. | n2=en:anti-glomerular basement membrane disease | rel=r_associated | relid=0 | w=40
  1035. S.E.P. -- r_associated #0: 40 / 0.17 -> en:arthropathy
    n1=S.E.P. | n2=en:arthropathy | rel=r_associated | relid=0 | w=40
  1036. S.E.P. -- r_associated #0: 40 / 0.17 -> en:atrial fibrillation and flutter
    n1=S.E.P. | n2=en:atrial fibrillation and flutter | rel=r_associated | relid=0 | w=40
  1037. S.E.P. -- r_associated #0: 40 / 0.17 -> en:autoimmune endocrine disease
    n1=S.E.P. | n2=en:autoimmune endocrine disease | rel=r_associated | relid=0 | w=40
  1038. S.E.P. -- r_associated #0: 40 / 0.17 -> en:autoimmune polyendocrinopathy syndrome
    n1=S.E.P. | n2=en:autoimmune polyendocrinopathy syndrome | rel=r_associated | relid=0 | w=40
  1039. S.E.P. -- r_associated #0: 40 / 0.17 -> en:back injury
    n1=S.E.P. | n2=en:back injury | rel=r_associated | relid=0 | w=40
  1040. S.E.P. -- r_associated #0: 40 / 0.17 -> en:balanitis
    n1=S.E.P. | n2=en:balanitis | rel=r_associated | relid=0 | w=40
  1041. S.E.P. -- r_associated #0: 40 / 0.17 -> en:balo's concentric sclerosis
    n1=S.E.P. | n2=en:balo's concentric sclerosis | rel=r_associated | relid=0 | w=40
  1042. S.E.P. -- r_associated #0: 40 / 0.17 -> en:benign female breast neoplasm
    n1=S.E.P. | n2=en:benign female breast neoplasm | rel=r_associated | relid=0 | w=40
  1043. S.E.P. -- r_associated #0: 40 / 0.17 -> en:benign nervous system neoplasm
    n1=S.E.P. | n2=en:benign nervous system neoplasm | rel=r_associated | relid=0 | w=40
  1044. S.E.P. -- r_associated #0: 40 / 0.17 -> en:bickerstaff's brainstem encephalitis
    n1=S.E.P. | n2=en:bickerstaff's brainstem encephalitis | rel=r_associated | relid=0 | w=40
  1045. S.E.P. -- r_associated #0: 40 / 0.17 -> en:bile duct stenosis
    n1=S.E.P. | n2=en:bile duct stenosis | rel=r_associated | relid=0 | w=40
  1046. S.E.P. -- r_associated #0: 40 / 0.17 -> en:boil/abscess nose
    n1=S.E.P. | n2=en:boil/abscess nose | rel=r_associated | relid=0 | w=40
  1047. S.E.P. -- r_associated #0: 40 / 0.17 -> en:brain disorder
    n1=S.E.P. | n2=en:brain disorder | rel=r_associated | relid=0 | w=40
  1048. S.E.P. -- r_associated #0: 40 / 0.17 -> en:cartilage diseases
    n1=S.E.P. | n2=en:cartilage diseases | rel=r_associated | relid=0 | w=40
  1049. S.E.P. -- r_associated #0: 40 / 0.17 -> en:cataract
    n1=S.E.P. | n2=en:cataract | rel=r_associated | relid=0 | w=40
  1050. S.E.P. -- r_associated #0: 40 / 0.17 -> en:central nervous system candidiasis
    n1=S.E.P. | n2=en:central nervous system candidiasis | rel=r_associated | relid=0 | w=40
  1051. S.E.P. -- r_associated #0: 40 / 0.17 -> en:central nervous system degenerative disorder
    n1=S.E.P. | n2=en:central nervous system degenerative disorder | rel=r_associated | relid=0 | w=40
  1052. S.E.P. -- r_associated #0: 40 / 0.17 -> en:cerebrovascular disorder
    n1=S.E.P. | n2=en:cerebrovascular disorder | rel=r_associated | relid=0 | w=40
  1053. S.E.P. -- r_associated #0: 40 / 0.17 -> en:chronic cystic disease breast
    n1=S.E.P. | n2=en:chronic cystic disease breast | rel=r_associated | relid=0 | w=40
  1054. S.E.P. -- r_associated #0: 40 / 0.17 -> en:cns general
    n1=S.E.P. | n2=en:cns general | rel=r_associated | relid=0 | w=40
  1055. S.E.P. -- r_associated #0: 40 / 0.17 -> en:cold sensitivity neuropathy
    n1=S.E.P. | n2=en:cold sensitivity neuropathy | rel=r_associated | relid=0 | w=40
  1056. S.E.P. -- r_associated #0: 40 / 0.17 -> en:coma
    n1=S.E.P. | n2=en:coma | rel=r_associated | relid=0 | w=40
  1057. S.E.P. -- r_associated #0: 40 / 0.17 -> en:complex regional pain syndromes
    n1=S.E.P. | n2=en:complex regional pain syndromes | rel=r_associated | relid=0 | w=40
  1058. S.E.P. -- r_associated #0: 40 / 0.17 -> en:compression neuropathy of trunk
    n1=S.E.P. | n2=en:compression neuropathy of trunk | rel=r_associated | relid=0 | w=40
  1059. S.E.P. -- r_associated #0: 40 / 0.17 -> en:condylomata acuminata in men
    n1=S.E.P. | n2=en:condylomata acuminata in men | rel=r_associated | relid=0 | w=40
  1060. S.E.P. -- r_associated #0: 40 / 0.17 -> en:congenital anomalies of mother
    n1=S.E.P. | n2=en:congenital anomalies of mother | rel=r_associated | relid=0 | w=40
  1061. S.E.P. -- r_associated #0: 40 / 0.17 -> en:congenital musculoskeletal defect
    n1=S.E.P. | n2=en:congenital musculoskeletal defect | rel=r_associated | relid=0 | w=40
  1062. S.E.P. -- r_associated #0: 40 / 0.17 -> en:corneal ulcer
    n1=S.E.P. | n2=en:corneal ulcer | rel=r_associated | relid=0 | w=40
  1063. S.E.P. -- r_associated #0: 40 / 0.17 -> en:ctrp terminology
    n1=S.E.P. | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=40
  1064. S.E.P. -- r_associated #0: 40 / 0.17 -> en:cystitis/other urinary infection nos
    n1=S.E.P. | n2=en:cystitis/other urinary infection nos | rel=r_associated | relid=0 | w=40
  1065. S.E.P. -- r_associated #0: 40 / 0.17 -> en:demyelinating encephalopathy
    n1=S.E.P. | n2=en:demyelinating encephalopathy | rel=r_associated | relid=0 | w=40
  1066. S.E.P. -- r_associated #0: 40 / 0.17 -> en:diffuse hyperplastic perilobar nephroblastomatosis
    n1=S.E.P. | n2=en:diffuse hyperplastic perilobar nephroblastomatosis | rel=r_associated | relid=0 | w=40
  1067. S.E.P. -- r_associated #0: 40 / 0.17 -> en:disease history:hx:pt:^patient:nom:phenx
    n1=S.E.P. | n2=en:disease history:hx:pt:^patient:nom:phenx | rel=r_associated | relid=0 | w=40
  1068. S.E.P. -- r_associated #0: 40 / 0.17 -> en:disease of mouth/tongue/lips
    n1=S.E.P. | n2=en:disease of mouth/tongue/lips | rel=r_associated | relid=0 | w=40
  1069. S.E.P. -- r_associated #0: 40 / 0.17 -> en:disorder of central nervous system co-occurrent with human immunodeficiency virus infection
    n1=S.E.P. | n2=en:disorder of central nervous system co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=40
  1070. S.E.P. -- r_associated #0: 40 / 0.17 -> en:disseminated sclerosis with narcolepsy
    n1=S.E.P. | n2=en:disseminated sclerosis with narcolepsy | rel=r_associated | relid=0 | w=40
  1071. S.E.P. -- r_associated #0: 40 / 0.17 -> en:dyshidrosis [pompholyx]
    n1=S.E.P. | n2=en:dyshidrosis [pompholyx] | rel=r_associated | relid=0 | w=40
  1072. S.E.P. -- r_associated #0: 40 / 0.17 -> en:eustachian tube salpingitis
    n1=S.E.P. | n2=en:eustachian tube salpingitis | rel=r_associated | relid=0 | w=40
  1073. S.E.P. -- r_associated #0: 40 / 0.17 -> en:flaccid paralysis
    n1=S.E.P. | n2=en:flaccid paralysis | rel=r_associated | relid=0 | w=40
  1074. S.E.P. -- r_associated #0: 40 / 0.17 -> en:functional disease of the cns with neuroendocrine disturbance
    n1=S.E.P. | n2=en:functional disease of the cns with neuroendocrine disturbance | rel=r_associated | relid=0 | w=40
  1075. S.E.P. -- r_associated #0: 40 / 0.17 -> en:gliosis
    n1=S.E.P. | n2=en:gliosis | rel=r_associated | relid=0 | w=40
  1076. S.E.P. -- r_associated #0: 40 / 0.17 -> en:gonorrhea male
    n1=S.E.P. | n2=en:gonorrhea male | rel=r_associated | relid=0 | w=40
  1077. S.E.P. -- r_associated #0: 40 / 0.17 -> en:heel injuries and disorders
    n1=S.E.P. | n2=en:heel injuries and disorders | rel=r_associated | relid=0 | w=40
  1078. S.E.P. -- r_associated #0: 40 / 0.17 -> en:hemangiomas and lymphangiomas of any site
    n1=S.E.P. | n2=en:hemangiomas and lymphangiomas of any site | rel=r_associated | relid=0 | w=40
  1079. S.E.P. -- r_associated #0: 40 / 0.17 -> en:il17a wt allele
    n1=S.E.P. | n2=en:il17a wt allele | rel=r_associated | relid=0 | w=40
  1080. S.E.P. -- r_associated #0: 40 / 0.17 -> en:ischemic neuropathy
    n1=S.E.P. | n2=en:ischemic neuropathy | rel=r_associated | relid=0 | w=40
  1081. S.E.P. -- r_associated #0: 40 / 0.17 -> en:juvenile rheumatoid arthritis
    n1=S.E.P. | n2=en:juvenile rheumatoid arthritis | rel=r_associated | relid=0 | w=40
  1082. S.E.P. -- r_associated #0: 40 / 0.17 -> en:leptospira infection of the central nervous system
    n1=S.E.P. | n2=en:leptospira infection of the central nervous system | rel=r_associated | relid=0 | w=40
  1083. S.E.P. -- r_associated #0: 40 / 0.17 -> en:malignant obstetric neoplasm
    n1=S.E.P. | n2=en:malignant obstetric neoplasm | rel=r_associated | relid=0 | w=40
  1084. S.E.P. -- r_associated #0: 40 / 0.17 -> en:malignant thyroid gland neoplasm
    n1=S.E.P. | n2=en:malignant thyroid gland neoplasm | rel=r_associated | relid=0 | w=40
  1085. S.E.P. -- r_associated #0: 40 / 0.17 -> en:measles
    n1=S.E.P. | n2=en:measles | rel=r_associated | relid=0 | w=40
  1086. S.E.P. -- r_associated #0: 40 / 0.17 -> en:mental retardation, but majority of patients are normal
    n1=S.E.P. | n2=en:mental retardation, but majority of patients are normal | rel=r_associated | relid=0 | w=40
  1087. S.E.P. -- r_associated #0: 40 / 0.17 -> en:mitozantrone 2mg/ml infusion concentrate 10ml vial
    n1=S.E.P. | n2=en:mitozantrone 2mg/ml infusion concentrate 10ml vial | rel=r_associated | relid=0 | w=40
  1088. S.E.P. -- r_associated #0: 40 / 0.17 -> en:monomac syndrome
    n1=S.E.P. | n2=en:monomac syndrome | rel=r_associated | relid=0 | w=40
  1089. S.E.P. -- r_associated #0: 40 / 0.17 -> en:mononeuritis of lower limb, unspecified
    n1=S.E.P. | n2=en:mononeuritis of lower limb, unspecified | rel=r_associated | relid=0 | w=40
  1090. S.E.P. -- r_associated #0: 40 / 0.17 -> en:movement disorder
    n1=S.E.P. | n2=en:movement disorder | rel=r_associated | relid=0 | w=40
  1091. S.E.P. -- r_associated #0: 40 / 0.17 -> en:multiple congenital anomalies
    n1=S.E.P. | n2=en:multiple congenital anomalies | rel=r_associated | relid=0 | w=40
  1092. S.E.P. -- r_associated #0: 40 / 0.17 -> en:multiple sclerosis, acute fulminating
    n1=S.E.P. | n2=en:multiple sclerosis, acute fulminating | rel=r_associated | relid=0 | w=40
  1093. S.E.P. -- r_associated #0: 40 / 0.17 -> en:mumps
    n1=S.E.P. | n2=en:mumps | rel=r_associated | relid=0 | w=40
  1094. S.E.P. -- r_associated #0: 40 / 0.17 -> en:nerve root disorder
    n1=S.E.P. | n2=en:nerve root disorder | rel=r_associated | relid=0 | w=40
  1095. S.E.P. -- r_associated #0: 40 / 0.17 -> en:neurofibromatosis type 1
    n1=S.E.P. | n2=en:neurofibromatosis type 1 | rel=r_associated | relid=0 | w=40
  1096. S.E.P. -- r_associated #0: 40 / 0.17 -> en:neuromuscular diseases
    n1=S.E.P. | n2=en:neuromuscular diseases | rel=r_associated | relid=0 | w=40
  1097. S.E.P. -- r_associated #0: 40 / 0.17 -> en:non-cancer diagnosis
    n1=S.E.P. | n2=en:non-cancer diagnosis | rel=r_associated | relid=0 | w=40
  1098. S.E.P. -- r_associated #0: 40 / 0.17 -> en:non-neoplastic central nervous system disorder
    n1=S.E.P. | n2=en:non-neoplastic central nervous system disorder | rel=r_associated | relid=0 | w=40
  1099. S.E.P. -- r_associated #0: 40 / 0.17 -> en:orthostatic hypotension
    n1=S.E.P. | n2=en:orthostatic hypotension | rel=r_associated | relid=0 | w=40
  1100. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other and unspecified disorders of the circulatory system
    n1=S.E.P. | n2=en:other and unspecified disorders of the circulatory system | rel=r_associated | relid=0 | w=40
  1101. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other disease of pregnancy/delivery/puerperium
    n1=S.E.P. | n2=en:other disease of pregnancy/delivery/puerperium | rel=r_associated | relid=0 | w=40
  1102. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other disorders of the nervous system
    n1=S.E.P. | n2=en:other disorders of the nervous system | rel=r_associated | relid=0 | w=40
  1103. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other malignant respiratory neoplasm
    n1=S.E.P. | n2=en:other malignant respiratory neoplasm | rel=r_associated | relid=0 | w=40
  1104. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other specified demyelinating diseases of the central nervous system
    n1=S.E.P. | n2=en:other specified demyelinating diseases of the central nervous system | rel=r_associated | relid=0 | w=40
  1105. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other specified disorders of central nervous system
    n1=S.E.P. | n2=en:other specified disorders of central nervous system | rel=r_associated | relid=0 | w=40
  1106. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other viral disease with exanthems
    n1=S.E.P. | n2=en:other viral disease with exanthems | rel=r_associated | relid=0 | w=40
  1107. S.E.P. -- r_associated #0: 40 / 0.17 -> en:other viral diseases
    n1=S.E.P. | n2=en:other viral diseases | rel=r_associated | relid=0 | w=40
  1108. S.E.P. -- r_associated #0: 40 / 0.17 -> en:parvovirus infection of the central nervous system
    n1=S.E.P. | n2=en:parvovirus infection of the central nervous system | rel=r_associated | relid=0 | w=40
  1109. S.E.P. -- r_associated #0: 40 / 0.17 -> en:peripheral nervous system neoplasm
    n1=S.E.P. | n2=en:peripheral nervous system neoplasm | rel=r_associated | relid=0 | w=40
  1110. S.E.P. -- r_associated #0: 40 / 0.17 -> en:peripheral neuropathy due to inflammation
    n1=S.E.P. | n2=en:peripheral neuropathy due to inflammation | rel=r_associated | relid=0 | w=40
  1111. S.E.P. -- r_associated #0: 40 / 0.17 -> en:peripheral sensory neuropathy
    n1=S.E.P. | n2=en:peripheral sensory neuropathy | rel=r_associated | relid=0 | w=40
  1112. S.E.P. -- r_associated #0: 40 / 0.17 -> en:phenylketonuria
    n1=S.E.P. | n2=en:phenylketonuria | rel=r_associated | relid=0 | w=40
  1113. S.E.P. -- r_associated #0: 40 / 0.17 -> en:pneumocephalus
    n1=S.E.P. | n2=en:pneumocephalus | rel=r_associated | relid=0 | w=40
  1114. S.E.P. -- r_associated #0: 40 / 0.17 -> en:poisoning by medical agent
    n1=S.E.P. | n2=en:poisoning by medical agent | rel=r_associated | relid=0 | w=40
  1115. S.E.P. -- r_associated #0: 40 / 0.17 -> en:premature birth of newborn
    n1=S.E.P. | n2=en:premature birth of newborn | rel=r_associated | relid=0 | w=40
  1116. S.E.P. -- r_associated #0: 40 / 0.17 -> en:premenstrual tension
    n1=S.E.P. | n2=en:premenstrual tension | rel=r_associated | relid=0 | w=40
  1117. S.E.P. -- r_associated #0: 40 / 0.17 -> en:primary demyelination
    n1=S.E.P. | n2=en:primary demyelination | rel=r_associated | relid=0 | w=40
  1118. S.E.P. -- r_associated #0: 40 / 0.17 -> en:progression of multiple sclerosis
    n1=S.E.P. | n2=en:progression of multiple sclerosis | rel=r_associated | relid=0 | w=40
  1119. S.E.P. -- r_associated #0: 40 / 0.17 -> en:psoriasis
    n1=S.E.P. | n2=en:psoriasis | rel=r_associated | relid=0 | w=40
  1120. S.E.P. -- r_associated #0: 40 / 0.17 -> en:psoriatic arthritis
    n1=S.E.P. | n2=en:psoriatic arthritis | rel=r_associated | relid=0 | w=40
  1121. S.E.P. -- r_associated #0: 40 / 0.17 -> en:pulmonary emphysema
    n1=S.E.P. | n2=en:pulmonary emphysema | rel=r_associated | relid=0 | w=40
  1122. S.E.P. -- r_associated #0: 40 / 0.17 -> en:radiotherapeutic
    n1=S.E.P. | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=40
  1123. S.E.P. -- r_associated #0: 40 / 0.17 -> en:sebaceous cyst
    n1=S.E.P. | n2=en:sebaceous cyst | rel=r_associated | relid=0 | w=40
  1124. S.E.P. -- r_associated #0: 40 / 0.17 -> en:secretory otitis media
    n1=S.E.P. | n2=en:secretory otitis media | rel=r_associated | relid=0 | w=40
  1125. S.E.P. -- r_associated #0: 40 / 0.17 -> en:segmental demyelination
    n1=S.E.P. | n2=en:segmental demyelination | rel=r_associated | relid=0 | w=40
  1126. S.E.P. -- r_associated #0: 40 / 0.17 -> en:spastic syndrome
    n1=S.E.P. | n2=en:spastic syndrome | rel=r_associated | relid=0 | w=40
  1127. S.E.P. -- r_associated #0: 40 / 0.17 -> en:speech disorder
    n1=S.E.P. | n2=en:speech disorder | rel=r_associated | relid=0 | w=40
  1128. S.E.P. -- r_associated #0: 40 / 0.17 -> en:splenic disorder
    n1=S.E.P. | n2=en:splenic disorder | rel=r_associated | relid=0 | w=40
  1129. S.E.P. -- r_associated #0: 40 / 0.17 -> en:superficial injury of ear
    n1=S.E.P. | n2=en:superficial injury of ear | rel=r_associated | relid=0 | w=40
  1130. S.E.P. -- r_associated #0: 40 / 0.17 -> en:syndromes of cervical spine
    n1=S.E.P. | n2=en:syndromes of cervical spine | rel=r_associated | relid=0 | w=40
  1131. S.E.P. -- r_associated #0: 40 / 0.17 -> en:taxonomic
    n1=S.E.P. | n2=en:taxonomic | rel=r_associated | relid=0 | w=40
  1132. S.E.P. -- r_associated #0: 40 / 0.17 -> en:toxic effect of other and unspecified substances
    n1=S.E.P. | n2=en:toxic effect of other and unspecified substances | rel=r_associated | relid=0 | w=40
  1133. S.E.P. -- r_associated #0: 40 / 0.17 -> en:uncomplicated hypertension
    n1=S.E.P. | n2=en:uncomplicated hypertension | rel=r_associated | relid=0 | w=40
  1134. S.E.P. -- r_associated #0: 40 / 0.17 -> en:uveomeningoencephalitic syndrome
    n1=S.E.P. | n2=en:uveomeningoencephalitic syndrome | rel=r_associated | relid=0 | w=40
  1135. S.E.P. -- r_associated #0: 40 / 0.17 -> en:varicose vein of lower extremities
    n1=S.E.P. | n2=en:varicose vein of lower extremities | rel=r_associated | relid=0 | w=40
  1136. S.E.P. -- r_associated #0: 40 / 0.17 -> en:wrist injuries
    n1=S.E.P. | n2=en:wrist injuries | rel=r_associated | relid=0 | w=40
  1137. S.E.P. -- r_associated #0: 40 / 0.17 -> interférons et sclérose en plaques
    n1=S.E.P. | n2=interférons et sclérose en plaques | rel=r_associated | relid=0 | w=40
  1138. S.E.P. -- r_associated #0: 40 / 0.17 -> interleukine-6
    n1=S.E.P. | n2=interleukine-6 | rel=r_associated | relid=0 | w=40
  1139. S.E.P. -- r_associated #0: 40 / 0.17 -> signe de Lhermitte
    n1=S.E.P. | n2=signe de Lhermitte | rel=r_associated | relid=0 | w=40
  1140. S.E.P. -- r_associated #0: 40 / 0.17 -> type de sclérose
    n1=S.E.P. | n2=type de sclérose | rel=r_associated | relid=0 | w=40
  1141. S.E.P. -- r_associated #0: 40 / 0.17 -> uvéonévraxite
    n1=S.E.P. | n2=uvéonévraxite | rel=r_associated | relid=0 | w=40
  1142. S.E.P. -- r_associated #0: 35 / 0.149 -> cause de handicap
    n1=S.E.P. | n2=cause de handicap | rel=r_associated | relid=0 | w=35
  1143. S.E.P. -- r_associated #0: 35 / 0.149 -> en:encephalopathy
    n1=S.E.P. | n2=en:encephalopathy | rel=r_associated | relid=0 | w=35
  1144. S.E.P. -- r_associated #0: 35 / 0.149 -> maladie du système nerveux d'origine dysimmunitaire
    n1=S.E.P. | n2=maladie du système nerveux d'origine dysimmunitaire | rel=r_associated | relid=0 | w=35
  1145. S.E.P. -- r_associated #0: 35 / 0.149 -> maladies auto-immunes
    n1=S.E.P. | n2=maladies auto-immunes | rel=r_associated | relid=0 | w=35
  1146. S.E.P. -- r_associated #0: 35 / 0.149 -> mitoxantrone
    n1=S.E.P. | n2=mitoxantrone | rel=r_associated | relid=0 | w=35
  1147. S.E.P. -- r_associated #0: 35 / 0.149 -> myélinisation
    n1=S.E.P. | n2=myélinisation | rel=r_associated | relid=0 | w=35
  1148. S.E.P. -- r_associated #0: 35 / 0.149 -> myoclonies vélopalatines et squelettiques
    n1=S.E.P. | n2=myoclonies vélopalatines et squelettiques | rel=r_associated | relid=0 | w=35
  1149. S.E.P. -- r_associated #0: 35 / 0.149 -> papillite
    n1=S.E.P. | n2=papillite | rel=r_associated | relid=0 | w=35
  1150. S.E.P. -- r_associated #0: 35 / 0.149 -> paralysie ascendante aiguë
    n1=S.E.P. | n2=paralysie ascendante aiguë | rel=r_associated | relid=0 | w=35
  1151. S.E.P. -- r_associated #0: 35 / 0.149 -> poussée
    n1=S.E.P. | n2=poussée | rel=r_associated | relid=0 | w=35
  1152. S.E.P. -- r_associated #0: 35 / 0.149 -> S.E.P
    n1=S.E.P. | n2=S.E.P | rel=r_associated | relid=0 | w=35
  1153. S.E.P. -- r_associated #0: 35 / 0.149 -> sclérose en plaques et troubles psychiques
    n1=S.E.P. | n2=sclérose en plaques et troubles psychiques | rel=r_associated | relid=0 | w=35
  1154. S.E.P. -- r_associated #0: 35 / 0.149 -> Uthoff (phénomène d')
    n1=S.E.P. | n2=Uthoff (phénomène d') | rel=r_associated | relid=0 | w=35
  1155. S.E.P. -- r_associated #0: 30 / 0.128 -> Baló (sclérose concentrique de)
    n1=S.E.P. | n2=Baló (sclérose concentrique de) | rel=r_associated | relid=0 | w=30
  1156. S.E.P. -- r_associated #0: 30 / 0.128 -> myélite aiguë ascendante
    n1=S.E.P. | n2=myélite aiguë ascendante | rel=r_associated | relid=0 | w=30
  1157. S.E.P. -- r_associated #0: 30 / 0.128 -> myélite nécrosante subaiguë
    n1=S.E.P. | n2=myélite nécrosante subaiguë | rel=r_associated | relid=0 | w=30
  1158. S.E.P. -- r_associated #0: 30 / 0.128 -> Uhthoff (phénomène d')
    n1=S.E.P. | n2=Uhthoff (phénomène d') | rel=r_associated | relid=0 | w=30
  1159. S.E.P. -- r_associated #0: 29 / 0.123 -> syndrome de sclérose combinée de la moelle
    n1=S.E.P. | n2=syndrome de sclérose combinée de la moelle | rel=r_associated | relid=0 | w=29
  1160. S.E.P. -- r_associated #0: 26 / 0.111 -> maladies autoimmunes
    n1=S.E.P. | n2=maladies autoimmunes | rel=r_associated | relid=0 | w=26
  1161. S.E.P. -- r_associated #0: 25 / 0.106 -> en:neurosciences
    n1=S.E.P. | n2=en:neurosciences | rel=r_associated | relid=0 | w=25
  1162. S.E.P. -- r_associated #0: 25 / 0.106 -> santé
    n1=S.E.P. | n2=santé | rel=r_associated | relid=0 | w=25
  1163. S.E.P. -- r_associated #0: 25 / 0.106 -> sclérodermie en plaques
    n1=S.E.P. | n2=sclérodermie en plaques | rel=r_associated | relid=0 | w=25
  1164. S.E.P. -- r_associated #0: 25 / 0.106 -> Sclérose en plaques
    n1=S.E.P. | n2=Sclérose en plaques | rel=r_associated | relid=0 | w=25
  1165. S.E.P. -- r_associated #0: 23 / 0.098 -> en:medicine
    n1=S.E.P. | n2=en:medicine | rel=r_associated | relid=0 | w=23
  1166. S.E.P. -- r_associated #0: 10 / 0.043 -> en:multiple
    n1=S.E.P. | n2=en:multiple | rel=r_associated | relid=0 | w=10
  1167. S.E.P. -- r_associated #0: 10 / 0.043 -> militaire
    n1=S.E.P. | n2=militaire | rel=r_associated | relid=0 | w=10
  1168. S.E.P. -- r_associated #0: 6 / 0.026 -> en:biloxi
    n1=S.E.P. | n2=en:biloxi | rel=r_associated | relid=0 | w=6
  1169. S.E.P. -- r_associated #0: 6 / 0.026 -> en:capital of mississippi
    n1=S.E.P. | n2=en:capital of mississippi | rel=r_associated | relid=0 | w=6
  1170. S.E.P. -- r_associated #0: 6 / 0.026 -> en:columbus
    n1=S.E.P. | n2=en:columbus | rel=r_associated | relid=0 | w=6
  1171. S.E.P. -- r_associated #0: 6 / 0.026 -> en:greenville
    n1=S.E.P. | n2=en:greenville | rel=r_associated | relid=0 | w=6
  1172. S.E.P. -- r_associated #0: 6 / 0.026 -> en:hattiesburg
    n1=S.E.P. | n2=en:hattiesburg | rel=r_associated | relid=0 | w=6
  1173. S.E.P. -- r_associated #0: 6 / 0.026 -> en:jackson
    n1=S.E.P. | n2=en:jackson | rel=r_associated | relid=0 | w=6
  1174. S.E.P. -- r_associated #0: 6 / 0.026 -> en:meridian
    n1=S.E.P. | n2=en:meridian | rel=r_associated | relid=0 | w=6
  1175. S.E.P. -- r_associated #0: 6 / 0.026 -> en:natchez
    n1=S.E.P. | n2=en:natchez | rel=r_associated | relid=0 | w=6
  1176. S.E.P. -- r_associated #0: 6 / 0.026 -> en:pearl river
    n1=S.E.P. | n2=en:pearl river | rel=r_associated | relid=0 | w=6
  1177. S.E.P. -- r_associated #0: 6 / 0.026 -> en:tombigbee
    n1=S.E.P. | n2=en:tombigbee | rel=r_associated | relid=0 | w=6
  1178. S.E.P. -- r_associated #0: 6 / 0.026 -> en:tupelo
    n1=S.E.P. | n2=en:tupelo | rel=r_associated | relid=0 | w=6
  1179. S.E.P. -- r_associated #0: 6 / 0.026 -> en:vicksburg
    n1=S.E.P. | n2=en:vicksburg | rel=r_associated | relid=0 | w=6
  1180. S.E.P. -- r_associated #0: 6 / 0.026 -> en:yazoo
    n1=S.E.P. | n2=en:yazoo | rel=r_associated | relid=0 | w=6
  1181. S.E.P. -- r_associated #0: 6 / 0.026 -> en:yazoo river
    n1=S.E.P. | n2=en:yazoo river | rel=r_associated | relid=0 | w=6
  1182. S.E.P. -- r_associated #0: 1 / 0.004 -> en:neurodegenerative disorders
    n1=S.E.P. | n2=en:neurodegenerative disorders | rel=r_associated | relid=0 | w=1
  1183. S.E.P. -- r_associated #0: 1 / 0.004 -> maladie auto immune
    n1=S.E.P. | n2=maladie auto immune | rel=r_associated | relid=0 | w=1
  1184. S.E.P. -- r_associated #0: 1 / 0.004 -> troubles neurodégénératifs
    n1=S.E.P. | n2=troubles neurodégénératifs | rel=r_associated | relid=0 | w=1
≈ 1529 relations entrantes

  1. médecine --- r_associated #0: 175 --> S.E.P.
    n1=médecine | n2=S.E.P. | rel=r_associated | relid=0 | w=175
  2. sclérose en plaques --- r_associated #0: 57 --> S.E.P.
    n1=sclérose en plaques | n2=S.E.P. | rel=r_associated | relid=0 | w=57
  3. en:multiple sclerosis --- r_associated #0: 53 --> S.E.P.
    n1=en:multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=53
  4. sclérose multiple --- r_associated #0: 49 --> S.E.P.
    n1=sclérose multiple | n2=S.E.P. | rel=r_associated | relid=0 | w=49
  5. en:MS --- r_associated #0: 46 --> S.E.P.
    n1=en:MS | n2=S.E.P. | rel=r_associated | relid=0 | w=46
  6. hyposomnie --- r_associated #0: 45 --> S.E.P.
    n1=hyposomnie | n2=S.E.P. | rel=r_associated | relid=0 | w=45
  7. trouble insomniaque --- r_associated #0: 45 --> S.E.P.
    n1=trouble insomniaque | n2=S.E.P. | rel=r_associated | relid=0 | w=45
  8. Sclérose en plaques --- r_associated #0: 42 --> S.E.P.
    n1=Sclérose en plaques | n2=S.E.P. | rel=r_associated | relid=0 | w=42
  9. en:insomnia --- r_associated #0: 40 --> S.E.P.
    n1=en:insomnia | n2=S.E.P. | rel=r_associated | relid=0 | w=40
  10. trouble endormissement et maintien du sommeil --- r_associated #0: 40 --> S.E.P.
    n1=trouble endormissement et maintien du sommeil | n2=S.E.P. | rel=r_associated | relid=0 | w=40
  11. encéphalomyélite aiguë nécrosante hémorragique --- r_associated #0: 35 --> S.E.P.
    n1=encéphalomyélite aiguë nécrosante hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=35
  12. leuco-encéphalite aiguë hémorragique --- r_associated #0: 35 --> S.E.P.
    n1=leuco-encéphalite aiguë hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=35
  13. leuco-encéphalite aigüe hémorragique --- r_associated #0: 35 --> S.E.P.
    n1=leuco-encéphalite aigüe hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=35
  14. leuco-encéphalite subaiguë hémorragique --- r_associated #0: 35 --> S.E.P.
    n1=leuco-encéphalite subaiguë hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=35
  15. sclérose en plaque --- r_associated #0: 35 --> S.E.P.
    n1=sclérose en plaque | n2=S.E.P. | rel=r_associated | relid=0 | w=35
  16. troubles endormissement et maintien du sommeil --- r_associated #0: 35 --> S.E.P.
    n1=troubles endormissement et maintien du sommeil | n2=S.E.P. | rel=r_associated | relid=0 | w=35
  17. en:leukoencephalitis, acute hemorrhagic --- r_associated #0: 30 --> S.E.P.
    n1=en:leukoencephalitis, acute hemorrhagic | n2=S.E.P. | rel=r_associated | relid=0 | w=30
  18. en:subacute hemorrhagic leukoencephalitis --- r_associated #0: 30 --> S.E.P.
    n1=en:subacute hemorrhagic leukoencephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=30
  19. en:insular sclerosis --- r_associated #0: 29 --> S.E.P.
    n1=en:insular sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=29
  20. MatC --- r_associated #0: 25 --> S.E.P.
    n1=MatC | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  21. en:disseminated sclerosis --- r_associated #0: 25 --> S.E.P.
    n1=en:disseminated sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  22. leucoencéphalite aigüe hémorragique --- r_associated #0: 25 --> S.E.P.
    n1=leucoencéphalite aigüe hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  23. leucoencéphalite subaiguë hémorragique --- r_associated #0: 25 --> S.E.P.
    n1=leucoencéphalite subaiguë hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  24. maladie de trousseau --- r_associated #0: 25 --> S.E.P.
    n1=maladie de trousseau | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  25. neuralgie trigéminale --- r_associated #0: 25 --> S.E.P.
    n1=neuralgie trigéminale | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  26. névralgie du nerf trijumeau --- r_associated #0: 25 --> S.E.P.
    n1=névralgie du nerf trijumeau | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  27. tics douloureux de la face --- r_associated #0: 25 --> S.E.P.
    n1=tics douloureux de la face | n2=S.E.P. | rel=r_associated | relid=0 | w=25
  28. en:focal sclerosis --- r_associated #0: 23 --> S.E.P.
    n1=en:focal sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=23
  29. Baló (sclérose concentrique de) --- r_associated #0: 20 --> S.E.P.
    n1=Baló (sclérose concentrique de) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  30. FLAIR --- r_associated #0: 20 --> S.E.P.
    n1=FLAIR | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  31. IRM --- r_associated #0: 20 --> S.E.P.
    n1=IRM | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  32. Médecine --- r_associated #0: 20 --> S.E.P.
    n1=Médecine | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  33. Méningoencéphalite --- r_associated #0: 20 --> S.E.P.
    n1=Méningoencéphalite | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  34. S.E.P --- r_associated #0: 20 --> S.E.P.
    n1=S.E.P | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  35. Sclérose --- r_associated #0: 20 --> S.E.P.
    n1=Sclérose | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  36. Signe de Lhermitte --- r_associated #0: 20 --> S.E.P.
    n1=Signe de Lhermitte | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  37. Uhthoff (phénomène d') --- r_associated #0: 20 --> S.E.P.
    n1=Uhthoff (phénomène d') | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  38. Uthoff (phénomène d') --- r_associated #0: 20 --> S.E.P.
    n1=Uthoff (phénomène d') | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  39. abr --- r_associated #0: 20 --> S.E.P.
    n1=abr | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  40. adréno-leucodystrophie --- r_associated #0: 20 --> S.E.P.
    n1=adréno-leucodystrophie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  41. asthénie --- r_associated #0: 20 --> S.E.P.
    n1=asthénie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  42. auto-immune --- r_associated #0: 20 --> S.E.P.
    n1=auto-immune | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  43. cancer du pancréas --- r_associated #0: 20 --> S.E.P.
    n1=cancer du pancréas | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  44. cancer osseux --- r_associated #0: 20 --> S.E.P.
    n1=cancer osseux | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  45. cause de handicap --- r_associated #0: 20 --> S.E.P.
    n1=cause de handicap | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  46. coeur pulmonaire chronique --- r_associated #0: 20 --> S.E.P.
    n1=coeur pulmonaire chronique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  47. dermatite séborrhéique --- r_associated #0: 20 --> S.E.P.
    n1=dermatite séborrhéique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  48. dermatophytose --- r_associated #0: 20 --> S.E.P.
    n1=dermatophytose | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  49. douleur de la face --- r_associated #0: 20 --> S.E.P.
    n1=douleur de la face | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  50. douleur faciale --- r_associated #0: 20 --> S.E.P.
    n1=douleur faciale | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  51. dysarthrie --- r_associated #0: 20 --> S.E.P.
    n1=dysarthrie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  52. démyélinisation --- r_associated #0: 20 --> S.E.P.
    n1=démyélinisation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  53. en:abducens nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:abducens nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  54. en:abnormal pap smear --- r_associated #0: 20 --> S.E.P.
    n1=en:abnormal pap smear | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  55. en:abnormal results investigation nos --- r_associated #0: 20 --> S.E.P.
    n1=en:abnormal results investigation nos | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  56. en:abnormal urine test result --- r_associated #0: 20 --> S.E.P.
    n1=en:abnormal urine test result | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  57. en:abnormality of the cerebrospinal fluid --- r_associated #0: 20 --> S.E.P.
    n1=en:abnormality of the cerebrospinal fluid | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  58. en:acne --- r_associated #0: 20 --> S.E.P.
    n1=en:acne | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  59. en:acoustic schwannoma --- r_associated #0: 20 --> S.E.P.
    n1=en:acoustic schwannoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  60. en:acoustic trauma --- r_associated #0: 20 --> S.E.P.
    n1=en:acoustic trauma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  61. en:acquired deformity of limb --- r_associated #0: 20 --> S.E.P.
    n1=en:acquired deformity of limb | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  62. en:acquired deformity of spine --- r_associated #0: 20 --> S.E.P.
    n1=en:acquired deformity of spine | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  63. en:acquired immunodeficiency syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:acquired immunodeficiency syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  64. en:acquired myelocele --- r_associated #0: 20 --> S.E.P.
    n1=en:acquired myelocele | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  65. en:acrodynia --- r_associated #0: 20 --> S.E.P.
    n1=en:acrodynia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  66. en:acute ascending myelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute ascending myelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  67. en:acute bronchitis and bronchiolitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute bronchitis and bronchiolitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  68. en:acute damage meniscus knee --- r_associated #0: 20 --> S.E.P.
    n1=en:acute damage meniscus knee | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  69. en:acute disseminated encephalomyelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute disseminated encephalomyelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  70. en:acute episodes of neuropathic symptoms --- r_associated #0: 20 --> S.E.P.
    n1=en:acute episodes of neuropathic symptoms | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  71. en:acute hemorrhagic leukoencephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute hemorrhagic leukoencephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  72. en:acute laryngitis and/or tracheitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute laryngitis and/or tracheitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  73. en:acute lymphadenitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute lymphadenitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  74. en:acute miliary tuberculosis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute miliary tuberculosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  75. en:acute motor and sensory axonal neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:acute motor and sensory axonal neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  76. en:acute motor axonal neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:acute motor axonal neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  77. en:acute myocardial infarction --- r_associated #0: 20 --> S.E.P.
    n1=en:acute myocardial infarction | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  78. en:acute nasopharyngitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute nasopharyngitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  79. en:acute non-infective transverse myelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute non-infective transverse myelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  80. en:acute otitis media/myringitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute otitis media/myringitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  81. en:acute polyneuropathies --- r_associated #0: 20 --> S.E.P.
    n1=en:acute polyneuropathies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  82. en:acute tonsillitis --- r_associated #0: 20 --> S.E.P.
    n1=en:acute tonsillitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  83. en:addison's disease --- r_associated #0: 20 --> S.E.P.
    n1=en:addison's disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  84. en:adenomatous polyp --- r_associated #0: 20 --> S.E.P.
    n1=en:adenomatous polyp | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  85. en:adrenoleukodystrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:adrenoleukodystrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  86. en:adverse effect medical agent proper dose --- r_associated #0: 20 --> S.E.P.
    n1=en:adverse effect medical agent proper dose | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  87. en:adverse effect of physical agent --- r_associated #0: 20 --> S.E.P.
    n1=en:adverse effect of physical agent | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  88. en:affective psychosis --- r_associated #0: 20 --> S.E.P.
    n1=en:affective psychosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  89. en:alcoholic polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:alcoholic polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  90. en:alice in wonderland syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:alice in wonderland syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  91. en:all other perinatal morbidity --- r_associated #0: 20 --> S.E.P.
    n1=en:all other perinatal morbidity | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  92. en:allergic arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:allergic arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  93. en:allergic encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:allergic encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  94. en:alzheimer's caregivers --- r_associated #0: 20 --> S.E.P.
    n1=en:alzheimer's caregivers | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  95. en:alzheimer's disease --- r_associated #0: 20 --> S.E.P.
    n1=en:alzheimer's disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  96. en:ambulation difficulty --- r_associated #0: 20 --> S.E.P.
    n1=en:ambulation difficulty | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  97. en:amebic infection of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:amebic infection of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  98. en:amputees --- r_associated #0: 20 --> S.E.P.
    n1=en:amputees | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  99. en:amyloid neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:amyloid neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  100. en:amyotrophic lateral sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:amyotrophic lateral sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  101. en:anal fissure/perianal abscess --- r_associated #0: 20 --> S.E.P.
    n1=en:anal fissure/perianal abscess | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  102. en:anatomic structures --- r_associated #0: 20 --> S.E.P.
    n1=en:anatomic structures | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  103. en:angina --- r_associated #0: 20 --> S.E.P.
    n1=en:angina | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  104. en:angiofollicular lymphoid hyperplasia --- r_associated #0: 20 --> S.E.P.
    n1=en:angiofollicular lymphoid hyperplasia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  105. en:ankle injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:ankle injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  106. en:ankylosing spondylitis --- r_associated #0: 20 --> S.E.P.
    n1=en:ankylosing spondylitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  107. en:anti-glomerular basement membrane disease --- r_associated #0: 20 --> S.E.P.
    n1=en:anti-glomerular basement membrane disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  108. en:anti-myelin-associated glycoprotein associated polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:anti-myelin-associated glycoprotein associated polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  109. en:anti-neutrophil cytoplasmic antibody-associated vasculitis --- r_associated #0: 20 --> S.E.P.
    n1=en:anti-neutrophil cytoplasmic antibody-associated vasculitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  110. en:anti-nmda receptor encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:anti-nmda receptor encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  111. en:antiphospholipid syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:antiphospholipid syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  112. en:antisynthetase syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:antisynthetase syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  113. en:anxiety disorder/anxiety state --- r_associated #0: 20 --> S.E.P.
    n1=en:anxiety disorder/anxiety state | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  114. en:aphasia --- r_associated #0: 20 --> S.E.P.
    n1=en:aphasia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  115. en:appendicitis --- r_associated #0: 20 --> S.E.P.
    n1=en:appendicitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  116. en:arm injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:arm injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  117. en:arnold-chiari malformation --- r_associated #0: 20 --> S.E.P.
    n1=en:arnold-chiari malformation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  118. en:arrhythmia --- r_associated #0: 20 --> S.E.P.
    n1=en:arrhythmia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  119. en:arteriovenous hemangioma --- r_associated #0: 20 --> S.E.P.
    n1=en:arteriovenous hemangioma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  120. en:arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  121. en:arthropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:arthropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  122. en:arthroplasty of the knee --- r_associated #0: 20 --> S.E.P.
    n1=en:arthroplasty of the knee | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  123. en:aspects of mortality statistics --- r_associated #0: 20 --> S.E.P.
    n1=en:aspects of mortality statistics | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  124. en:aspects of radionuclide imaging --- r_associated #0: 20 --> S.E.P.
    n1=en:aspects of radionuclide imaging | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  125. en:asthma --- r_associated #0: 20 --> S.E.P.
    n1=en:asthma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  126. en:ataxia telangiectasia syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:ataxia telangiectasia syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  127. en:atherosclerosis excluding heart/brain --- r_associated #0: 20 --> S.E.P.
    n1=en:atherosclerosis excluding heart/brain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  128. en:atopic conjunctivitis --- r_associated #0: 20 --> S.E.P.
    n1=en:atopic conjunctivitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  129. en:atopic dermatitis/eczema --- r_associated #0: 20 --> S.E.P.
    n1=en:atopic dermatitis/eczema | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  130. en:atrial fibrillation and flutter --- r_associated #0: 20 --> S.E.P.
    n1=en:atrial fibrillation and flutter | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  131. en:attention deficit hyperactivity disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:attention deficit hyperactivity disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  132. en:autoimmune antibody positivity --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune antibody positivity | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  133. en:autoimmune cholangitis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune cholangitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  134. en:autoimmune demyelinating disease --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune demyelinating disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  135. en:autoimmune disease --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  136. en:autoimmune disease, nec in mdr --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune disease, nec in mdr | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  137. en:autoimmune disorder of inner ear --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune disorder of inner ear | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  138. en:autoimmune disorders nec --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune disorders nec | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  139. en:autoimmune encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  140. en:autoimmune endocrine disease --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune endocrine disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  141. en:autoimmune enteropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune enteropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  142. en:autoimmune hematologic disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune hematologic disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  143. en:autoimmune hemolytic anemia --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune hemolytic anemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  144. en:autoimmune hepatitis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune hepatitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  145. en:autoimmune hypophysitis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune hypophysitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  146. en:autoimmune inflammation of skeletal muscle --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune inflammation of skeletal muscle | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  147. en:autoimmune leukopenia --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune leukopenia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  148. en:autoimmune liver disease --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune liver disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  149. en:autoimmune lymphoproliferative syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune lymphoproliferative syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  150. en:autoimmune necrotizing myopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune necrotizing myopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  151. en:autoimmune neonatal thrombocytopenia --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune neonatal thrombocytopenia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  152. en:autoimmune nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  153. en:autoimmune neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  154. en:autoimmune neutropenia --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune neutropenia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  155. en:autoimmune pancreatitis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune pancreatitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  156. en:autoimmune pancytopenia --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune pancytopenia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  157. en:autoimmune polyendocrinopathy syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune polyendocrinopathy syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  158. en:autoimmune skin disease --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune skin disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  159. en:autoimmune thyroiditis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune thyroiditis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  160. en:autoimmune vasculitis --- r_associated #0: 20 --> S.E.P.
    n1=en:autoimmune vasculitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  161. en:autonomic dysfunction, variable --- r_associated #0: 20 --> S.E.P.
    n1=en:autonomic dysfunction, variable | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  162. en:autonomic nervous system disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:autonomic nervous system disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  163. en:autosomal dominant optic atrophy and peripheral neuropathy syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:autosomal dominant optic atrophy and peripheral neuropathy syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  164. en:babinski sign --- r_associated #0: 20 --> S.E.P.
    n1=en:babinski sign | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  165. en:back injury --- r_associated #0: 20 --> S.E.P.
    n1=en:back injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  166. en:back pain --- r_associated #0: 20 --> S.E.P.
    n1=en:back pain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  167. en:balanitis --- r_associated #0: 20 --> S.E.P.
    n1=en:balanitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  168. en:balo's concentric sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:balo's concentric sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  169. en:band sensation --- r_associated #0: 20 --> S.E.P.
    n1=en:band sensation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  170. en:behavioral/psychiatric manifestations --- r_associated #0: 20 --> S.E.P.
    n1=en:behavioral/psychiatric manifestations | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  171. en:benign digestive system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign digestive system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  172. en:benign female breast neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign female breast neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  173. en:benign lymphoepithelial lesion of the salivary gland --- r_associated #0: 20 --> S.E.P.
    n1=en:benign lymphoepithelial lesion of the salivary gland | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  174. en:benign neoplasm of male genital organ --- r_associated #0: 20 --> S.E.P.
    n1=en:benign neoplasm of male genital organ | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  175. en:benign nervous system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign nervous system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  176. en:benign obstetric neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign obstetric neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  177. en:benign prostatic hyperplasia --- r_associated #0: 20 --> S.E.P.
    n1=en:benign prostatic hyperplasia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  178. en:benign respiratory neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign respiratory neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  179. en:benign thyroid gland neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign thyroid gland neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  180. en:benign urinary system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:benign urinary system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  181. en:benign/unspecified neoplasms --- r_associated #0: 20 --> S.E.P.
    n1=en:benign/unspecified neoplasms | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  182. en:bickerstaff's brainstem encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:bickerstaff's brainstem encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  183. en:bile duct stenosis --- r_associated #0: 20 --> S.E.P.
    n1=en:bile duct stenosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  184. en:binswanger's encephalopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:binswanger's encephalopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  185. en:blastomyces infection of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:blastomyces infection of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  186. en:blau syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:blau syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  187. en:blepharitis/stye/chalazion --- r_associated #0: 20 --> S.E.P.
    n1=en:blepharitis/stye/chalazion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  188. en:blepharospasm --- r_associated #0: 20 --> S.E.P.
    n1=en:blepharospasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  189. en:blindness all degrees/types --- r_associated #0: 20 --> S.E.P.
    n1=en:blindness all degrees/types | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  190. en:blocked lacrimal duct of infant --- r_associated #0: 20 --> S.E.P.
    n1=en:blocked lacrimal duct of infant | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  191. en:body mass index 30+ - obesity --- r_associated #0: 20 --> S.E.P.
    n1=en:body mass index 30+ - obesity | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  192. en:boil/abscess nose --- r_associated #0: 20 --> S.E.P.
    n1=en:boil/abscess nose | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  193. en:bone diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:bone diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  194. en:bone graft - material --- r_associated #0: 20 --> S.E.P.
    n1=en:bone graft - material | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  195. en:bone infection --- r_associated #0: 20 --> S.E.P.
    n1=en:bone infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  196. en:bone mineral density --- r_associated #0: 20 --> S.E.P.
    n1=en:bone mineral density | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  197. en:bone necrosis --- r_associated #0: 20 --> S.E.P.
    n1=en:bone necrosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  198. en:bone paget disease --- r_associated #0: 20 --> S.E.P.
    n1=en:bone paget disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  199. en:bones, joints and muscles --- r_associated #0: 20 --> S.E.P.
    n1=en:bones, joints and muscles | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  200. en:brachial plexopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:brachial plexopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  201. en:brachial plexus injury --- r_associated #0: 20 --> S.E.P.
    n1=en:brachial plexus injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  202. en:brain and nerves --- r_associated #0: 20 --> S.E.P.
    n1=en:brain and nerves | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  203. en:brain aneurysm --- r_associated #0: 20 --> S.E.P.
    n1=en:brain aneurysm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  204. en:brain disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:brain disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  205. en:brain edema --- r_associated #0: 20 --> S.E.P.
    n1=en:brain edema | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  206. en:brain injury --- r_associated #0: 20 --> S.E.P.
    n1=en:brain injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  207. en:brain neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:brain neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  208. en:brain stem disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:brain stem disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  209. en:breast disorder in pregnancy/puerperium other --- r_associated #0: 20 --> S.E.P.
    n1=en:breast disorder in pregnancy/puerperium other | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  210. en:bruns nystagmus --- r_associated #0: 20 --> S.E.P.
    n1=en:bruns nystagmus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  211. en:bullous pemphigoid --- r_associated #0: 20 --> S.E.P.
    n1=en:bullous pemphigoid | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  212. en:bursitis --- r_associated #0: 20 --> S.E.P.
    n1=en:bursitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  213. en:carcinomatosis (unknown primary site) --- r_associated #0: 20 --> S.E.P.
    n1=en:carcinomatosis (unknown primary site) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  214. en:cardiovascular neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:cardiovascular neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  215. en:carpal tunnel syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:carpal tunnel syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  216. en:cartilage diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:cartilage diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  217. en:cataplexy --- r_associated #0: 20 --> S.E.P.
    n1=en:cataplexy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  218. en:cataract --- r_associated #0: 20 --> S.E.P.
    n1=en:cataract | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  219. en:celiac plexus syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:celiac plexus syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  220. en:central nervous disorder associated with aids --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous disorder associated with aids | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  221. en:central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  222. en:central nervous system candidiasis --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system candidiasis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  223. en:central nervous system complication --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system complication | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  224. en:central nervous system cyst --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system cyst | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  225. en:central nervous system degenerative disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system degenerative disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  226. en:central nervous system demyelinating disease associated with aids --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system demyelinating disease associated with aids | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  227. en:central nervous system depression (disorder) --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system depression (disorder) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  228. en:central nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  229. en:central nervous system dysfunction in newborn --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system dysfunction in newborn | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  230. en:central nervous system hamartoma --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system hamartoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  231. en:central nervous system infectious disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system infectious disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  232. en:central nervous system lupus --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system lupus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  233. en:central nervous system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  234. en:central nervous system parasitic infections --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system parasitic infections | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  235. en:central nervous system vasculitis --- r_associated #0: 20 --> S.E.P.
    n1=en:central nervous system vasculitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  236. en:central pain syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:central pain syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  237. en:central pontine myelinolysis --- r_associated #0: 20 --> S.E.P.
    n1=en:central pontine myelinolysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  238. en:cerebellar diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebellar diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  239. en:cerebral atrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebral atrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  240. en:cerebral palsy --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebral palsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  241. en:cerebrospinal fluid leakage --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebrospinal fluid leakage | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  242. en:cerebrovascular accident --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebrovascular accident | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  243. en:cerebrovascular and spinal vascular disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebrovascular and spinal vascular disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  244. en:cerebrovascular disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:cerebrovascular disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  245. en:cervical disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:cervical disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  246. en:charcot-marie-tooth disease --- r_associated #0: 20 --> S.E.P.
    n1=en:charcot-marie-tooth disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  247. en:chemically induced --- r_associated #0: 20 --> S.E.P.
    n1=en:chemically induced | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  248. en:chemotherapy-induced peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:chemotherapy-induced peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  249. en:chicken pox --- r_associated #0: 20 --> S.E.P.
    n1=en:chicken pox | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  250. en:childhood brain neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:childhood brain neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  251. en:cholecystitis with cholelithiasis --- r_associated #0: 20 --> S.E.P.
    n1=en:cholecystitis with cholelithiasis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  252. en:chronic bronchitis/bronchiectasis --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic bronchitis/bronchiectasis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  253. en:chronic cystic disease breast --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic cystic disease breast | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  254. en:chronic enteritis/ulcerative colitis --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic enteritis/ulcerative colitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  255. en:chronic fatigue syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic fatigue syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  256. en:chronic inflammatory demyelinating polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic inflammatory demyelinating polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  257. en:chronic inflammatory demyelinating polyradiculoneuropathy with central nervous system demyelination --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic inflammatory demyelinating polyradiculoneuropathy with central nervous system demyelination | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  258. en:chronic internal knee derangement --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic internal knee derangement | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  259. en:chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  260. en:chronic otitis other infection ear --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic otitis other infection ear | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  261. en:chronic pain --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic pain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  262. en:chronic polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  263. en:chronic sensorineural polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic sensorineural polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  264. en:chronic skin ulcer --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic skin ulcer | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  265. en:chronic/non specific lymphadenitis --- r_associated #0: 20 --> S.E.P.
    n1=en:chronic/non specific lymphadenitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  266. en:cirrhosis/other liver disease --- r_associated #0: 20 --> S.E.P.
    n1=en:cirrhosis/other liver disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  267. en:clinically isolated syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:clinically isolated syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  268. en:clinician-diagnosed illness:find:pt:^patient:nom:phenx --- r_associated #0: 20 --> S.E.P.
    n1=en:clinician-diagnosed illness:find:pt:^patient:nom:phenx | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  269. en:cluster headache --- r_associated #0: 20 --> S.E.P.
    n1=en:cluster headache | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  270. en:cns general --- r_associated #0: 20 --> S.E.P.
    n1=en:cns general | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  271. en:cns inflammation or infection --- r_associated #0: 20 --> S.E.P.
    n1=en:cns inflammation or infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  272. en:cns stimulation (finding) --- r_associated #0: 20 --> S.E.P.
    n1=en:cns stimulation (finding) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  273. en:cochlear nerve diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:cochlear nerve diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  274. en:cold sensitivity neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:cold sensitivity neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  275. en:coma --- r_associated #0: 20 --> S.E.P.
    n1=en:coma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  276. en:complex regional pain syndromes --- r_associated #0: 20 --> S.E.P.
    n1=en:complex regional pain syndromes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  277. en:complicated delivery deadborn --- r_associated #0: 20 --> S.E.P.
    n1=en:complicated delivery deadborn | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  278. en:complicated delivery liveborn --- r_associated #0: 20 --> S.E.P.
    n1=en:complicated delivery liveborn | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  279. en:complication aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:complication aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  280. en:complication of surgical and medical care, unspecified --- r_associated #0: 20 --> S.E.P.
    n1=en:complication of surgical and medical care, unspecified | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  281. en:compression neuropathy of trunk --- r_associated #0: 20 --> S.E.P.
    n1=en:compression neuropathy of trunk | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  282. en:concussion --- r_associated #0: 20 --> S.E.P.
    n1=en:concussion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  283. en:condyloma acuminatum --- r_associated #0: 20 --> S.E.P.
    n1=en:condyloma acuminatum | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  284. en:condylomata acuminata in men --- r_associated #0: 20 --> S.E.P.
    n1=en:condylomata acuminata in men | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  285. en:condylomata acuminata in women --- r_associated #0: 20 --> S.E.P.
    n1=en:condylomata acuminata in women | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  286. en:confirmation of pregnancy --- r_associated #0: 20 --> S.E.P.
    n1=en:confirmation of pregnancy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  287. en:congenital abnormality --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital abnormality | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  288. en:congenital anomalies of mother --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomalies of mother | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  289. en:congenital anomaly of brain --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomaly of brain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  290. en:congenital anomaly of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomaly of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  291. en:congenital anomaly of female genital system --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomaly of female genital system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  292. en:congenital anomaly of male genital system --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomaly of male genital system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  293. en:congenital anomaly of peripheral nerve --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomaly of peripheral nerve | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  294. en:congenital anomaly of the peripheral nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital anomaly of the peripheral nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  295. en:congenital cardiovascular abnormality --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital cardiovascular abnormality | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  296. en:congenital ear anomaly nos (disorder) --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital ear anomaly nos (disorder) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  297. en:congenital ischemic atrophy of central nervous system structure --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital ischemic atrophy of central nervous system structure | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  298. en:congenital mesh qualifier --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital mesh qualifier | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  299. en:congenital musculoskeletal defect --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital musculoskeletal defect | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  300. en:congenital pain insensitivity --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital pain insensitivity | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  301. en:congenital peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  302. en:congenital respiratory system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital respiratory system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  303. en:congenital spastic foot --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital spastic foot | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  304. en:congenital urinary system abnormality --- r_associated #0: 20 --> S.E.P.
    n1=en:congenital urinary system abnormality | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  305. en:connective and soft tissue injury --- r_associated #0: 20 --> S.E.P.
    n1=en:connective and soft tissue injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  306. en:connective tissue disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:connective tissue disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  307. en:contact dermatitis and other eczema --- r_associated #0: 20 --> S.E.P.
    n1=en:contact dermatitis and other eczema | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  308. en:contracting cord sign --- r_associated #0: 20 --> S.E.P.
    n1=en:contracting cord sign | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  309. en:contusion/hemorrhage eye --- r_associated #0: 20 --> S.E.P.
    n1=en:contusion/hemorrhage eye | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  310. en:convulsive seizures --- r_associated #0: 20 --> S.E.P.
    n1=en:convulsive seizures | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  311. en:cop 1 (polymer) --- r_associated #0: 20 --> S.E.P.
    n1=en:cop 1 (polymer) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  312. en:cor pulmonale --- r_associated #0: 20 --> S.E.P.
    n1=en:cor pulmonale | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  313. en:corneal ulcer --- r_associated #0: 20 --> S.E.P.
    n1=en:corneal ulcer | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  314. en:craniofacial abnormalities --- r_associated #0: 20 --> S.E.P.
    n1=en:craniofacial abnormalities | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  315. en:creutzfeldt-jakob disease --- r_associated #0: 20 --> S.E.P.
    n1=en:creutzfeldt-jakob disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  316. en:crohn disease --- r_associated #0: 20 --> S.E.P.
    n1=en:crohn disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  317. en:crohn disease-associated dysplasia --- r_associated #0: 20 --> S.E.P.
    n1=en:crohn disease-associated dysplasia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  318. en:cryptococcus infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:cryptococcus infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  319. en:ctla4 haploinsufficiency --- r_associated #0: 20 --> S.E.P.
    n1=en:ctla4 haploinsufficiency | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  320. en:ctrp terminology --- r_associated #0: 20 --> S.E.P.
    n1=en:ctrp terminology | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  321. en:cystitis/other urinary infection nos --- r_associated #0: 20 --> S.E.P.
    n1=en:cystitis/other urinary infection nos | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  322. en:cytomegaloviral infection --- r_associated #0: 20 --> S.E.P.
    n1=en:cytomegaloviral infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  323. en:de barsy syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:de barsy syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  324. en:deafness --- r_associated #0: 20 --> S.E.P.
    n1=en:deafness | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  325. en:death --- r_associated #0: 20 --> S.E.P.
    n1=en:death | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  326. en:decreased libido --- r_associated #0: 20 --> S.E.P.
    n1=en:decreased libido | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  327. en:degenerative nerve diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:degenerative nerve diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  328. en:delirium --- r_associated #0: 20 --> S.E.P.
    n1=en:delirium | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  329. en:dementia --- r_associated #0: 20 --> S.E.P.
    n1=en:dementia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  330. en:dementia associated with multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:dementia associated with multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  331. en:dementia senile/alzheimer --- r_associated #0: 20 --> S.E.P.
    n1=en:dementia senile/alzheimer | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  332. en:demyelinating autoimmune diseases, cns --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating autoimmune diseases, cns | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  333. en:demyelinating disease (excl multiple sclerosis) --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating disease (excl multiple sclerosis) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  334. en:demyelinating disease of central nervous system co-occurrent with human immunodeficiency virus infection --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating disease of central nervous system co-occurrent with human immunodeficiency virus infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  335. en:demyelinating disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  336. en:demyelinating disorder of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating disorder of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  337. en:demyelinating encephalopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating encephalopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  338. en:demyelinating polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelinating polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  339. en:demyelination --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelination | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  340. en:demyelination of spinal cord --- r_associated #0: 20 --> S.E.P.
    n1=en:demyelination of spinal cord | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  341. en:depressive disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:depressive disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  342. en:dermatitis herpetiformis --- r_associated #0: 20 --> S.E.P.
    n1=en:dermatitis herpetiformis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  343. en:dermatomyositis --- r_associated #0: 20 --> S.E.P.
    n1=en:dermatomyositis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  344. en:dermatophytosis --- r_associated #0: 20 --> S.E.P.
    n1=en:dermatophytosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  345. en:diabetes mellitus --- r_associated #0: 20 --> S.E.P.
    n1=en:diabetes mellitus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  346. en:diabetic foot --- r_associated #0: 20 --> S.E.P.
    n1=en:diabetic foot | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  347. en:diabetic nerve problems --- r_associated #0: 20 --> S.E.P.
    n1=en:diabetic nerve problems | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  348. en:diabetic neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:diabetic neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  349. en:diagnosis aspect --- r_associated #0: 20 --> S.E.P.
    n1=en:diagnosis aspect | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  350. en:diagnosis/diseases component --- r_associated #0: 20 --> S.E.P.
    n1=en:diagnosis/diseases component | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  351. en:diaper dermatitis --- r_associated #0: 20 --> S.E.P.
    n1=en:diaper dermatitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  352. en:dietary calcium --- r_associated #0: 20 --> S.E.P.
    n1=en:dietary calcium | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  353. en:diffuse cerebral sclerosis of schilder --- r_associated #0: 20 --> S.E.P.
    n1=en:diffuse cerebral sclerosis of schilder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  354. en:diffuse hyperplastic perilobar nephroblastomatosis --- r_associated #0: 20 --> S.E.P.
    n1=en:diffuse hyperplastic perilobar nephroblastomatosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  355. en:disease history:hx:pt:^patient:nom:phenx --- r_associated #0: 20 --> S.E.P.
    n1=en:disease history:hx:pt:^patient:nom:phenx | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  356. en:disease of mouth/tongue/lips --- r_associated #0: 20 --> S.E.P.
    n1=en:disease of mouth/tongue/lips | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  357. en:disease of teeth/gums --- r_associated #0: 20 --> S.E.P.
    n1=en:disease of teeth/gums | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  358. en:disk, herniated --- r_associated #0: 20 --> S.E.P.
    n1=en:disk, herniated | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  359. en:dislocation --- r_associated #0: 20 --> S.E.P.
    n1=en:dislocation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  360. en:disorder of central nervous system co-occurrent and due to acute lymphoid leukemia --- r_associated #0: 20 --> S.E.P.
    n1=en:disorder of central nervous system co-occurrent and due to acute lymphoid leukemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  361. en:disorder of central nervous system co-occurrent with human immunodeficiency virus infection --- r_associated #0: 20 --> S.E.P.
    n1=en:disorder of central nervous system co-occurrent with human immunodeficiency virus infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  362. en:disorder of nerve root and/or plexus --- r_associated #0: 20 --> S.E.P.
    n1=en:disorder of nerve root and/or plexus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  363. en:disorder of peripheral nerve graft --- r_associated #0: 20 --> S.E.P.
    n1=en:disorder of peripheral nerve graft | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  364. en:disorder of peripheral nervous system co-occurrent with human immunodeficiency virus infection --- r_associated #0: 20 --> S.E.P.
    n1=en:disorder of peripheral nervous system co-occurrent with human immunodeficiency virus infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  365. en:disorders of cerebrospinal fluid and intracranial pressure --- r_associated #0: 20 --> S.E.P.
    n1=en:disorders of cerebrospinal fluid and intracranial pressure | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  366. en:disorders of meninges, not elsewhere classified in icd10cm --- r_associated #0: 20 --> S.E.P.
    n1=en:disorders of meninges, not elsewhere classified in icd10cm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  367. en:disorders of other cranial nerves --- r_associated #0: 20 --> S.E.P.
    n1=en:disorders of other cranial nerves | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  368. en:disseminated or multiple sclerosis nos --- r_associated #0: 20 --> S.E.P.
    n1=en:disseminated or multiple sclerosis nos | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  369. en:disseminated or multiple sclerosis, brain stem --- r_associated #0: 20 --> S.E.P.
    n1=en:disseminated or multiple sclerosis, brain stem | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  370. en:disseminated or multiple sclerosis, cord --- r_associated #0: 20 --> S.E.P.
    n1=en:disseminated or multiple sclerosis, cord | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  371. en:disseminated or multiple sclerosis, generalized --- r_associated #0: 20 --> S.E.P.
    n1=en:disseminated or multiple sclerosis, generalized | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  372. en:disseminated sclerosis with narcolepsy --- r_associated #0: 20 --> S.E.P.
    n1=en:disseminated sclerosis with narcolepsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  373. en:disturbances of smell and taste --- r_associated #0: 20 --> S.E.P.
    n1=en:disturbances of smell and taste | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  374. en:diverticulosis --- r_associated #0: 20 --> S.E.P.
    n1=en:diverticulosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  375. en:dizziness adverse event --- r_associated #0: 20 --> S.E.P.
    n1=en:dizziness adverse event | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  376. en:dizziness and vertigo --- r_associated #0: 20 --> S.E.P.
    n1=en:dizziness and vertigo | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  377. en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx --- r_associated #0: 20 --> S.E.P.
    n1=en:do you or your child have any of the following diseases:find:pt:^patient:nom:phenx | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  378. en:duodenal ulcer --- r_associated #0: 20 --> S.E.P.
    n1=en:duodenal ulcer | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  379. en:dwarfism --- r_associated #0: 20 --> S.E.P.
    n1=en:dwarfism | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  380. en:dysarthria --- r_associated #0: 20 --> S.E.P.
    n1=en:dysarthria | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  381. en:dyshidrosis [pompholyx] --- r_associated #0: 20 --> S.E.P.
    n1=en:dyshidrosis [pompholyx] | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  382. en:dystonia disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:dystonia disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  383. en:ear neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:ear neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  384. en:ectopic pregnancy --- r_associated #0: 20 --> S.E.P.
    n1=en:ectopic pregnancy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  385. en:eeg shows generalized and focal spike and wave complexes --- r_associated #0: 20 --> S.E.P.
    n1=en:eeg shows generalized and focal spike and wave complexes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  386. en:eeg with photoparoxysmal response --- r_associated #0: 20 --> S.E.P.
    n1=en:eeg with photoparoxysmal response | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  387. en:effect prosthetic device --- r_associated #0: 20 --> S.E.P.
    n1=en:effect prosthetic device | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  388. en:ehlers-danlos syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:ehlers-danlos syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  389. en:ehrlichia infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:ehrlichia infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  390. en:elbow injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:elbow injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  391. en:electrophysiologic studies indicate cortical origin --- r_associated #0: 20 --> S.E.P.
    n1=en:electrophysiologic studies indicate cortical origin | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  392. en:embryologic --- r_associated #0: 20 --> S.E.P.
    n1=en:embryologic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  393. en:encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  394. en:encephalomyelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:encephalomyelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  395. en:encephalopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:encephalopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  396. en:endocrine infection --- r_associated #0: 20 --> S.E.P.
    n1=en:endocrine infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  397. en:endometrial hyperplasia without atypia --- r_associated #0: 20 --> S.E.P.
    n1=en:endometrial hyperplasia without atypia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  398. en:enhancement of the c-reflex --- r_associated #0: 20 --> S.E.P.
    n1=en:enhancement of the c-reflex | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  399. en:enterovirus infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:enterovirus infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  400. en:entrapment neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:entrapment neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  401. en:enzymology --- r_associated #0: 20 --> S.E.P.
    n1=en:enzymology | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  402. en:ependymal cyst of spinal nerve --- r_associated #0: 20 --> S.E.P.
    n1=en:ependymal cyst of spinal nerve | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  403. en:epidemiologic --- r_associated #0: 20 --> S.E.P.
    n1=en:epidemiologic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  404. en:epididymo-orchitis --- r_associated #0: 20 --> S.E.P.
    n1=en:epididymo-orchitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  405. en:epilepsy and recurrent seizures --- r_associated #0: 20 --> S.E.P.
    n1=en:epilepsy and recurrent seizures | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  406. en:episodic peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:episodic peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  407. en:epstein-barr virus infection --- r_associated #0: 20 --> S.E.P.
    n1=en:epstein-barr virus infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  408. en:erdheim-chester disease --- r_associated #0: 20 --> S.E.P.
    n1=en:erdheim-chester disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  409. en:escherichia coli infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:escherichia coli infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  410. en:esophageal disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:esophageal disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  411. en:esophageal stricture --- r_associated #0: 20 --> S.E.P.
    n1=en:esophageal stricture | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  412. en:ethnologic --- r_associated #0: 20 --> S.E.P.
    n1=en:ethnologic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  413. en:etiology aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:etiology aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  414. en:eustachian tube salpingitis --- r_associated #0: 20 --> S.E.P.
    n1=en:eustachian tube salpingitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  415. en:evans syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:evans syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  416. en:excessive cerumen --- r_associated #0: 20 --> S.E.P.
    n1=en:excessive cerumen | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  417. en:exophthalmos --- r_associated #0: 20 --> S.E.P.
    n1=en:exophthalmos | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  418. en:experimental allergic encephalomyelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:experimental allergic encephalomyelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  419. en:exposure as collected domain --- r_associated #0: 20 --> S.E.P.
    n1=en:exposure as collected domain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  420. en:extrapontine myelinolyses --- r_associated #0: 20 --> S.E.P.
    n1=en:extrapontine myelinolyses | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  421. en:f8 gene --- r_associated #0: 20 --> S.E.P.
    n1=en:f8 gene | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  422. en:facial injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:facial injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  423. en:facial nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:facial nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  424. en:facial nerve palsy --- r_associated #0: 20 --> S.E.P.
    n1=en:facial nerve palsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  425. en:facial neuralgia --- r_associated #0: 20 --> S.E.P.
    n1=en:facial neuralgia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  426. en:facial pain --- r_associated #0: 20 --> S.E.P.
    n1=en:facial pain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  427. en:facial paralysis --- r_associated #0: 20 --> S.E.P.
    n1=en:facial paralysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  428. en:familial periodic paralysis --- r_associated #0: 20 --> S.E.P.
    n1=en:familial periodic paralysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  429. en:fear of cancer neurological system --- r_associated #0: 20 --> S.E.P.
    n1=en:fear of cancer neurological system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  430. en:fear of other neurological disease --- r_associated #0: 20 --> S.E.P.
    n1=en:fear of other neurological disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  431. en:female genital injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:female genital injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  432. en:femur fracture --- r_associated #0: 20 --> S.E.P.
    n1=en:femur fracture | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  433. en:fetus with central nervous system malformation --- r_associated #0: 20 --> S.E.P.
    n1=en:fetus with central nervous system malformation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  434. en:fh: multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:fh: multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  435. en:fibroid/myoma (uterus/cervix) --- r_associated #0: 20 --> S.E.P.
    n1=en:fibroid/myoma (uterus/cervix) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  436. en:fibromyalgia --- r_associated #0: 20 --> S.E.P.
    n1=en:fibromyalgia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  437. en:finger injury --- r_associated #0: 20 --> S.E.P.
    n1=en:finger injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  438. en:fisher syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:fisher syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  439. en:flaccid paralysis --- r_associated #0: 20 --> S.E.P.
    n1=en:flaccid paralysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  440. en:foot health --- r_associated #0: 20 --> S.E.P.
    n1=en:foot health | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  441. en:foot injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:foot injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  442. en:foreign body in auditory canal --- r_associated #0: 20 --> S.E.P.
    n1=en:foreign body in auditory canal | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  443. en:foreign body nose/larynx/bronchus --- r_associated #0: 20 --> S.E.P.
    n1=en:foreign body nose/larynx/bronchus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  444. en:fracture --- r_associated #0: 20 --> S.E.P.
    n1=en:fracture | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  445. en:fracture hand/foot bones --- r_associated #0: 20 --> S.E.P.
    n1=en:fracture hand/foot bones | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  446. en:fracture of radius and ulna --- r_associated #0: 20 --> S.E.P.
    n1=en:fracture of radius and ulna | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  447. en:fracture of tibia and fibula --- r_associated #0: 20 --> S.E.P.
    n1=en:fracture of tibia and fibula | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  448. en:fracture other --- r_associated #0: 20 --> S.E.P.
    n1=en:fracture other | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  449. en:friedreich ataxia --- r_associated #0: 20 --> S.E.P.
    n1=en:friedreich ataxia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  450. en:functional disease of the cns with neuroendocrine disturbance --- r_associated #0: 20 --> S.E.P.
    n1=en:functional disease of the cns with neuroendocrine disturbance | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  451. en:gait disturbance --- r_associated #0: 20 --> S.E.P.
    n1=en:gait disturbance | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  452. en:ganglion joint/tendon --- r_associated #0: 20 --> S.E.P.
    n1=en:ganglion joint/tendon | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  453. en:gastroenteritis presumed infectious --- r_associated #0: 20 --> S.E.P.
    n1=en:gastroenteritis presumed infectious | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  454. en:generalized tonic-clonic seizures (gtcs), infrequent --- r_associated #0: 20 --> S.E.P.
    n1=en:generalized tonic-clonic seizures (gtcs), infrequent | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  455. en:genetic aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:genetic aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  456. en:genetic brain disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:genetic brain disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  457. en:genital herpes in men --- r_associated #0: 20 --> S.E.P.
    n1=en:genital herpes in men | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  458. en:genital herpes in women --- r_associated #0: 20 --> S.E.P.
    n1=en:genital herpes in women | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  459. en:giant axonal neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:giant axonal neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  460. en:giant somatosensory evoked potentials --- r_associated #0: 20 --> S.E.P.
    n1=en:giant somatosensory evoked potentials | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  461. en:glaucoma --- r_associated #0: 20 --> S.E.P.
    n1=en:glaucoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  462. en:gliosis --- r_associated #0: 20 --> S.E.P.
    n1=en:gliosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  463. en:glomerulonephritis --- r_associated #0: 20 --> S.E.P.
    n1=en:glomerulonephritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  464. en:glomerulonephritis/nephrosis --- r_associated #0: 20 --> S.E.P.
    n1=en:glomerulonephritis/nephrosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  465. en:glossopharyngeal nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:glossopharyngeal nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  466. en:glycosuria, renal --- r_associated #0: 20 --> S.E.P.
    n1=en:glycosuria, renal | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  467. en:goiter --- r_associated #0: 20 --> S.E.P.
    n1=en:goiter | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  468. en:gonorrhea female --- r_associated #0: 20 --> S.E.P.
    n1=en:gonorrhea female | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  469. en:gonorrhea male --- r_associated #0: 20 --> S.E.P.
    n1=en:gonorrhea male | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  470. en:gout --- r_associated #0: 20 --> S.E.P.
    n1=en:gout | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  471. en:grand mal epilepsy --- r_associated #0: 20 --> S.E.P.
    n1=en:grand mal epilepsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  472. en:graves disease --- r_associated #0: 20 --> S.E.P.
    n1=en:graves disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  473. en:guillain-barre syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:guillain-barre syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  474. en:hand injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:hand injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  475. en:hand-arm vibration syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:hand-arm vibration syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  476. en:hashimoto thyroiditis --- r_associated #0: 20 --> S.E.P.
    n1=en:hashimoto thyroiditis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  477. en:headache --- r_associated #0: 20 --> S.E.P.
    n1=en:headache | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  478. en:headache, primary thunderclap --- r_associated #0: 20 --> S.E.P.
    n1=en:headache, primary thunderclap | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  479. en:heart failure --- r_associated #0: 20 --> S.E.P.
    n1=en:heart failure | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  480. en:heart murmur --- r_associated #0: 20 --> S.E.P.
    n1=en:heart murmur | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  481. en:heel injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:heel injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  482. en:helicobacter pylori infection --- r_associated #0: 20 --> S.E.P.
    n1=en:helicobacter pylori infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  483. en:hemangiomas and lymphangiomas of any site --- r_associated #0: 20 --> S.E.P.
    n1=en:hemangiomas and lymphangiomas of any site | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  484. en:hemiparesis --- r_associated #0: 20 --> S.E.P.
    n1=en:hemiparesis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  485. en:hemiplegia --- r_associated #0: 20 --> S.E.P.
    n1=en:hemiplegia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  486. en:hemiplegia/hemiparesis --- r_associated #0: 20 --> S.E.P.
    n1=en:hemiplegia/hemiparesis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  487. en:hemophagocytic lymphohistiocytosis --- r_associated #0: 20 --> S.E.P.
    n1=en:hemophagocytic lymphohistiocytosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  488. en:hemorrhagic cerebrovascular accident --- r_associated #0: 20 --> S.E.P.
    n1=en:hemorrhagic cerebrovascular accident | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  489. en:hemorrhoid --- r_associated #0: 20 --> S.E.P.
    n1=en:hemorrhoid | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  490. en:hepatic autoimmune disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:hepatic autoimmune disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  491. en:hepatitis b infection --- r_associated #0: 20 --> S.E.P.
    n1=en:hepatitis b infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  492. en:hepatitis c infection --- r_associated #0: 20 --> S.E.P.
    n1=en:hepatitis c infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  493. en:hepatolenticular degeneration --- r_associated #0: 20 --> S.E.P.
    n1=en:hepatolenticular degeneration | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  494. en:hepatomegaly --- r_associated #0: 20 --> S.E.P.
    n1=en:hepatomegaly | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  495. en:hereditary and idiopathic peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary and idiopathic peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  496. en:hereditary and idiopathic peripheral neuropathy, other --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary and idiopathic peripheral neuropathy, other | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  497. en:hereditary degenerative disease of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary degenerative disease of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  498. en:hereditary hemolytic anemia --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary hemolytic anemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  499. en:hereditary neuraxial edema --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary neuraxial edema | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  500. en:hereditary peripheral nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary peripheral nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  501. en:hereditary peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:hereditary peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  502. en:herpes simplex infections --- r_associated #0: 20 --> S.E.P.
    n1=en:herpes simplex infections | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  503. en:herpes virus infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:herpes virus infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  504. en:herpes zoster --- r_associated #0: 20 --> S.E.P.
    n1=en:herpes zoster | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  505. en:hiatal hernia --- r_associated #0: 20 --> S.E.P.
    n1=en:hiatal hernia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  506. en:high pressure neurological syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:high pressure neurological syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  507. en:high risk pregnancy --- r_associated #0: 20 --> S.E.P.
    n1=en:high risk pregnancy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  508. en:hip injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:hip injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  509. en:hip osteoarthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:hip osteoarthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  510. en:hip replacement arthroplasty (procedure) --- r_associated #0: 20 --> S.E.P.
    n1=en:hip replacement arthroplasty (procedure) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  511. en:histoplasma infection of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:histoplasma infection of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  512. en:historical aspects qualifier --- r_associated #0: 20 --> S.E.P.
    n1=en:historical aspects qualifier | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  513. en:hiv infection --- r_associated #0: 20 --> S.E.P.
    n1=en:hiv infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  514. en:hiv/aids --- r_associated #0: 20 --> S.E.P.
    n1=en:hiv/aids | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  515. en:hodgkin lymphoma --- r_associated #0: 20 --> S.E.P.
    n1=en:hodgkin lymphoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  516. en:htlv-1 infection --- r_associated #0: 20 --> S.E.P.
    n1=en:htlv-1 infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  517. en:human papillomavirus infection --- r_associated #0: 20 --> S.E.P.
    n1=en:human papillomavirus infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  518. en:huntington's disease --- r_associated #0: 20 --> S.E.P.
    n1=en:huntington's disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  519. en:hurler syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:hurler syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  520. en:hydrocephalus --- r_associated #0: 20 --> S.E.P.
    n1=en:hydrocephalus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  521. en:hyperalgesia --- r_associated #0: 20 --> S.E.P.
    n1=en:hyperalgesia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  522. en:hyperesthesia --- r_associated #0: 20 --> S.E.P.
    n1=en:hyperesthesia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  523. en:hyperparathyroidism --- r_associated #0: 20 --> S.E.P.
    n1=en:hyperparathyroidism | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  524. en:hypertension --- r_associated #0: 20 --> S.E.P.
    n1=en:hypertension | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  525. en:hypertension with involvement target organs --- r_associated #0: 20 --> S.E.P.
    n1=en:hypertension with involvement target organs | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  526. en:hypertrophic interstitial neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:hypertrophic interstitial neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  527. en:hypertrophy of tonsils and adenoids --- r_associated #0: 20 --> S.E.P.
    n1=en:hypertrophy of tonsils and adenoids | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  528. en:hyperventilation --- r_associated #0: 20 --> S.E.P.
    n1=en:hyperventilation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  529. en:hypoalgesia --- r_associated #0: 20 --> S.E.P.
    n1=en:hypoalgesia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  530. en:hypoesthesia --- r_associated #0: 20 --> S.E.P.
    n1=en:hypoesthesia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  531. en:hypoglossal nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:hypoglossal nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  532. en:hypoglycemia --- r_associated #0: 20 --> S.E.P.
    n1=en:hypoglycemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  533. en:hypospadias --- r_associated #0: 20 --> S.E.P.
    n1=en:hypospadias | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  534. en:hysterical/hypochondriacal disease --- r_associated #0: 20 --> S.E.P.
    n1=en:hysterical/hypochondriacal disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  535. en:idiopathic neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:idiopathic neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  536. en:idiopathic peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:idiopathic peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  537. en:idiopathic thrombocytopenic purpura --- r_associated #0: 20 --> S.E.P.
    n1=en:idiopathic thrombocytopenic purpura | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  538. en:iga nephropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:iga nephropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  539. en:il17a gene --- r_associated #0: 20 --> S.E.P.
    n1=en:il17a gene | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  540. en:il17a wt allele --- r_associated #0: 20 --> S.E.P.
    n1=en:il17a wt allele | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  541. en:immune system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:immune system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  542. en:immunology aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:immunology aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  543. en:impetigo --- r_associated #0: 20 --> S.E.P.
    n1=en:impetigo | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  544. en:in blood --- r_associated #0: 20 --> S.E.P.
    n1=en:in blood | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  545. en:in cerebrospinal fluid --- r_associated #0: 20 --> S.E.P.
    n1=en:in cerebrospinal fluid | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  546. en:in urine --- r_associated #0: 20 --> S.E.P.
    n1=en:in urine | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  547. en:increase in blood pressure --- r_associated #0: 20 --> S.E.P.
    n1=en:increase in blood pressure | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  548. en:increased libido --- r_associated #0: 20 --> S.E.P.
    n1=en:increased libido | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  549. en:indolent systemic mastocytosis --- r_associated #0: 20 --> S.E.P.
    n1=en:indolent systemic mastocytosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  550. en:induced abortion finding --- r_associated #0: 20 --> S.E.P.
    n1=en:induced abortion finding | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  551. en:infantile cerebral palsy --- r_associated #0: 20 --> S.E.P.
    n1=en:infantile cerebral palsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  552. en:infantile neuroaxonal dystrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:infantile neuroaxonal dystrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  553. en:infections of musculoskeletal system --- r_associated #0: 20 --> S.E.P.
    n1=en:infections of musculoskeletal system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  554. en:infectious conjunctivitis --- r_associated #0: 20 --> S.E.P.
    n1=en:infectious conjunctivitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  555. en:infectious diarrhea/dysentery --- r_associated #0: 20 --> S.E.P.
    n1=en:infectious diarrhea/dysentery | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  556. en:infectious disease circulatory system --- r_associated #0: 20 --> S.E.P.
    n1=en:infectious disease circulatory system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  557. en:infectious mononucleosis --- r_associated #0: 20 --> S.E.P.
    n1=en:infectious mononucleosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  558. en:infective arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:infective arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  559. en:inflammatory and toxic neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:inflammatory and toxic neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  560. en:inflammatory disease of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:inflammatory disease of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  561. en:influenza (proven) without pneumonia --- r_associated #0: 20 --> S.E.P.
    n1=en:influenza (proven) without pneumonia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  562. en:influenza of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:influenza of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  563. en:ingrown toenail/other disease of nail --- r_associated #0: 20 --> S.E.P.
    n1=en:ingrown toenail/other disease of nail | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  564. en:inguinal hernia --- r_associated #0: 20 --> S.E.P.
    n1=en:inguinal hernia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  565. en:inherited neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:inherited neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  566. en:injection neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:injection neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  567. en:injuries complicating pregnancy --- r_associated #0: 20 --> S.E.P.
    n1=en:injuries complicating pregnancy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  568. en:injury of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:injury of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  569. en:insulin resistance - type b --- r_associated #0: 20 --> S.E.P.
    n1=en:insulin resistance - type b | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  570. en:intercostal neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:intercostal neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  571. en:interleukin-17a --- r_associated #0: 20 --> S.E.P.
    n1=en:interleukin-17a | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  572. en:intracranial hemorrhage --- r_associated #0: 20 --> S.E.P.
    n1=en:intracranial hemorrhage | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  573. en:intracranial hypertension --- r_associated #0: 20 --> S.E.P.
    n1=en:intracranial hypertension | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  574. en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers --- r_associated #0: 20 --> S.E.P.
    n1=en:involuntary rhythmic myoclonic movements ('tremor') of the distal extremities, usually fingers | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  575. en:iron-deficiency anemia --- r_associated #0: 20 --> S.E.P.
    n1=en:iron-deficiency anemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  576. en:irritable bowel syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:irritable bowel syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  577. en:isaacs syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:isaacs syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  578. en:ischemic cerebrovascular accident --- r_associated #0: 20 --> S.E.P.
    n1=en:ischemic cerebrovascular accident | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  579. en:ischemic neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:ischemic neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  580. en:jerk-locked premyoclonus spikes --- r_associated #0: 20 --> S.E.P.
    n1=en:jerk-locked premyoclonus spikes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  581. en:juvenile arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:juvenile arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  582. en:juvenile rheumatoid arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:juvenile rheumatoid arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  583. en:knee injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:knee injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  584. en:lambert eaton myasthenic syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:lambert eaton myasthenic syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  585. en:late effect of trauma --- r_associated #0: 20 --> S.E.P.
    n1=en:late effect of trauma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  586. en:late effects of central nervous system tuberculosis --- r_associated #0: 20 --> S.E.P.
    n1=en:late effects of central nervous system tuberculosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  587. en:late effects of poliomyelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:late effects of poliomyelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  588. en:late secondary abnormalities of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:late secondary abnormalities of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  589. en:lateral epicondylitis --- r_associated #0: 20 --> S.E.P.
    n1=en:lateral epicondylitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  590. en:learning difficulties (classic feature) --- r_associated #0: 20 --> S.E.P.
    n1=en:learning difficulties (classic feature) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  591. en:leg cramp --- r_associated #0: 20 --> S.E.P.
    n1=en:leg cramp | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  592. en:leg injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:leg injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  593. en:leprosy neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:leprosy neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  594. en:leptospira infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:leptospira infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  595. en:leukemia --- r_associated #0: 20 --> S.E.P.
    n1=en:leukemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  596. en:leukodystrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:leukodystrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  597. en:leukoencephalomyelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:leukoencephalomyelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  598. en:lewy body dementia --- r_associated #0: 20 --> S.E.P.
    n1=en:lewy body dementia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  599. en:limbic encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:limbic encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  600. en:limited neurologic function --- r_associated #0: 20 --> S.E.P.
    n1=en:limited neurologic function | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  601. en:linear iga bullous dermatosis --- r_associated #0: 20 --> S.E.P.
    n1=en:linear iga bullous dermatosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  602. en:lipid metabolism disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:lipid metabolism disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  603. en:lipoma --- r_associated #0: 20 --> S.E.P.
    n1=en:lipoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  604. en:listeria infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:listeria infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  605. en:localized scleroderma --- r_associated #0: 20 --> S.E.P.
    n1=en:localized scleroderma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  606. en:long thoracic nerve lesion --- r_associated #0: 20 --> S.E.P.
    n1=en:long thoracic nerve lesion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  607. en:lumbar disc lesion/radiation --- r_associated #0: 20 --> S.E.P.
    n1=en:lumbar disc lesion/radiation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  608. en:lupus erythematosus --- r_associated #0: 20 --> S.E.P.
    n1=en:lupus erythematosus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  609. en:lupus erythematosus and associated conditions --- r_associated #0: 20 --> S.E.P.
    n1=en:lupus erythematosus and associated conditions | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  610. en:lymphangioleiomyomatosis --- r_associated #0: 20 --> S.E.P.
    n1=en:lymphangioleiomyomatosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  611. en:lymphatic diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:lymphatic diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  612. en:macular degeneration --- r_associated #0: 20 --> S.E.P.
    n1=en:macular degeneration | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  613. en:malaria --- r_associated #0: 20 --> S.E.P.
    n1=en:malaria | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  614. en:male genital injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:male genital injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  615. en:malignant bladder neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant bladder neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  616. en:malignant bone neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant bone neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  617. en:malignant cervical neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant cervical neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  618. en:malignant gastric neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant gastric neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  619. en:malignant kidney neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant kidney neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  620. en:malignant neoplasm of colon with rectum --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant neoplasm of colon with rectum | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  621. en:malignant neoplasm of female breast --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant neoplasm of female breast | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  622. en:malignant neoplasm other/unspecified --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant neoplasm other/unspecified | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  623. en:malignant neoplasm: bronchus or lung, unspecified --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant neoplasm: bronchus or lung, unspecified | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  624. en:malignant nervous system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant nervous system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  625. en:malignant obstetric neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant obstetric neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  626. en:malignant pancreatic neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant pancreatic neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  627. en:malignant prostate neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant prostate neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  628. en:malignant skin neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant skin neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  629. en:malignant thyroid gland neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:malignant thyroid gland neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  630. en:mandibular injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:mandibular injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  631. en:marburg's variant multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:marburg's variant multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  632. en:marchiafava-bignami disease --- r_associated #0: 20 --> S.E.P.
    n1=en:marchiafava-bignami disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  633. en:mastitis, postpartum --- r_associated #0: 20 --> S.E.P.
    n1=en:mastitis, postpartum | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  634. en:measles --- r_associated #0: 20 --> S.E.P.
    n1=en:measles | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  635. en:measles of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:measles of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  636. en:membranous glomerulonephritis --- r_associated #0: 20 --> S.E.P.
    n1=en:membranous glomerulonephritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  637. en:memory --- r_associated #0: 20 --> S.E.P.
    n1=en:memory | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  638. en:meningeal disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:meningeal disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  639. en:meningitis --- r_associated #0: 20 --> S.E.P.
    n1=en:meningitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  640. en:meningitis/encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:meningitis/encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  641. en:mental retardation --- r_associated #0: 20 --> S.E.P.
    n1=en:mental retardation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  642. en:mental retardation (classic feature) --- r_associated #0: 20 --> S.E.P.
    n1=en:mental retardation (classic feature) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  643. en:mental retardation, but majority of patients are normal --- r_associated #0: 20 --> S.E.P.
    n1=en:mental retardation, but majority of patients are normal | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  644. en:metabolic aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:metabolic aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  645. en:microbiological --- r_associated #0: 20 --> S.E.P.
    n1=en:microbiological | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  646. en:migraine --- r_associated #0: 20 --> S.E.P.
    n1=en:migraine | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  647. en:mikulicz disease --- r_associated #0: 20 --> S.E.P.
    n1=en:mikulicz disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  648. en:mild cognitive disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:mild cognitive disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  649. en:mitoxantrone --- r_associated #0: 20 --> S.E.P.
    n1=en:mitoxantrone | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  650. en:mitoxantrone hydrochloride --- r_associated #0: 20 --> S.E.P.
    n1=en:mitoxantrone hydrochloride | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  651. en:mitozantrone 2mg/ml infusion concentrate 10ml vial --- r_associated #0: 20 --> S.E.P.
    n1=en:mitozantrone 2mg/ml infusion concentrate 10ml vial | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  652. en:mixed connective tissue disease --- r_associated #0: 20 --> S.E.P.
    n1=en:mixed connective tissue disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  653. en:mixed demyelinating and axonal polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:mixed demyelinating and axonal polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  654. en:molluscum contagiosum --- r_associated #0: 20 --> S.E.P.
    n1=en:molluscum contagiosum | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  655. en:moniliasis genital female --- r_associated #0: 20 --> S.E.P.
    n1=en:moniliasis genital female | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  656. en:moniliasis/candida (excluding x72 y75) --- r_associated #0: 20 --> S.E.P.
    n1=en:moniliasis/candida (excluding x72 y75) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  657. en:monomac syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:monomac syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  658. en:mononeuritis of lower limb, unspecified --- r_associated #0: 20 --> S.E.P.
    n1=en:mononeuritis of lower limb, unspecified | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  659. en:mononeuritis of upper limb and mononeuritis multiplex --- r_associated #0: 20 --> S.E.P.
    n1=en:mononeuritis of upper limb and mononeuritis multiplex | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  660. en:mononeuropathies --- r_associated #0: 20 --> S.E.P.
    n1=en:mononeuropathies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  661. en:monoplegias --- r_associated #0: 20 --> S.E.P.
    n1=en:monoplegias | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  662. en:motor neuron disease --- r_associated #0: 20 --> S.E.P.
    n1=en:motor neuron disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  663. en:movement disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:movement disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  664. en:movements ('tremors') characterized by 8 to 10-hz discharges --- r_associated #0: 20 --> S.E.P.
    n1=en:movements ('tremors') characterized by 8 to 10-hz discharges | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  665. en:ms aggravated --- r_associated #0: 20 --> S.E.P.
    n1=en:ms aggravated | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  666. en:ms gene --- r_associated #0: 20 --> S.E.P.
    n1=en:ms gene | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  667. en:multiple congenital anomalies --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple congenital anomalies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  668. en:multiple sclerosis acute and progressive --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis acute and progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  669. en:multiple sclerosis brain lesion --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis brain lesion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  670. en:multiple sclerosis of the brainstem --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis of the brainstem | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  671. en:multiple sclerosis of the spinal cord --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis of the spinal cord | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  672. en:multiple sclerosis plaque --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis plaque | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  673. en:multiple sclerosis relapse --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis relapse | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  674. en:multiple sclerosis spinal cord lesion --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis spinal cord lesion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  675. en:multiple sclerosis, acute fulminating --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis, acute fulminating | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  676. en:multiple sclerosis, chronic progressive --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis, chronic progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  677. en:multiple sclerosis, relapsing-remitting --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis, relapsing-remitting | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  678. en:multiple sclerosis, susceptibility to --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis, susceptibility to | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  679. en:multiple sclerosis:find:pt:^patient:ord:mds --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple sclerosis:find:pt:^patient:ord:mds | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  680. en:multiple trauma/internal injury --- r_associated #0: 20 --> S.E.P.
    n1=en:multiple trauma/internal injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  681. en:mumps --- r_associated #0: 20 --> S.E.P.
    n1=en:mumps | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  682. en:muscle cramp --- r_associated #0: 20 --> S.E.P.
    n1=en:muscle cramp | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  683. en:muscular autoimmune disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:muscular autoimmune disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  684. en:muscular dystrophies and other myopathies --- r_associated #0: 20 --> S.E.P.
    n1=en:muscular dystrophies and other myopathies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  685. en:muscular dystrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:muscular dystrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  686. en:myasthenia gravis --- r_associated #0: 20 --> S.E.P.
    n1=en:myasthenia gravis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  687. en:myelin-oligodendrocyte glycoprotein --- r_associated #0: 20 --> S.E.P.
    n1=en:myelin-oligodendrocyte glycoprotein | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  688. en:myelinopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:myelinopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  689. en:myelitis --- r_associated #0: 20 --> S.E.P.
    n1=en:myelitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  690. en:myelitis, transverse --- r_associated #0: 20 --> S.E.P.
    n1=en:myelitis, transverse | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  691. en:myopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:myopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  692. en:myositis --- r_associated #0: 20 --> S.E.P.
    n1=en:myositis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  693. en:myxedema --- r_associated #0: 20 --> S.E.P.
    n1=en:myxedema | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  694. en:narcolepsy --- r_associated #0: 20 --> S.E.P.
    n1=en:narcolepsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  695. en:neck injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:neck injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  696. en:neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  697. en:neoplasm of ocular adnexa --- r_associated #0: 20 --> S.E.P.
    n1=en:neoplasm of ocular adnexa | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  698. en:nerve compression syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:nerve compression syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  699. en:nerve root and plexus disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:nerve root and plexus disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  700. en:nerve root disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:nerve root disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  701. en:nervous system autoimmune disease, experimental --- r_associated #0: 20 --> S.E.P.
    n1=en:nervous system autoimmune disease, experimental | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  702. en:nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  703. en:nervous system disorders, general and nec --- r_associated #0: 20 --> S.E.P.
    n1=en:nervous system disorders, general and nec | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  704. en:neural tube defect --- r_associated #0: 20 --> S.E.P.
    n1=en:neural tube defect | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  705. en:neuralgia --- r_associated #0: 20 --> S.E.P.
    n1=en:neuralgia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  706. en:neuralgic amyotrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:neuralgic amyotrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  707. en:neurasthenia/surmenage --- r_associated #0: 20 --> S.E.P.
    n1=en:neurasthenia/surmenage | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  708. en:neuritis --- r_associated #0: 20 --> S.E.P.
    n1=en:neuritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  709. en:neuroblastoma --- r_associated #0: 20 --> S.E.P.
    n1=en:neuroblastoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  710. en:neurodegenerative disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:neurodegenerative disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  711. en:neurodegenerative disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:neurodegenerative disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  712. en:neurodevelopmental disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:neurodevelopmental disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  713. en:neurofibromatosis --- r_associated #0: 20 --> S.E.P.
    n1=en:neurofibromatosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  714. en:neurofibromatosis type 1 --- r_associated #0: 20 --> S.E.P.
    n1=en:neurofibromatosis type 1 | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  715. en:neurologic --- r_associated #0: 20 --> S.E.P.
    n1=en:neurologic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  716. en:neuromuscular diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:neuromuscular diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  717. en:neuromyelitis optica --- r_associated #0: 20 --> S.E.P.
    n1=en:neuromyelitis optica | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  718. en:neuronal intestinal pseudoobstruction --- r_associated #0: 20 --> S.E.P.
    n1=en:neuronal intestinal pseudoobstruction | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  719. en:neuronitis --- r_associated #0: 20 --> S.E.P.
    n1=en:neuronitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  720. en:neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  721. en:neuropathy of lower limb --- r_associated #0: 20 --> S.E.P.
    n1=en:neuropathy of lower limb | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  722. en:neuropathy of upper limb --- r_associated #0: 20 --> S.E.P.
    n1=en:neuropathy of upper limb | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  723. en:nevus/mole --- r_associated #0: 20 --> S.E.P.
    n1=en:nevus/mole | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  724. en:no disease --- r_associated #0: 20 --> S.E.P.
    n1=en:no disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  725. en:no neurologic abnormalities --- r_associated #0: 20 --> S.E.P.
    n1=en:no neurologic abnormalities | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  726. en:non-cancer diagnosis --- r_associated #0: 20 --> S.E.P.
    n1=en:non-cancer diagnosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  727. en:non-gonococcal urethritis --- r_associated #0: 20 --> S.E.P.
    n1=en:non-gonococcal urethritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  728. en:non-neoplastic brain disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:non-neoplastic brain disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  729. en:non-neoplastic central nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:non-neoplastic central nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  730. en:non-neoplastic peripheral nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:non-neoplastic peripheral nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  731. en:non-rheum heart valve disease --- r_associated #0: 20 --> S.E.P.
    n1=en:non-rheum heart valve disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  732. en:normal delivery deadborn --- r_associated #0: 20 --> S.E.P.
    n1=en:normal delivery deadborn | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  733. en:normal delivery liveborn --- r_associated #0: 20 --> S.E.P.
    n1=en:normal delivery liveborn | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  734. en:normal early motor milestones --- r_associated #0: 20 --> S.E.P.
    n1=en:normal early motor milestones | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  735. en:nursing therapy --- r_associated #0: 20 --> S.E.P.
    n1=en:nursing therapy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  736. en:nutritional management --- r_associated #0: 20 --> S.E.P.
    n1=en:nutritional management | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  737. en:obtundation --- r_associated #0: 20 --> S.E.P.
    n1=en:obtundation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  738. en:ocular foreign body --- r_associated #0: 20 --> S.E.P.
    n1=en:ocular foreign body | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  739. en:ocular motility disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:ocular motility disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  740. en:oculogyric crisis --- r_associated #0: 20 --> S.E.P.
    n1=en:oculogyric crisis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  741. en:oculomotor nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:oculomotor nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  742. en:oculovestibuloauditory syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:oculovestibuloauditory syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  743. en:oncocytic neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:oncocytic neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  744. en:ophthalmia, sympathetic --- r_associated #0: 20 --> S.E.P.
    n1=en:ophthalmia, sympathetic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  745. en:optic neuritis --- r_associated #0: 20 --> S.E.P.
    n1=en:optic neuritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  746. en:optic neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:optic neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  747. en:opticospinal multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:opticospinal multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  748. en:orthostatic hypotension --- r_associated #0: 20 --> S.E.P.
    n1=en:orthostatic hypotension | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  749. en:orthostatic proteinuria --- r_associated #0: 20 --> S.E.P.
    n1=en:orthostatic proteinuria | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  750. en:osgood-schlatter's disease --- r_associated #0: 20 --> S.E.P.
    n1=en:osgood-schlatter's disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  751. en:osteoarthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:osteoarthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  752. en:osteoarthritis, knee --- r_associated #0: 20 --> S.E.P.
    n1=en:osteoarthritis, knee | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  753. en:osteoarthritis, spine --- r_associated #0: 20 --> S.E.P.
    n1=en:osteoarthritis, spine | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  754. en:osteogenesis imperfecta --- r_associated #0: 20 --> S.E.P.
    n1=en:osteogenesis imperfecta | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  755. en:osteoporosis --- r_associated #0: 20 --> S.E.P.
    n1=en:osteoporosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  756. en:other abdominal hernia --- r_associated #0: 20 --> S.E.P.
    n1=en:other abdominal hernia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  757. en:other acute disseminated demyelination --- r_associated #0: 20 --> S.E.P.
    n1=en:other acute disseminated demyelination | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  758. en:other anaemias --- r_associated #0: 20 --> S.E.P.
    n1=en:other anaemias | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  759. en:other and unspecified disorders of the circulatory system --- r_associated #0: 20 --> S.E.P.
    n1=en:other and unspecified disorders of the circulatory system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  760. en:other arterial obstructive/peripheral vascular disease --- r_associated #0: 20 --> S.E.P.
    n1=en:other arterial obstructive/peripheral vascular disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  761. en:other auditory injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:other auditory injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  762. en:other benign neoplasm female genital --- r_associated #0: 20 --> S.E.P.
    n1=en:other benign neoplasm female genital | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  763. en:other benign neoplasm of skin, unspecified --- r_associated #0: 20 --> S.E.P.
    n1=en:other benign neoplasm of skin, unspecified | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  764. en:other central nervous system demyelinating diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:other central nervous system demyelinating diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  765. en:other complications of the puerperium --- r_associated #0: 20 --> S.E.P.
    n1=en:other complications of the puerperium | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  766. en:other conditions of brain --- r_associated #0: 20 --> S.E.P.
    n1=en:other conditions of brain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  767. en:other congenital malformations of eye --- r_associated #0: 20 --> S.E.P.
    n1=en:other congenital malformations of eye | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  768. en:other dermatologic congenital anomalies --- r_associated #0: 20 --> S.E.P.
    n1=en:other dermatologic congenital anomalies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  769. en:other digestive system injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:other digestive system injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  770. en:other disease blood/lymph/spleen --- r_associated #0: 20 --> S.E.P.
    n1=en:other disease blood/lymph/spleen | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  771. en:other disease male genital including breast --- r_associated #0: 20 --> S.E.P.
    n1=en:other disease male genital including breast | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  772. en:other disease of neurological system --- r_associated #0: 20 --> S.E.P.
    n1=en:other disease of neurological system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  773. en:other disease of pregnancy/delivery/puerperium --- r_associated #0: 20 --> S.E.P.
    n1=en:other disease of pregnancy/delivery/puerperium | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  774. en:other diseases female genital system --- r_associated #0: 20 --> S.E.P.
    n1=en:other diseases female genital system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  775. en:other diseases of digestive system --- r_associated #0: 20 --> S.E.P.
    n1=en:other diseases of digestive system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  776. en:other diseases of ear/mastoid --- r_associated #0: 20 --> S.E.P.
    n1=en:other diseases of ear/mastoid | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  777. en:other disorders of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:other disorders of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  778. en:other disorders of eye --- r_associated #0: 20 --> S.E.P.
    n1=en:other disorders of eye | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  779. en:other disorders of the nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:other disorders of the nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  780. en:other disorders of the skin and subcutaneous tissue --- r_associated #0: 20 --> S.E.P.
    n1=en:other disorders of the skin and subcutaneous tissue | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  781. en:other disorders of urinary system --- r_associated #0: 20 --> S.E.P.
    n1=en:other disorders of urinary system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  782. en:other endocrine or metabolic congenital anomalies --- r_associated #0: 20 --> S.E.P.
    n1=en:other endocrine or metabolic congenital anomalies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  783. en:other endocrine/metabolic nutritional disease --- r_associated #0: 20 --> S.E.P.
    n1=en:other endocrine/metabolic nutritional disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  784. en:other female genital malignant neoplasms --- r_associated #0: 20 --> S.E.P.
    n1=en:other female genital malignant neoplasms | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  785. en:other forms of chronic ischaemic heart disease --- r_associated #0: 20 --> S.E.P.
    n1=en:other forms of chronic ischaemic heart disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  786. en:other forms of heart disease --- r_associated #0: 20 --> S.E.P.
    n1=en:other forms of heart disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  787. en:other general/unspecified diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:other general/unspecified diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  788. en:other head injury without skull fracture --- r_associated #0: 20 --> S.E.P.
    n1=en:other head injury without skull fracture | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  789. en:other health condition:find:pt:^patient:nom --- r_associated #0: 20 --> S.E.P.
    n1=en:other health condition:find:pt:^patient:nom | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  790. en:other hematologic congenital anomalies --- r_associated #0: 20 --> S.E.P.
    n1=en:other hematologic congenital anomalies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  791. en:other hematologic injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:other hematologic injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  792. en:other hematologic malignant neoplasms --- r_associated #0: 20 --> S.E.P.
    n1=en:other hematologic malignant neoplasms | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  793. en:other hematological abnormality --- r_associated #0: 20 --> S.E.P.
    n1=en:other hematological abnormality | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  794. en:other infection neurological system --- r_associated #0: 20 --> S.E.P.
    n1=en:other infection neurological system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  795. en:other infection/inflammation of eye (excluding herpes) --- r_associated #0: 20 --> S.E.P.
    n1=en:other infection/inflammation of eye (excluding herpes) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  796. en:other infections of respiratory system --- r_associated #0: 20 --> S.E.P.
    n1=en:other infections of respiratory system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  797. en:other infectious diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:other infectious diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  798. en:other infectious skin disease --- r_associated #0: 20 --> S.E.P.
    n1=en:other infectious skin disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  799. en:other inflammatory and toxic neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:other inflammatory and toxic neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  800. en:other male genital malignant neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:other male genital malignant neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  801. en:other malignant neoplasm urinary tract --- r_associated #0: 20 --> S.E.P.
    n1=en:other malignant neoplasm urinary tract | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  802. en:other malignant respiratory neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:other malignant respiratory neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  803. en:other mental/psychological disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:other mental/psychological disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  804. en:other musculoskeletal disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:other musculoskeletal disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  805. en:other neurologic injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:other neurologic injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  806. en:other neurotic disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:other neurotic disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  807. en:other non-obstetrical conditions --- r_associated #0: 20 --> S.E.P.
    n1=en:other non-obstetrical conditions | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  808. en:other ocular injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:other ocular injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  809. en:other organic psychosis --- r_associated #0: 20 --> S.E.P.
    n1=en:other organic psychosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  810. en:other osteoarthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:other osteoarthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  811. en:other paralytic syndromes --- r_associated #0: 20 --> S.E.P.
    n1=en:other paralytic syndromes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  812. en:other peptic ulcers --- r_associated #0: 20 --> S.E.P.
    n1=en:other peptic ulcers | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  813. en:other peripheral neuritis --- r_associated #0: 20 --> S.E.P.
    n1=en:other peripheral neuritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  814. en:other psychoses --- r_associated #0: 20 --> S.E.P.
    n1=en:other psychoses | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  815. en:other respiratory injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:other respiratory injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  816. en:other respiratory system diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:other respiratory system diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  817. en:other sensation disturbance/abnormal involuntary movement --- r_associated #0: 20 --> S.E.P.
    n1=en:other sensation disturbance/abnormal involuntary movement | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  818. en:other specified demyelinating diseases of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:other specified demyelinating diseases of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  819. en:other specified disorders of central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:other specified disorders of central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  820. en:other specified idiopathic peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:other specified idiopathic peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  821. en:other symptom/complaint neurological system --- r_associated #0: 20 --> S.E.P.
    n1=en:other symptom/complaint neurological system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  822. en:other viral disease with exanthems --- r_associated #0: 20 --> S.E.P.
    n1=en:other viral disease with exanthems | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  823. en:other viral diseases --- r_associated #0: 20 --> S.E.P.
    n1=en:other viral diseases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  824. en:other/unspecified neoplasm female genital --- r_associated #0: 20 --> S.E.P.
    n1=en:other/unspecified neoplasm female genital | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  825. en:other/unspecified neoplasm skin --- r_associated #0: 20 --> S.E.P.
    n1=en:other/unspecified neoplasm skin | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  826. en:other/unspecified neoplasms --- r_associated #0: 20 --> S.E.P.
    n1=en:other/unspecified neoplasms | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  827. en:otitis externa --- r_associated #0: 20 --> S.E.P.
    n1=en:otitis externa | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  828. en:otosclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:otosclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  829. en:overlap syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:overlap syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  830. en:overweight --- r_associated #0: 20 --> S.E.P.
    n1=en:overweight | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  831. en:pain --- r_associated #0: 20 --> S.E.P.
    n1=en:pain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  832. en:paralysis --- r_associated #0: 20 --> S.E.P.
    n1=en:paralysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  833. en:paralysis vocal cord --- r_associated #0: 20 --> S.E.P.
    n1=en:paralysis vocal cord | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  834. en:paralysis/weakness (excluding a04) --- r_associated #0: 20 --> S.E.P.
    n1=en:paralysis/weakness (excluding a04) | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  835. en:paraneoplastic polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:paraneoplastic polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  836. en:paraplegia --- r_associated #0: 20 --> S.E.P.
    n1=en:paraplegia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  837. en:parasitology --- r_associated #0: 20 --> S.E.P.
    n1=en:parasitology | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  838. en:parkinson's disease --- r_associated #0: 20 --> S.E.P.
    n1=en:parkinson's disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  839. en:parkinsonism --- r_associated #0: 20 --> S.E.P.
    n1=en:parkinsonism | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  840. en:parvovirus infection of the central nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:parvovirus infection of the central nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  841. en:pathological aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:pathological aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  842. en:pediatric adverse events terminology --- r_associated #0: 20 --> S.E.P.
    n1=en:pediatric adverse events terminology | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  843. en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections --- r_associated #0: 20 --> S.E.P.
    n1=en:pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  844. en:pediatric terminology --- r_associated #0: 20 --> S.E.P.
    n1=en:pediatric terminology | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  845. en:pediculosis/other skin infestation --- r_associated #0: 20 --> S.E.P.
    n1=en:pediculosis/other skin infestation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  846. en:pelvic inflammatory disease --- r_associated #0: 20 --> S.E.P.
    n1=en:pelvic inflammatory disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  847. en:pemphigus --- r_associated #0: 20 --> S.E.P.
    n1=en:pemphigus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  848. en:perinatal mortality --- r_associated #0: 20 --> S.E.P.
    n1=en:perinatal mortality | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  849. en:perinatal subependymal hemorrhage --- r_associated #0: 20 --> S.E.P.
    n1=en:perinatal subependymal hemorrhage | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  850. en:perineural cyst --- r_associated #0: 20 --> S.E.P.
    n1=en:perineural cyst | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  851. en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:periodic fever, aphthous stomatitis, pharyngitis, adenitis syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  852. en:peripheral axonal neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral axonal neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  853. en:peripheral motor neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral motor neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  854. en:peripheral nerve decompression injury --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nerve decompression injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  855. en:peripheral nerve disorder associated with repair of hernia --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nerve disorder associated with repair of hernia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  856. en:peripheral nerve injury --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nerve injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  857. en:peripheral nervous system --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nervous system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  858. en:peripheral nervous system disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nervous system disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  859. en:peripheral nervous system infectious disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nervous system infectious disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  860. en:peripheral nervous system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral nervous system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  861. en:peripheral neuralgia --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuralgia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  862. en:peripheral neuritis in pregnancy --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuritis in pregnancy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  863. en:peripheral neuritis in pregnancy, delivered, with mention of postpartum complication --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuritis in pregnancy, delivered, with mention of postpartum complication | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  864. en:peripheral neuritis in pregnancy, delivered, with or without mention of antepartum condition --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuritis in pregnancy, delivered, with or without mention of antepartum condition | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  865. en:peripheral neuritis in pregnancy, postpartum condition or complication --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuritis in pregnancy, postpartum condition or complication | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  866. en:peripheral neuritis in pregnancy, unspecified as to episode of care or not applicable --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuritis in pregnancy, unspecified as to episode of care or not applicable | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  867. en:peripheral neuropathies nec --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuropathies nec | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  868. en:peripheral neuropathy - hereditary or idiopathic --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuropathy - hereditary or idiopathic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  869. en:peripheral neuropathy aggravated --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuropathy aggravated | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  870. en:peripheral neuropathy caused by toxin --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuropathy caused by toxin | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  871. en:peripheral neuropathy due to inflammation --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuropathy due to inflammation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  872. en:peripheral neuropathy due to metabolic disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral neuropathy due to metabolic disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  873. en:peripheral sensory neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:peripheral sensory neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  874. en:pernicious/folate deficiency anemias --- r_associated #0: 20 --> S.E.P.
    n1=en:pernicious/folate deficiency anemias | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  875. en:personality disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:personality disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  876. en:phantom pain --- r_associated #0: 20 --> S.E.P.
    n1=en:phantom pain | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  877. en:pharmacotherapeutic --- r_associated #0: 20 --> S.E.P.
    n1=en:pharmacotherapeutic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  878. en:phenylketonuria --- r_associated #0: 20 --> S.E.P.
    n1=en:phenylketonuria | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  879. en:phlebitis and thrombophlebitis --- r_associated #0: 20 --> S.E.P.
    n1=en:phlebitis and thrombophlebitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  880. en:phrenic nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:phrenic nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  881. en:physiopathological --- r_associated #0: 20 --> S.E.P.
    n1=en:physiopathological | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  882. en:pilonidal cyst/fistula --- r_associated #0: 20 --> S.E.P.
    n1=en:pilonidal cyst/fistula | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  883. en:pituitary gland disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:pituitary gland disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  884. en:pityriasis rosea --- r_associated #0: 20 --> S.E.P.
    n1=en:pityriasis rosea | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  885. en:pleural effusion --- r_associated #0: 20 --> S.E.P.
    n1=en:pleural effusion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  886. en:pleurisy with pleural effusion --- r_associated #0: 20 --> S.E.P.
    n1=en:pleurisy with pleural effusion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  887. en:pneumocephalus --- r_associated #0: 20 --> S.E.P.
    n1=en:pneumocephalus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  888. en:pneumonia --- r_associated #0: 20 --> S.E.P.
    n1=en:pneumonia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  889. en:poems syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:poems syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  890. en:poisoning by medical agent --- r_associated #0: 20 --> S.E.P.
    n1=en:poisoning by medical agent | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  891. en:polio and post-polio syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:polio and post-polio syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  892. en:poliomyelitis/other enterovirus --- r_associated #0: 20 --> S.E.P.
    n1=en:poliomyelitis/other enterovirus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  893. en:polymyalgia rheumatica --- r_associated #0: 20 --> S.E.P.
    n1=en:polymyalgia rheumatica | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  894. en:polyneuropathies, motor --- r_associated #0: 20 --> S.E.P.
    n1=en:polyneuropathies, motor | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  895. en:polyneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:polyneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  896. en:polyradiculoneuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:polyradiculoneuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  897. en:polyradiculopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:polyradiculopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  898. en:pregnancy complications, infectious --- r_associated #0: 20 --> S.E.P.
    n1=en:pregnancy complications, infectious | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  899. en:premature birth of newborn --- r_associated #0: 20 --> S.E.P.
    n1=en:premature birth of newborn | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  900. en:premenstrual tension --- r_associated #0: 20 --> S.E.P.
    n1=en:premenstrual tension | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  901. en:presbycusis --- r_associated #0: 20 --> S.E.P.
    n1=en:presbycusis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  902. en:primary demyelination --- r_associated #0: 20 --> S.E.P.
    n1=en:primary demyelination | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  903. en:primary health condition:find:pt:^patient:nom --- r_associated #0: 20 --> S.E.P.
    n1=en:primary health condition:find:pt:^patient:nom | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  904. en:primary progressive multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:primary progressive multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  905. en:primary sclerosing cholangitis --- r_associated #0: 20 --> S.E.P.
    n1=en:primary sclerosing cholangitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  906. en:progression of multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:progression of multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  907. en:progressive multifocal leukoencephalopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:progressive multifocal leukoencephalopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  908. en:progressive multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:progressive multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  909. en:progressive peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:progressive peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  910. en:progressive supranuclear palsy --- r_associated #0: 20 --> S.E.P.
    n1=en:progressive supranuclear palsy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  911. en:prostatitis/seminal vesiculitis --- r_associated #0: 20 --> S.E.P.
    n1=en:prostatitis/seminal vesiculitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  912. en:psoriasis --- r_associated #0: 20 --> S.E.P.
    n1=en:psoriasis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  913. en:psoriatic arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:psoriatic arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  914. en:psychology qualifier --- r_associated #0: 20 --> S.E.P.
    n1=en:psychology qualifier | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  915. en:ptprc gene --- r_associated #0: 20 --> S.E.P.
    n1=en:ptprc gene | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  916. en:ptprc wt allele --- r_associated #0: 20 --> S.E.P.
    n1=en:ptprc wt allele | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  917. en:pudendal nerve neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:pudendal nerve neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  918. en:puerperal infection/sepsis --- r_associated #0: 20 --> S.E.P.
    n1=en:puerperal infection/sepsis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  919. en:pulmonary alveolar proteinosis, acquired --- r_associated #0: 20 --> S.E.P.
    n1=en:pulmonary alveolar proteinosis, acquired | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  920. en:pulmonary embolism --- r_associated #0: 20 --> S.E.P.
    n1=en:pulmonary embolism | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  921. en:pulmonary emphysema --- r_associated #0: 20 --> S.E.P.
    n1=en:pulmonary emphysema | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  922. en:pulmonary tuberculosis --- r_associated #0: 20 --> S.E.P.
    n1=en:pulmonary tuberculosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  923. en:purpura/coagulation defects/abnormal platelets --- r_associated #0: 20 --> S.E.P.
    n1=en:purpura/coagulation defects/abnormal platelets | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  924. en:pyelonephritis/pyelitis acute --- r_associated #0: 20 --> S.E.P.
    n1=en:pyelonephritis/pyelitis acute | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  925. en:quadriplegia --- r_associated #0: 20 --> S.E.P.
    n1=en:quadriplegia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  926. en:rabies --- r_associated #0: 20 --> S.E.P.
    n1=en:rabies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  927. en:radiation-induced myelopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:radiation-induced myelopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  928. en:radiculopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:radiculopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  929. en:radiotherapeutic --- r_associated #0: 20 --> S.E.P.
    n1=en:radiotherapeutic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  930. en:rasmussen subacute encephalitis --- r_associated #0: 20 --> S.E.P.
    n1=en:rasmussen subacute encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  931. en:receptor-type tyrosine-protein phosphatase c --- r_associated #0: 20 --> S.E.P.
    n1=en:receptor-type tyrosine-protein phosphatase c | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  932. en:redundant prepuce and phimosis --- r_associated #0: 20 --> S.E.P.
    n1=en:redundant prepuce and phimosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  933. en:refractive error --- r_associated #0: 20 --> S.E.P.
    n1=en:refractive error | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  934. en:rehabilitation aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:rehabilitation aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  935. en:reiter syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:reiter syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  936. en:remittent-progressive multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:remittent-progressive multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  937. en:restless leg syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:restless leg syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  938. en:retinal detachment --- r_associated #0: 20 --> S.E.P.
    n1=en:retinal detachment | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  939. en:retinopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:retinopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  940. en:rett syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:rett syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  941. en:reye syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:reye syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  942. en:rheumatic heart disease --- r_associated #0: 20 --> S.E.P.
    n1=en:rheumatic heart disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  943. en:rheumatoid arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:rheumatoid arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  944. en:rheumatoid arthritis and associated conditions --- r_associated #0: 20 --> S.E.P.
    n1=en:rheumatoid arthritis and associated conditions | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  945. en:rhinitis seasonal --- r_associated #0: 20 --> S.E.P.
    n1=en:rhinitis seasonal | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  946. en:rickets --- r_associated #0: 20 --> S.E.P.
    n1=en:rickets | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  947. en:roentgenographic --- r_associated #0: 20 --> S.E.P.
    n1=en:roentgenographic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  948. en:rotator cuff injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:rotator cuff injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  949. en:rubella infection --- r_associated #0: 20 --> S.E.P.
    n1=en:rubella infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  950. en:sarcoidosis --- r_associated #0: 20 --> S.E.P.
    n1=en:sarcoidosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  951. en:scabies and other acariases --- r_associated #0: 20 --> S.E.P.
    n1=en:scabies and other acariases | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  952. en:schizophrenia --- r_associated #0: 20 --> S.E.P.
    n1=en:schizophrenia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  953. en:sciatica --- r_associated #0: 20 --> S.E.P.
    n1=en:sciatica | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  954. en:science of ergonomics --- r_associated #0: 20 --> S.E.P.
    n1=en:science of ergonomics | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  955. en:scleroderma --- r_associated #0: 20 --> S.E.P.
    n1=en:scleroderma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  956. en:scleroderma and associated disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:scleroderma and associated disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  957. en:scoliosis --- r_associated #0: 20 --> S.E.P.
    n1=en:scoliosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  958. en:sebaceous cyst --- r_associated #0: 20 --> S.E.P.
    n1=en:sebaceous cyst | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  959. en:seborrheic dermatitis --- r_associated #0: 20 --> S.E.P.
    n1=en:seborrheic dermatitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  960. en:secondary cerebellar degeneration --- r_associated #0: 20 --> S.E.P.
    n1=en:secondary cerebellar degeneration | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  961. en:secondary parkinsonism --- r_associated #0: 20 --> S.E.P.
    n1=en:secondary parkinsonism | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  962. en:secondary peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:secondary peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  963. en:secondary progressive multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:secondary progressive multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  964. en:secretory otitis media --- r_associated #0: 20 --> S.E.P.
    n1=en:secretory otitis media | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  965. en:segmental demyelination --- r_associated #0: 20 --> S.E.P.
    n1=en:segmental demyelination | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  966. en:seizure --- r_associated #0: 20 --> S.E.P.
    n1=en:seizure | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  967. en:seizure disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:seizure disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  968. en:sensorimotor neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:sensorimotor neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  969. en:sensorimotor polyneuropathy affecting arms more than legs --- r_associated #0: 20 --> S.E.P.
    n1=en:sensorimotor polyneuropathy affecting arms more than legs | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  970. en:sensory disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:sensory disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  971. en:seropositive rheumatoid arthritis --- r_associated #0: 20 --> S.E.P.
    n1=en:seropositive rheumatoid arthritis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  972. en:shoulder injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:shoulder injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  973. en:shoulder syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:shoulder syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  974. en:sinusitis acute/chronic --- r_associated #0: 20 --> S.E.P.
    n1=en:sinusitis acute/chronic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  975. en:sjogren syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:sjogren syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  976. en:skin autoimmune disorders nec --- r_associated #0: 20 --> S.E.P.
    n1=en:skin autoimmune disorders nec | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  977. en:sleep apnea --- r_associated #0: 20 --> S.E.P.
    n1=en:sleep apnea | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  978. en:sleep disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:sleep disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  979. en:slow viral central nervous system infection --- r_associated #0: 20 --> S.E.P.
    n1=en:slow viral central nervous system infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  980. en:small fiber neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:small fiber neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  981. en:spastic paralysis --- r_associated #0: 20 --> S.E.P.
    n1=en:spastic paralysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  982. en:spastic syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:spastic syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  983. en:speech abnormality if untreated --- r_associated #0: 20 --> S.E.P.
    n1=en:speech abnormality if untreated | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  984. en:speech and communication disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:speech and communication disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  985. en:speech and language problems in children --- r_associated #0: 20 --> S.E.P.
    n1=en:speech and language problems in children | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  986. en:speech disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:speech disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  987. en:spina bifida --- r_associated #0: 20 --> S.E.P.
    n1=en:spina bifida | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  988. en:spinal cord disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:spinal cord disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  989. en:spinal cord injury --- r_associated #0: 20 --> S.E.P.
    n1=en:spinal cord injury | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  990. en:spinal muscular atrophy --- r_associated #0: 20 --> S.E.P.
    n1=en:spinal muscular atrophy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  991. en:spinal stenosis --- r_associated #0: 20 --> S.E.P.
    n1=en:spinal stenosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  992. en:spine injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:spine injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  993. en:splenic disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:splenic disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  994. en:splenic rupture --- r_associated #0: 20 --> S.E.P.
    n1=en:splenic rupture | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  995. en:splenomegaly --- r_associated #0: 20 --> S.E.P.
    n1=en:splenomegaly | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  996. en:spontaneous abortion --- r_associated #0: 20 --> S.E.P.
    n1=en:spontaneous abortion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  997. en:sprain and strain of ankle --- r_associated #0: 20 --> S.E.P.
    n1=en:sprain and strain of ankle | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  998. en:sprains and strains --- r_associated #0: 20 --> S.E.P.
    n1=en:sprains and strains | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  999. en:stiff person syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:stiff person syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1000. en:stomach function disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:stomach function disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1001. en:strabismus --- r_associated #0: 20 --> S.E.P.
    n1=en:strabismus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1002. en:strachan's syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:strachan's syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1003. en:strep throat/scarlet fever --- r_associated #0: 20 --> S.E.P.
    n1=en:strep throat/scarlet fever | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1004. en:stroke rehabilitation --- r_associated #0: 20 --> S.E.P.
    n1=en:stroke rehabilitation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1005. en:stump hallucination --- r_associated #0: 20 --> S.E.P.
    n1=en:stump hallucination | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1006. en:stutter --- r_associated #0: 20 --> S.E.P.
    n1=en:stutter | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1007. en:suicide attempt --- r_associated #0: 20 --> S.E.P.
    n1=en:suicide attempt | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1008. en:superficial injury of ear --- r_associated #0: 20 --> S.E.P.
    n1=en:superficial injury of ear | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1009. en:surgical aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:surgical aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1010. en:susac syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:susac syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1011. en:suspected multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:suspected multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1012. en:swallowed foreign body in digestive system --- r_associated #0: 20 --> S.E.P.
    n1=en:swallowed foreign body in digestive system | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1013. en:syncope --- r_associated #0: 20 --> S.E.P.
    n1=en:syncope | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1014. en:syndrome ms-like --- r_associated #0: 20 --> S.E.P.
    n1=en:syndrome ms-like | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1015. en:syndrome screaming --- r_associated #0: 20 --> S.E.P.
    n1=en:syndrome screaming | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1016. en:syndromes of cervical spine --- r_associated #0: 20 --> S.E.P.
    n1=en:syndromes of cervical spine | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1017. en:syndromes, narcolepsy-cataplexy --- r_associated #0: 20 --> S.E.P.
    n1=en:syndromes, narcolepsy-cataplexy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1018. en:syphilis female --- r_associated #0: 20 --> S.E.P.
    n1=en:syphilis female | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1019. en:syphilis male --- r_associated #0: 20 --> S.E.P.
    n1=en:syphilis male | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1020. en:syringomyelia --- r_associated #0: 20 --> S.E.P.
    n1=en:syringomyelia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1021. en:syringomyelia-like syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:syringomyelia-like syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1022. en:systemic lupus erythematosus --- r_associated #0: 20 --> S.E.P.
    n1=en:systemic lupus erythematosus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1023. en:systemic scleroderma --- r_associated #0: 20 --> S.E.P.
    n1=en:systemic scleroderma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1024. en:tachycardia, paroxysmal --- r_associated #0: 20 --> S.E.P.
    n1=en:tachycardia, paroxysmal | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1025. en:tailbone disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:tailbone disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1026. en:tap2 gene --- r_associated #0: 20 --> S.E.P.
    n1=en:tap2 gene | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1027. en:tap2 wt allele --- r_associated #0: 20 --> S.E.P.
    n1=en:tap2 wt allele | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1028. en:taxonomic --- r_associated #0: 20 --> S.E.P.
    n1=en:taxonomic | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1029. en:tay-sachs disease --- r_associated #0: 20 --> S.E.P.
    n1=en:tay-sachs disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1030. en:tendonitis --- r_associated #0: 20 --> S.E.P.
    n1=en:tendonitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1031. en:tension headache --- r_associated #0: 20 --> S.E.P.
    n1=en:tension headache | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1032. en:testicular hydrocele --- r_associated #0: 20 --> S.E.P.
    n1=en:testicular hydrocele | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1033. en:tetanus --- r_associated #0: 20 --> S.E.P.
    n1=en:tetanus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1034. en:tetany --- r_associated #0: 20 --> S.E.P.
    n1=en:tetany | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1035. en:thalassemia major --- r_associated #0: 20 --> S.E.P.
    n1=en:thalassemia major | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1036. en:therapeutic aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:therapeutic aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1037. en:thoracic injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:thoracic injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1038. en:thoracic outlet syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:thoracic outlet syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1039. en:thoracoabdominal neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:thoracoabdominal neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1040. en:thrombocytopenic purpura --- r_associated #0: 20 --> S.E.P.
    n1=en:thrombocytopenic purpura | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1041. en:thymus disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:thymus disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1042. en:thyroglossal duct cyst --- r_associated #0: 20 --> S.E.P.
    n1=en:thyroglossal duct cyst | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1043. en:thyrotoxicosis [hyperthyroidism] --- r_associated #0: 20 --> S.E.P.
    n1=en:thyrotoxicosis [hyperthyroidism] | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1044. en:tingling fingers/feet/toes --- r_associated #0: 20 --> S.E.P.
    n1=en:tingling fingers/feet/toes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1045. en:toe injuries and disorders --- r_associated #0: 20 --> S.E.P.
    n1=en:toe injuries and disorders | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1046. en:tourette syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:tourette syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1047. en:toxemia of pregnancy --- r_associated #0: 20 --> S.E.P.
    n1=en:toxemia of pregnancy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1048. en:toxic effect of other and unspecified substances --- r_associated #0: 20 --> S.E.P.
    n1=en:toxic effect of other and unspecified substances | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1049. en:toxic oil syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:toxic oil syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1050. en:toxoplasmosis --- r_associated #0: 20 --> S.E.P.
    n1=en:toxoplasmosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1051. en:trachoma --- r_associated #0: 20 --> S.E.P.
    n1=en:trachoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1052. en:transient cerebral ischemia --- r_associated #0: 20 --> S.E.P.
    n1=en:transient cerebral ischemia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1053. en:transient ischemic attack --- r_associated #0: 20 --> S.E.P.
    n1=en:transient ischemic attack | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1054. en:trauma/injury problem --- r_associated #0: 20 --> S.E.P.
    n1=en:trauma/injury problem | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1055. en:traumatic encephalopathy --- r_associated #0: 20 --> S.E.P.
    n1=en:traumatic encephalopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1056. en:tremor --- r_associated #0: 20 --> S.E.P.
    n1=en:tremor | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1057. en:trigeminal nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:trigeminal nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1058. en:trigeminal neuralgia --- r_associated #0: 20 --> S.E.P.
    n1=en:trigeminal neuralgia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1059. en:trochlear nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:trochlear nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1060. en:tuberous sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:tuberous sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1061. en:tumefactive multiple sclerosis --- r_associated #0: 20 --> S.E.P.
    n1=en:tumefactive multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1062. en:twitching --- r_associated #0: 20 --> S.E.P.
    n1=en:twitching | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1063. en:tympanic membrane perforation --- r_associated #0: 20 --> S.E.P.
    n1=en:tympanic membrane perforation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1064. en:type 1 diabetes mellitus --- r_associated #0: 20 --> S.E.P.
    n1=en:type 1 diabetes mellitus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1065. en:type iii hypersensitivity --- r_associated #0: 20 --> S.E.P.
    n1=en:type iii hypersensitivity | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1066. en:uhthoff's phenomenon --- r_associated #0: 20 --> S.E.P.
    n1=en:uhthoff's phenomenon | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1067. en:ulcerative colitis-associated low-grade dysplasia --- r_associated #0: 20 --> S.E.P.
    n1=en:ulcerative colitis-associated low-grade dysplasia | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1068. en:uncomplicated hypertension --- r_associated #0: 20 --> S.E.P.
    n1=en:uncomplicated hypertension | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1069. en:undescended testes --- r_associated #0: 20 --> S.E.P.
    n1=en:undescended testes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1070. en:undifferentiated connective tissue disease --- r_associated #0: 20 --> S.E.P.
    n1=en:undifferentiated connective tissue disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1071. en:unexplained abnormal blood test --- r_associated #0: 20 --> S.E.P.
    n1=en:unexplained abnormal blood test | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1072. en:unspecified hereditary and idiopathic peripheral neuropathy --- r_associated #0: 20 --> S.E.P.
    n1=en:unspecified hereditary and idiopathic peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1073. en:unspecified neoplasms --- r_associated #0: 20 --> S.E.P.
    n1=en:unspecified neoplasms | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1074. en:unwanted pregnancy confirmed --- r_associated #0: 20 --> S.E.P.
    n1=en:unwanted pregnancy confirmed | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1075. en:upper motor neuron disease --- r_associated #0: 20 --> S.E.P.
    n1=en:upper motor neuron disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1076. en:urinary stone --- r_associated #0: 20 --> S.E.P.
    n1=en:urinary stone | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1077. en:urinary system neoplasm --- r_associated #0: 20 --> S.E.P.
    n1=en:urinary system neoplasm | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1078. en:urogenital trichomoniasis proven --- r_associated #0: 20 --> S.E.P.
    n1=en:urogenital trichomoniasis proven | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1079. en:urologic injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:urologic injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1080. en:urticaria --- r_associated #0: 20 --> S.E.P.
    n1=en:urticaria | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1081. en:use of ultrasonography --- r_associated #0: 20 --> S.E.P.
    n1=en:use of ultrasonography | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1082. en:uterovaginal prolapse --- r_associated #0: 20 --> S.E.P.
    n1=en:uterovaginal prolapse | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1083. en:uveomeningoencephalitic syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:uveomeningoencephalitic syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1084. en:vaginitis/vulvitis nos --- r_associated #0: 20 --> S.E.P.
    n1=en:vaginitis/vulvitis nos | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1085. en:vagus nerve disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:vagus nerve disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1086. en:vanishing white matter disease --- r_associated #0: 20 --> S.E.P.
    n1=en:vanishing white matter disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1087. en:varicose vein of lower extremities --- r_associated #0: 20 --> S.E.P.
    n1=en:varicose vein of lower extremities | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1088. en:vertiginous syndrome --- r_associated #0: 20 --> S.E.P.
    n1=en:vertiginous syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1089. en:veterinary aspects --- r_associated #0: 20 --> S.E.P.
    n1=en:veterinary aspects | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1090. en:viral hepatitis --- r_associated #0: 20 --> S.E.P.
    n1=en:viral hepatitis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1091. en:viruses --- r_associated #0: 20 --> S.E.P.
    n1=en:viruses | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1092. en:visual pathway disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:visual pathway disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1093. en:vitamin deficiency/other nutritional/disease --- r_associated #0: 20 --> S.E.P.
    n1=en:vitamin deficiency/other nutritional/disease | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1094. en:voice disorder --- r_associated #0: 20 --> S.E.P.
    n1=en:voice disorder | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1095. en:west nile viral infection --- r_associated #0: 20 --> S.E.P.
    n1=en:west nile viral infection | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1096. en:white blood cell abnormality --- r_associated #0: 20 --> S.E.P.
    n1=en:white blood cell abnormality | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1097. en:whooping cough due to unspecified organism --- r_associated #0: 20 --> S.E.P.
    n1=en:whooping cough due to unspecified organism | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1098. en:wrist injuries --- r_associated #0: 20 --> S.E.P.
    n1=en:wrist injuries | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1099. encéphalomyélite aigüe nécrosante hémorragique --- r_associated #0: 20 --> S.E.P.
    n1=encéphalomyélite aigüe nécrosante hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1100. encéphalomyélite disséminée aiguë --- r_associated #0: 20 --> S.E.P.
    n1=encéphalomyélite disséminée aiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1101. encéphalomyélite myalgique bénigne --- r_associated #0: 20 --> S.E.P.
    n1=encéphalomyélite myalgique bénigne | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1102. encéphalopathie --- r_associated #0: 20 --> S.E.P.
    n1=encéphalopathie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1103. encéphalopathie alcoolique --- r_associated #0: 20 --> S.E.P.
    n1=encéphalopathie alcoolique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1104. encéphalopathie toxique --- r_associated #0: 20 --> S.E.P.
    n1=encéphalopathie toxique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1105. fibre nerveuse --- r_associated #0: 20 --> S.E.P.
    n1=fibre nerveuse | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1106. forme progressive primaire --- r_associated #0: 20 --> S.E.P.
    n1=forme progressive primaire | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1107. forme progressive secondaire --- r_associated #0: 20 --> S.E.P.
    n1=forme progressive secondaire | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1108. forme récurrente-rémittente --- r_associated #0: 20 --> S.E.P.
    n1=forme récurrente-rémittente | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1109. glaucoma --- r_associated #0: 20 --> S.E.P.
    n1=glaucoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1110. handicap --- r_associated #0: 20 --> S.E.P.
    n1=handicap | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1111. herpes zoster --- r_associated #0: 20 --> S.E.P.
    n1=herpes zoster | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1112. hypersignal T2 --- r_associated #0: 20 --> S.E.P.
    n1=hypersignal T2 | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1113. incurable --- r_associated #0: 20 --> S.E.P.
    n1=incurable | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1114. insomnie --- r_associated #0: 20 --> S.E.P.
    n1=insomnie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1115. interférons et sclérose en plaques --- r_associated #0: 20 --> S.E.P.
    n1=interférons et sclérose en plaques | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1116. interleukine-6 --- r_associated #0: 20 --> S.E.P.
    n1=interleukine-6 | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1117. leucoencéphalite aiguë hémorragique --- r_associated #0: 20 --> S.E.P.
    n1=leucoencéphalite aiguë hémorragique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1118. leucoencéphalite hémorragique aiguë --- r_associated #0: 20 --> S.E.P.
    n1=leucoencéphalite hémorragique aiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1119. leucomyélite ascendante aiguë --- r_associated #0: 20 --> S.E.P.
    n1=leucomyélite ascendante aiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1120. lésion --- r_associated #0: 20 --> S.E.P.
    n1=lésion | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1121. lésion
    (médecine)
     --- r_associated #0: 20 --> S.E.P.
    n1=lésion
    (médecine)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1122. maladie --- r_associated #0: 20 --> S.E.P.
    n1=maladie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1123. maladie auto immune --- r_associated #0: 20 --> S.E.P.
    n1=maladie auto immune | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1124. maladie auto-immune --- r_associated #0: 20 --> S.E.P.
    n1=maladie auto-immune | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1125. maladie autoimmune --- r_associated #0: 20 --> S.E.P.
    n1=maladie autoimmune | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1126. maladie d'Osgood-Schlatter --- r_associated #0: 20 --> S.E.P.
    n1=maladie d'Osgood-Schlatter | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1127. maladie de Seitelberger --- r_associated #0: 20 --> S.E.P.
    n1=maladie de Seitelberger | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1128. maladie du système nerveux --- r_associated #0: 20 --> S.E.P.
    n1=maladie du système nerveux | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1129. maladie du système nerveux central --- r_associated #0: 20 --> S.E.P.
    n1=maladie du système nerveux central | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1130. maladie du système nerveux d'origine dysimmunitaire --- r_associated #0: 20 --> S.E.P.
    n1=maladie du système nerveux d'origine dysimmunitaire | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1131. maladie dégénérative --- r_associated #0: 20 --> S.E.P.
    n1=maladie dégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1132. maladie nerveuse --- r_associated #0: 20 --> S.E.P.
    n1=maladie nerveuse | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1133. maladie neuro-dégénérative --- r_associated #0: 20 --> S.E.P.
    n1=maladie neuro-dégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1134. maladie neurodégénérative --- r_associated #0: 20 --> S.E.P.
    n1=maladie neurodégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1135. maladie neurologique --- r_associated #0: 20 --> S.E.P.
    n1=maladie neurologique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1136. maladie
    (médecine)
     --- r_associated #0: 20 --> S.E.P.
    n1=maladie
    (médecine)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1137. maladies --- r_associated #0: 20 --> S.E.P.
    n1=maladies | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1138. maladies auto-immunes --- r_associated #0: 20 --> S.E.P.
    n1=maladies auto-immunes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1139. maladies autoimmunes --- r_associated #0: 20 --> S.E.P.
    n1=maladies autoimmunes | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1140. mitoxantrone --- r_associated #0: 20 --> S.E.P.
    n1=mitoxantrone | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1141. murmure cardiaque --- r_associated #0: 20 --> S.E.P.
    n1=murmure cardiaque | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1142. myoclonies vélopalatines et squelettiques --- r_associated #0: 20 --> S.E.P.
    n1=myoclonies vélopalatines et squelettiques | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1143. myopathy --- r_associated #0: 20 --> S.E.P.
    n1=myopathy | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1144. myélinisation --- r_associated #0: 20 --> S.E.P.
    n1=myélinisation | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1145. myélinopathie --- r_associated #0: 20 --> S.E.P.
    n1=myélinopathie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1146. myélite aiguë ascendante --- r_associated #0: 20 --> S.E.P.
    n1=myélite aiguë ascendante | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1147. myélite aiguë diffuse --- r_associated #0: 20 --> S.E.P.
    n1=myélite aiguë diffuse | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1148. myélite ascendante aiguë --- r_associated #0: 20 --> S.E.P.
    n1=myélite ascendante aiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1149. myélite nécrosante subaiguë --- r_associated #0: 20 --> S.E.P.
    n1=myélite nécrosante subaiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1150. myélite nécrosante subaigüe --- r_associated #0: 20 --> S.E.P.
    n1=myélite nécrosante subaigüe | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1151. myélite transverse aiguë --- r_associated #0: 20 --> S.E.P.
    n1=myélite transverse aiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1152. myélite transverse aigüe --- r_associated #0: 20 --> S.E.P.
    n1=myélite transverse aigüe | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1153. médecine
    (science)
     --- r_associated #0: 20 --> S.E.P.
    n1=médecine
    (science)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1154. méningo-encéphalite --- r_associated #0: 20 --> S.E.P.
    n1=méningo-encéphalite | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1155. méningoencéphalite --- r_associated #0: 20 --> S.E.P.
    n1=méningoencéphalite | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1156. méningomyélite --- r_associated #0: 20 --> S.E.P.
    n1=méningomyélite | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1157. neurodégénérative --- r_associated #0: 20 --> S.E.P.
    n1=neurodégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1158. neurologie --- r_associated #0: 20 --> S.E.P.
    n1=neurologie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1159. neuropathie --- r_associated #0: 20 --> S.E.P.
    n1=neuropathie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1160. neurosciences --- r_associated #0: 20 --> S.E.P.
    n1=neurosciences | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1161. nevrilème --- r_associated #0: 20 --> S.E.P.
    n1=nevrilème | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1162. nosologie --- r_associated #0: 20 --> S.E.P.
    n1=nosologie | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1163. névralgie paroxystique --- r_associated #0: 20 --> S.E.P.
    n1=névralgie paroxystique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1164. papillite --- r_associated #0: 20 --> S.E.P.
    n1=papillite | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1165. paralysie ascendante aiguë --- r_associated #0: 20 --> S.E.P.
    n1=paralysie ascendante aiguë | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1166. paralysie faciale --- r_associated #0: 20 --> S.E.P.
    n1=paralysie faciale | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1167. paralysis --- r_associated #0: 20 --> S.E.P.
    n1=paralysis | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1168. plaque --- r_associated #0: 20 --> S.E.P.
    n1=plaque | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1169. plaques --- r_associated #0: 20 --> S.E.P.
    n1=plaques | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1170. poussée --- r_associated #0: 20 --> S.E.P.
    n1=poussée | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1171. poussée
    (médecine)
     --- r_associated #0: 20 --> S.E.P.
    n1=poussée
    (médecine)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1172. processus pathologique --- r_associated #0: 20 --> S.E.P.
    n1=processus pathologique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1173. pseudo-polyarthrite rhizomélique --- r_associated #0: 20 --> S.E.P.
    n1=pseudo-polyarthrite rhizomélique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1174. rare --- r_associated #0: 20 --> S.E.P.
    n1=rare | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1175. sciences --- r_associated #0: 20 --> S.E.P.
    n1=sciences | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1176. sclérose --- r_associated #0: 20 --> S.E.P.
    n1=sclérose | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1177. sclérose disséminée --- r_associated #0: 20 --> S.E.P.
    n1=sclérose disséminée | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1178. sclérose en plaques de la moelle épinière --- r_associated #0: 20 --> S.E.P.
    n1=sclérose en plaques de la moelle épinière | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1179. sclérose en plaques disséminée --- r_associated #0: 20 --> S.E.P.
    n1=sclérose en plaques disséminée | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1180. sclérose en plaques du tronc cérébral --- r_associated #0: 20 --> S.E.P.
    n1=sclérose en plaques du tronc cérébral | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1181. sclérose en plaques et troubles psychiques --- r_associated #0: 20 --> S.E.P.
    n1=sclérose en plaques et troubles psychiques | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1182. sclérose en plaques généralisée --- r_associated #0: 20 --> S.E.P.
    n1=sclérose en plaques généralisée | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1183. sep --- r_associated #0: 20 --> S.E.P.
    n1=sep | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1184. signe de Lhermitte --- r_associated #0: 20 --> S.E.P.
    n1=signe de Lhermitte | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1185. strabismus --- r_associated #0: 20 --> S.E.P.
    n1=strabismus | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1186. substance blanche --- r_associated #0: 20 --> S.E.P.
    n1=substance blanche | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1187. syndrome d'apnée du sommeil --- r_associated #0: 20 --> S.E.P.
    n1=syndrome d'apnée du sommeil | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1188. système nerveux central --- r_associated #0: 20 --> S.E.P.
    n1=système nerveux central | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1189. trachoma --- r_associated #0: 20 --> S.E.P.
    n1=trachoma | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1190. trouble de l'humeur --- r_associated #0: 20 --> S.E.P.
    n1=trouble de l'humeur | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1191. trouble du système immun --- r_associated #0: 20 --> S.E.P.
    n1=trouble du système immun | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1192. trouble neurodégénératif --- r_associated #0: 20 --> S.E.P.
    n1=trouble neurodégénératif | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1193. trouble neurologique --- r_associated #0: 20 --> S.E.P.
    n1=trouble neurologique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1194. type de sclérose --- r_associated #0: 20 --> S.E.P.
    n1=type de sclérose | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1195. uvéonévraxite --- r_associated #0: 20 --> S.E.P.
    n1=uvéonévraxite | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1196. vessie désinhibée --- r_associated #0: 20 --> S.E.P.
    n1=vessie désinhibée | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1197. vessie neurologique --- r_associated #0: 20 --> S.E.P.
    n1=vessie neurologique | n2=S.E.P. | rel=r_associated | relid=0 | w=20
  1198. Cancer osseux --- r_associated #0: 15 --> S.E.P.
    n1=Cancer osseux | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1199. Fibre nerveuse --- r_associated #0: 15 --> S.E.P.
    n1=Fibre nerveuse | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1200. affection des articulations --- r_associated #0: 15 --> S.E.P.
    n1=affection des articulations | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1201. angiocholite sclérosante primitive --- r_associated #0: 15 --> S.E.P.
    n1=angiocholite sclérosante primitive | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1202. apoplexie cérébrale --- r_associated #0: 15 --> S.E.P.
    n1=apoplexie cérébrale | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1203. arthrite infectieuse --- r_associated #0: 15 --> S.E.P.
    n1=arthrite infectieuse | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1204. cancer col --- r_associated #0: 15 --> S.E.P.
    n1=cancer col | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1205. chorée héréditaire --- r_associated #0: 15 --> S.E.P.
    n1=chorée héréditaire | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1206. dysrythmie cardiaque --- r_associated #0: 15 --> S.E.P.
    n1=dysrythmie cardiaque | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1207. dysrythmie cardiaque non précisée --- r_associated #0: 15 --> S.E.P.
    n1=dysrythmie cardiaque non précisée | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1208. glucosurie rénale --- r_associated #0: 15 --> S.E.P.
    n1=glucosurie rénale | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1209. hypertension --- r_associated #0: 15 --> S.E.P.
    n1=hypertension | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1210. hyperventilation --- r_associated #0: 15 --> S.E.P.
    n1=hyperventilation | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1211. hypospadias --- r_associated #0: 15 --> S.E.P.
    n1=hypospadias | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1212. ictus apoplectique --- r_associated #0: 15 --> S.E.P.
    n1=ictus apoplectique | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1213. ictus cérébral --- r_associated #0: 15 --> S.E.P.
    n1=ictus cérébral | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1214. kyste du canal thyroglossal --- r_associated #0: 15 --> S.E.P.
    n1=kyste du canal thyroglossal | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1215. lupus érythémateux --- r_associated #0: 15 --> S.E.P.
    n1=lupus érythémateux | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1216. maladie cérébrovasculaire aiguë mal définie --- r_associated #0: 15 --> S.E.P.
    n1=maladie cérébrovasculaire aiguë mal définie | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1217. maladie du système immunitaire --- r_associated #0: 15 --> S.E.P.
    n1=maladie du système immunitaire | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1218. maladies neuromusculaires --- r_associated #0: 15 --> S.E.P.
    n1=maladies neuromusculaires | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1219. malformation d'Arnold-Chiari --- r_associated #0: 15 --> S.E.P.
    n1=malformation d'Arnold-Chiari | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1220. myopathie primitive progressive --- r_associated #0: 15 --> S.E.P.
    n1=myopathie primitive progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1221. narcolepsy --- r_associated #0: 15 --> S.E.P.
    n1=narcolepsy | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1222. neuralgie --- r_associated #0: 15 --> S.E.P.
    n1=neuralgie | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1223. neurologique --- r_associated #0: 15 --> S.E.P.
    n1=neurologique | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1224. neuropathie périphérique d'origine alcoolique --- r_associated #0: 15 --> S.E.P.
    n1=neuropathie périphérique d'origine alcoolique | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1225. neuropathies alcooliques --- r_associated #0: 15 --> S.E.P.
    n1=neuropathies alcooliques | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1226. névralgie périphérique --- r_associated #0: 15 --> S.E.P.
    n1=névralgie périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1227. oedème de l'encéphale --- r_associated #0: 15 --> S.E.P.
    n1=oedème de l'encéphale | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1228. oreillons sans mention de complication --- r_associated #0: 15 --> S.E.P.
    n1=oreillons sans mention de complication | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1229. pneumocéphalie --- r_associated #0: 15 --> S.E.P.
    n1=pneumocéphalie | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1230. psoriasis --- r_associated #0: 15 --> S.E.P.
    n1=psoriasis | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1231. sclérodermie en plaques --- r_associated #0: 15 --> S.E.P.
    n1=sclérodermie en plaques | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1232. sclérose en plaques chronique progressive --- r_associated #0: 15 --> S.E.P.
    n1=sclérose en plaques chronique progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1233. sclérose en plaques progressive récidivante --- r_associated #0: 15 --> S.E.P.
    n1=sclérose en plaques progressive récidivante | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1234. sclérose systémique --- r_associated #0: 15 --> S.E.P.
    n1=sclérose systémique | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1235. sclérose systémique progressive --- r_associated #0: 15 --> S.E.P.
    n1=sclérose systémique progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1236. syndrome de Reye --- r_associated #0: 15 --> S.E.P.
    n1=syndrome de Reye | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1237. syndrome parkinsonien --- r_associated #0: 15 --> S.E.P.
    n1=syndrome parkinsonien | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1238. traumatisme superficiel oreille --- r_associated #0: 15 --> S.E.P.
    n1=traumatisme superficiel oreille | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1239. trouble articulaire --- r_associated #0: 15 --> S.E.P.
    n1=trouble articulaire | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1240. trouble du cerveau --- r_associated #0: 15 --> S.E.P.
    n1=trouble du cerveau | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1241. tumeur maligne des os --- r_associated #0: 15 --> S.E.P.
    n1=tumeur maligne des os | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1242. tumeur maligne osseuse --- r_associated #0: 15 --> S.E.P.
    n1=tumeur maligne osseuse | n2=S.E.P. | rel=r_associated | relid=0 | w=15
  1243. Auto-immune --- r_associated #0: 10 --> S.E.P.
    n1=Auto-immune | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1244. Dysarthrie --- r_associated #0: 10 --> S.E.P.
    n1=Dysarthrie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1245. Démyélinisation --- r_associated #0: 10 --> S.E.P.
    n1=Démyélinisation | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1246. Encéphalopathie --- r_associated #0: 10 --> S.E.P.
    n1=Encéphalopathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1247. Erdheim-Chester --- r_associated #0: 10 --> S.E.P.
    n1=Erdheim-Chester | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1248. Fothergill --- r_associated #0: 10 --> S.E.P.
    n1=Fothergill | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1249. Maladie autoimmune --- r_associated #0: 10 --> S.E.P.
    n1=Maladie autoimmune | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1250. Maladie neurodégénérative --- r_associated #0: 10 --> S.E.P.
    n1=Maladie neurodégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1251. Malformation d'Arnold-Chiari --- r_associated #0: 10 --> S.E.P.
    n1=Malformation d'Arnold-Chiari | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1252. Mitoxantrone --- r_associated #0: 10 --> S.E.P.
    n1=Mitoxantrone | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1253. Myélinisation --- r_associated #0: 10 --> S.E.P.
    n1=Myélinisation | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1254. Neurodégénérative --- r_associated #0: 10 --> S.E.P.
    n1=Neurodégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1255. Neurologie --- r_associated #0: 10 --> S.E.P.
    n1=Neurologie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1256. Neuropathie --- r_associated #0: 10 --> S.E.P.
    n1=Neuropathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1257. Nosologie --- r_associated #0: 10 --> S.E.P.
    n1=Nosologie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1258. PLAQUES --- r_associated #0: 10 --> S.E.P.
    n1=PLAQUES | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1259. Syndrome d'apnée du sommeil --- r_associated #0: 10 --> S.E.P.
    n1=Syndrome d'apnée du sommeil | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1260. accident cérébro-vasculaire --- r_associated #0: 10 --> S.E.P.
    n1=accident cérébro-vasculaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1261. accident ischémique cérébral --- r_associated #0: 10 --> S.E.P.
    n1=accident ischémique cérébral | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1262. accidents vasculaires cérébraux --- r_associated #0: 10 --> S.E.P.
    n1=accidents vasculaires cérébraux | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1263. affection du cerveau --- r_associated #0: 10 --> S.E.P.
    n1=affection du cerveau | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1264. affection du système nerveux périphérique --- r_associated #0: 10 --> S.E.P.
    n1=affection du système nerveux périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1265. agrypnie --- r_associated #0: 10 --> S.E.P.
    n1=agrypnie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1266. algie rachidienne --- r_associated #0: 10 --> S.E.P.
    n1=algie rachidienne | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1267. algie vasculaire de la face --- r_associated #0: 10 --> S.E.P.
    n1=algie vasculaire de la face | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1268. aphasie --- r_associated #0: 10 --> S.E.P.
    n1=aphasie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1269. arthropathie --- r_associated #0: 10 --> S.E.P.
    n1=arthropathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1270. arythmie cardiaque --- r_associated #0: 10 --> S.E.P.
    n1=arythmie cardiaque | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1271. association de tics vocaux et tics moteurs du syndrome de gilles de la tourette --- r_associated #0: 10 --> S.E.P.
    n1=association de tics vocaux et tics moteurs du syndrome de gilles de la tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1272. asthme --- r_associated #0: 10 --> S.E.P.
    n1=asthme | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1273. attaque apoplectique --- r_associated #0: 10 --> S.E.P.
    n1=attaque apoplectique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1274. attaque d'apoplexie --- r_associated #0: 10 --> S.E.P.
    n1=attaque d'apoplexie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1275. balanitis --- r_associated #0: 10 --> S.E.P.
    n1=balanitis | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1276. blépharospasme --- r_associated #0: 10 --> S.E.P.
    n1=blépharospasme | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1277. cancer de l'estomac --- r_associated #0: 10 --> S.E.P.
    n1=cancer de l'estomac | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1278. cancer de la prostate --- r_associated #0: 10 --> S.E.P.
    n1=cancer de la prostate | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1279. cancer des os --- r_associated #0: 10 --> S.E.P.
    n1=cancer des os | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1280. cancer prostatique --- r_associated #0: 10 --> S.E.P.
    n1=cancer prostatique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1281. cardite rhumatismale --- r_associated #0: 10 --> S.E.P.
    n1=cardite rhumatismale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1282. cas cliniques d'oreillons --- r_associated #0: 10 --> S.E.P.
    n1=cas cliniques d'oreillons | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1283. cataplexie --- r_associated #0: 10 --> S.E.P.
    n1=cataplexie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1284. chorée de Huntington --- r_associated #0: 10 --> S.E.P.
    n1=chorée de Huntington | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1285. contraction clonique --- r_associated #0: 10 --> S.E.P.
    n1=contraction clonique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1286. demence --- r_associated #0: 10 --> S.E.P.
    n1=demence | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1287. diminution de la sensibilité --- r_associated #0: 10 --> S.E.P.
    n1=diminution de la sensibilité | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1288. douleur du visage --- r_associated #0: 10 --> S.E.P.
    n1=douleur du visage | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1289. dysfonctionnement articulaire --- r_associated #0: 10 --> S.E.P.
    n1=dysfonctionnement articulaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1290. dystrophie musculaire --- r_associated #0: 10 --> S.E.P.
    n1=dystrophie musculaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1291. déficience congénitale --- r_associated #0: 10 --> S.E.P.
    n1=déficience congénitale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1292. déformation congénitale --- r_associated #0: 10 --> S.E.P.
    n1=déformation congénitale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1293. en:Alice in wonderland Syndrome --- r_associated #0: 10 --> S.E.P.
    n1=en:Alice in wonderland Syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1294. en:Bickerstaff's brainstem encephalitis --- r_associated #0: 10 --> S.E.P.
    n1=en:Bickerstaff's brainstem encephalitis | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1295. en:Ehlers-Danlos syndrome --- r_associated #0: 10 --> S.E.P.
    n1=en:Ehlers-Danlos syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1296. en:Friedreich ataxia --- r_associated #0: 10 --> S.E.P.
    n1=en:Friedreich ataxia | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1297. en:Mikulicz disease --- r_associated #0: 10 --> S.E.P.
    n1=en:Mikulicz disease | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1298. en:Osgood-Schlatter's disease --- r_associated #0: 10 --> S.E.P.
    n1=en:Osgood-Schlatter's disease | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1299. en:Strachan's syndrome --- r_associated #0: 10 --> S.E.P.
    n1=en:Strachan's syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1300. en:Tourette syndrome --- r_associated #0: 10 --> S.E.P.
    n1=en:Tourette syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1301. en:abbr --- r_associated #0: 10 --> S.E.P.
    n1=en:abbr | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1302. en:abbr. --- r_associated #0: 10 --> S.E.P.
    n1=en:abbr. | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1303. en:abbrev --- r_associated #0: 10 --> S.E.P.
    n1=en:abbrev | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1304. en:asthenia --- r_associated #0: 10 --> S.E.P.
    n1=en:asthenia | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1305. en:eds --- r_associated #0: 10 --> S.E.P.
    n1=en:eds | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1306. en:ehlers danlos syndrome --- r_associated #0: 10 --> S.E.P.
    n1=en:ehlers danlos syndrome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1307. en:facioplegia --- r_associated #0: 10 --> S.E.P.
    n1=en:facioplegia | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1308. en:malignant neoplasm of stomach --- r_associated #0: 10 --> S.E.P.
    n1=en:malignant neoplasm of stomach | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1309. en:morphoea --- r_associated #0: 10 --> S.E.P.
    n1=en:morphoea | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1310. en:mumps without complication --- r_associated #0: 10 --> S.E.P.
    n1=en:mumps without complication | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1311. en:muscle twitch --- r_associated #0: 10 --> S.E.P.
    n1=en:muscle twitch | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1312. en:nerve fiber --- r_associated #0: 10 --> S.E.P.
    n1=en:nerve fiber | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1313. en:nervous fiber --- r_associated #0: 10 --> S.E.P.
    n1=en:nervous fiber | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1314. en:neurosciences --- r_associated #0: 10 --> S.E.P.
    n1=en:neurosciences | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1315. en:plaque type scleroderma --- r_associated #0: 10 --> S.E.P.
    n1=en:plaque type scleroderma | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1316. en:prosopoplegia --- r_associated #0: 10 --> S.E.P.
    n1=en:prosopoplegia | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1317. encéphalite subaiguë de Rasmussen --- r_associated #0: 10 --> S.E.P.
    n1=encéphalite subaiguë de Rasmussen | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1318. ethnologique --- r_associated #0: 10 --> S.E.P.
    n1=ethnologique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1319. exophtalmie --- r_associated #0: 10 --> S.E.P.
    n1=exophtalmie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1320. glomérulonéphrite --- r_associated #0: 10 --> S.E.P.
    n1=glomérulonéphrite | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1321. glycosurie rénale --- r_associated #0: 10 --> S.E.P.
    n1=glycosurie rénale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1322. herpès zoster --- r_associated #0: 10 --> S.E.P.
    n1=herpès zoster | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1323. hydrocèle --- r_associated #0: 10 --> S.E.P.
    n1=hydrocèle | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1324. hydrocèle testiculaire --- r_associated #0: 10 --> S.E.P.
    n1=hydrocèle testiculaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1325. hydrocèle vaginal --- r_associated #0: 10 --> S.E.P.
    n1=hydrocèle vaginal | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1326. hyperparathyroïdisme --- r_associated #0: 10 --> S.E.P.
    n1=hyperparathyroïdisme | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1327. hypesthésie --- r_associated #0: 10 --> S.E.P.
    n1=hypesthésie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1328. hypo-esthésie --- r_associated #0: 10 --> S.E.P.
    n1=hypo-esthésie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1329. hypoesthésie --- r_associated #0: 10 --> S.E.P.
    n1=hypoesthésie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1330. hémorragie intracranienne --- r_associated #0: 10 --> S.E.P.
    n1=hémorragie intracranienne | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1331. hémorragie intracrânienne --- r_associated #0: 10 --> S.E.P.
    n1=hémorragie intracrânienne | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1332. hémorrhoïde --- r_associated #0: 10 --> S.E.P.
    n1=hémorrhoïde | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1333. hépatomégalie --- r_associated #0: 10 --> S.E.P.
    n1=hépatomégalie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1334. immobilité --- r_associated #0: 10 --> S.E.P.
    n1=immobilité | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1335. impétigo --- r_associated #0: 10 --> S.E.P.
    n1=impétigo | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1336. kyste du canal thyréoglosse --- r_associated #0: 10 --> S.E.P.
    n1=kyste du canal thyréoglosse | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1337. kyste du tractus thyréoglosse --- r_associated #0: 10 --> S.E.P.
    n1=kyste du tractus thyréoglosse | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1338. kyste sébacé --- r_associated #0: 10 --> S.E.P.
    n1=kyste sébacé | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1339. kyste thyréoglosse --- r_associated #0: 10 --> S.E.P.
    n1=kyste thyréoglosse | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1340. lcr anormal --- r_associated #0: 10 --> S.E.P.
    n1=lcr anormal | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1341. lupus erythematosus --- r_associated #0: 10 --> S.E.P.
    n1=lupus erythematosus | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1342. lupus érythémateux aigu disséminé --- r_associated #0: 10 --> S.E.P.
    n1=lupus érythémateux aigu disséminé | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1343. lésion d'un nerf périphérique --- r_associated #0: 10 --> S.E.P.
    n1=lésion d'un nerf périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1344. maladie d'Erdheim-Chester --- r_associated #0: 10 --> S.E.P.
    n1=maladie d'Erdheim-Chester | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1345. maladie de Gilles de la Tourette --- r_associated #0: 10 --> S.E.P.
    n1=maladie de Gilles de la Tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1346. maladie de Huntington --- r_associated #0: 10 --> S.E.P.
    n1=maladie de Huntington | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1347. maladie des tics --- r_associated #0: 10 --> S.E.P.
    n1=maladie des tics | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1348. maladie des tics de Gilles de la Tourette --- r_associated #0: 10 --> S.E.P.
    n1=maladie des tics de Gilles de la Tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1349. maladie du système nerveux périphérique --- r_associated #0: 10 --> S.E.P.
    n1=maladie du système nerveux périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1350. maladies de gilles de la tourette --- r_associated #0: 10 --> S.E.P.
    n1=maladies de gilles de la tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1351. maladies immunologiques --- r_associated #0: 10 --> S.E.P.
    n1=maladies immunologiques | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1352. manque de sommeil --- r_associated #0: 10 --> S.E.P.
    n1=manque de sommeil | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1353. molluscum contagiosum --- r_associated #0: 10 --> S.E.P.
    n1=molluscum contagiosum | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1354. myopathie --- r_associated #0: 10 --> S.E.P.
    n1=myopathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1355. nanisme --- r_associated #0: 10 --> S.E.P.
    n1=nanisme | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1356. narcolepsie --- r_associated #0: 10 --> S.E.P.
    n1=narcolepsie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1357. neuropathie alcoolique --- r_associated #0: 10 --> S.E.P.
    n1=neuropathie alcoolique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1358. neuropathie périphérique alcoolique --- r_associated #0: 10 --> S.E.P.
    n1=neuropathie périphérique alcoolique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1359. non précisée, hydrocèle --- r_associated #0: 10 --> S.E.P.
    n1=non précisée, hydrocèle | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1360. non précisée, tumeur maligne du col de l'utérus --- r_associated #0: 10 --> S.E.P.
    n1=non précisée, tumeur maligne du col de l'utérus | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1361. névralgie du trijumeau --- r_associated #0: 10 --> S.E.P.
    n1=névralgie du trijumeau | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1362. névralgie essentielle du trijumeau --- r_associated #0: 10 --> S.E.P.
    n1=névralgie essentielle du trijumeau | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1363. névralgie faciale --- r_associated #0: 10 --> S.E.P.
    n1=névralgie faciale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1364. névralgie trigéminale --- r_associated #0: 10 --> S.E.P.
    n1=névralgie trigéminale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1365. névraxe --- r_associated #0: 10 --> S.E.P.
    n1=névraxe | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1366. oreillons --- r_associated #0: 10 --> S.E.P.
    n1=oreillons | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1367. oreillons sans complication --- r_associated #0: 10 --> S.E.P.
    n1=oreillons sans complication | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1368. oreillons sans mention de complications --- r_associated #0: 10 --> S.E.P.
    n1=oreillons sans mention de complications | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1369. osteogenesis imperfecta --- r_associated #0: 10 --> S.E.P.
    n1=osteogenesis imperfecta | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1370. ostéogénèse imparfaite --- r_associated #0: 10 --> S.E.P.
    n1=ostéogénèse imparfaite | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1371. ostéoporose --- r_associated #0: 10 --> S.E.P.
    n1=ostéoporose | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1372. otite séromuqueuse --- r_associated #0: 10 --> S.E.P.
    n1=otite séromuqueuse | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1373. palud
    (paludisme)
     --- r_associated #0: 10 --> S.E.P.
    n1=palud
    (paludisme)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1374. paralysies périodiques familiales --- r_associated #0: 10 --> S.E.P.
    n1=paralysies périodiques familiales | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1375. parkinsonisme --- r_associated #0: 10 --> S.E.P.
    n1=parkinsonisme | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1376. parotidite infectieuse --- r_associated #0: 10 --> S.E.P.
    n1=parotidite infectieuse | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1377. parotidite ourlienne --- r_associated #0: 10 --> S.E.P.
    n1=parotidite ourlienne | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1378. parotidite épidémique --- r_associated #0: 10 --> S.E.P.
    n1=parotidite épidémique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1379. partie périphérique du système nerveux --- r_associated #0: 10 --> S.E.P.
    n1=partie périphérique du système nerveux | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1380. phénomène d'Uthoff --- r_associated #0: 10 --> S.E.P.
    n1=phénomène d'Uthoff | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1381. pneumatocèle intracrânien post-traumatique --- r_associated #0: 10 --> S.E.P.
    n1=pneumatocèle intracrânien post-traumatique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1382. pneumencéphalie --- r_associated #0: 10 --> S.E.P.
    n1=pneumencéphalie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1383. pneumocéphale --- r_associated #0: 10 --> S.E.P.
    n1=pneumocéphale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1384. pneumonia --- r_associated #0: 10 --> S.E.P.
    n1=pneumonia | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1385. polyadénome --- r_associated #0: 10 --> S.E.P.
    n1=polyadénome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1386. polymyalgia rheumatica --- r_associated #0: 10 --> S.E.P.
    n1=polymyalgia rheumatica | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1387. polyneuropathie --- r_associated #0: 10 --> S.E.P.
    n1=polyneuropathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1388. polynévrite alcoolique --- r_associated #0: 10 --> S.E.P.
    n1=polynévrite alcoolique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1389. polyradiculoneuropathie --- r_associated #0: 10 --> S.E.P.
    n1=polyradiculoneuropathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1390. proptose --- r_associated #0: 10 --> S.E.P.
    n1=proptose | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1391. radiculopathie --- r_associated #0: 10 --> S.E.P.
    n1=radiculopathie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1392. scleroderma --- r_associated #0: 10 --> S.E.P.
    n1=scleroderma | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1393. sclérodermie --- r_associated #0: 10 --> S.E.P.
    n1=sclérodermie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1394. sclérodermie généralisée progressive --- r_associated #0: 10 --> S.E.P.
    n1=sclérodermie généralisée progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1395. sclérose combinée de la moelle (syndrome de) --- r_associated #0: 10 --> S.E.P.
    n1=sclérose combinée de la moelle (syndrome de) | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1396. sclérose en plaques progressive primaire --- r_associated #0: 10 --> S.E.P.
    n1=sclérose en plaques progressive primaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1397. sclérose en plaques progressive primitive --- r_associated #0: 10 --> S.E.P.
    n1=sclérose en plaques progressive primitive | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1398. sclérose générale --- r_associated #0: 10 --> S.E.P.
    n1=sclérose générale | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1399. secousse musculaire --- r_associated #0: 10 --> S.E.P.
    n1=secousse musculaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1400. spina bifida --- r_associated #0: 10 --> S.E.P.
    n1=spina bifida | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1401. splénomégalie --- r_associated #0: 10 --> S.E.P.
    n1=splénomégalie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1402. strabisme --- r_associated #0: 10 --> S.E.P.
    n1=strabisme | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1403. syndrome de Gilles de la Tourette --- r_associated #0: 10 --> S.E.P.
    n1=syndrome de Gilles de la Tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1404. syndrome de Rett --- r_associated #0: 10 --> S.E.P.
    n1=syndrome de Rett | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1405. syndrome de la Tourette --- r_associated #0: 10 --> S.E.P.
    n1=syndrome de la Tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1406. syndrome de tourette --- r_associated #0: 10 --> S.E.P.
    n1=syndrome de tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1407. syndrome des tics de Gilles de la Tourette --- r_associated #0: 10 --> S.E.P.
    n1=syndrome des tics de Gilles de la Tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1408. tic douloureux --- r_associated #0: 10 --> S.E.P.
    n1=tic douloureux | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1409. tic douloureux de la face --- r_associated #0: 10 --> S.E.P.
    n1=tic douloureux de la face | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1410. toxoplasmose --- r_associated #0: 10 --> S.E.P.
    n1=toxoplasmose | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1411. trachome --- r_associated #0: 10 --> S.E.P.
    n1=trachome | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1412. trouble auto-immun --- r_associated #0: 10 --> S.E.P.
    n1=trouble auto-immun | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1413. trouble de gilles de la tourette --- r_associated #0: 10 --> S.E.P.
    n1=trouble de gilles de la tourette | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1414. trouble de la conduction du coeur --- r_associated #0: 10 --> S.E.P.
    n1=trouble de la conduction du coeur | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1415. trouble du rythme cardiaque --- r_associated #0: 10 --> S.E.P.
    n1=trouble du rythme cardiaque | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1416. trouble du système immunitaire --- r_associated #0: 10 --> S.E.P.
    n1=trouble du système immunitaire | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1417. trouble du système nerveux --- r_associated #0: 10 --> S.E.P.
    n1=trouble du système nerveux | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1418. trouble neurologique du développement --- r_associated #0: 10 --> S.E.P.
    n1=trouble neurologique du développement | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1419. tumeur de la prostate --- r_associated #0: 10 --> S.E.P.
    n1=tumeur de la prostate | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1420. tumeur du système nerveux central --- r_associated #0: 10 --> S.E.P.
    n1=tumeur du système nerveux central | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1421. tumeur du système nerveux périphérique --- r_associated #0: 10 --> S.E.P.
    n1=tumeur du système nerveux périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1422. tumeur maligne de la peau --- r_associated #0: 10 --> S.E.P.
    n1=tumeur maligne de la peau | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1423. tumeur maligne du col de l'utérus --- r_associated #0: 10 --> S.E.P.
    n1=tumeur maligne du col de l'utérus | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1424. tumeur maligne du col utérin --- r_associated #0: 10 --> S.E.P.
    n1=tumeur maligne du col utérin | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1425. tumeur maligne gastrique --- r_associated #0: 10 --> S.E.P.
    n1=tumeur maligne gastrique | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1426. tétanie --- r_associated #0: 10 --> S.E.P.
    n1=tétanie | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1427. épanchement pleural --- r_associated #0: 10 --> S.E.P.
    n1=épanchement pleural | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1428. érythème fessier du nourrisson --- r_associated #0: 10 --> S.E.P.
    n1=érythème fessier du nourrisson | n2=S.E.P. | rel=r_associated | relid=0 | w=10
  1429. DMO
    (densité minérale osseuse)
     --- r_associated #0: 5 --> S.E.P.
    n1=DMO
    (densité minérale osseuse)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1430. Lupus érythémateux --- r_associated #0: 5 --> S.E.P.
    n1=Lupus érythémateux | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1431. Lésion
    (médecine)
     --- r_associated #0: 5 --> S.E.P.
    n1=Lésion
    (médecine)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1432. MS --- r_associated #0: 5 --> S.E.P.
    n1=MS | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1433. Maladie auto-immune --- r_associated #0: 5 --> S.E.P.
    n1=Maladie auto-immune | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1434. Maladie dégénérative --- r_associated #0: 5 --> S.E.P.
    n1=Maladie dégénérative | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1435. Maladies auto-immunes --- r_associated #0: 5 --> S.E.P.
    n1=Maladies auto-immunes | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1436. NEUROSCIENCES --- r_associated #0: 5 --> S.E.P.
    n1=NEUROSCIENCES | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1437. SEP --- r_associated #0: 5 --> S.E.P.
    n1=SEP | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1438. SEP
    (sclérose en plaques)
     --- r_associated #0: 5 --> S.E.P.
    n1=SEP
    (sclérose en plaques)
    | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1439. Substance blanche --- r_associated #0: 5 --> S.E.P.
    n1=Substance blanche | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1440. Système Nerveux Central --- r_associated #0: 5 --> S.E.P.
    n1=Système Nerveux Central | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1441. Système nerveux central --- r_associated #0: 5 --> S.E.P.
    n1=Système nerveux central | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1442. Trouble de l'humeur --- r_associated #0: 5 --> S.E.P.
    n1=Trouble de l'humeur | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1443. UUKV --- r_associated #0: 5 --> S.E.P.
    n1=UUKV | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1444. aVf --- r_associated #0: 5 --> S.E.P.
    n1=aVf | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1445. accident cérébrovasculaire --- r_associated #0: 5 --> S.E.P.
    n1=accident cérébrovasculaire | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1446. accident vasculaire cérébral --- r_associated #0: 5 --> S.E.P.
    n1=accident vasculaire cérébral | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1447. adénome polypoïde --- r_associated #0: 5 --> S.E.P.
    n1=adénome polypoïde | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1448. affection du nerf facial --- r_associated #0: 5 --> S.E.P.
    n1=affection du nerf facial | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1449. affection nerveuse périphérique --- r_associated #0: 5 --> S.E.P.
    n1=affection nerveuse périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1450. anomalie congénitale --- r_associated #0: 5 --> S.E.P.
    n1=anomalie congénitale | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1451. anomalie du lcr --- r_associated #0: 5 --> S.E.P.
    n1=anomalie du lcr | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1452. arthrite --- r_associated #0: 5 --> S.E.P.
    n1=arthrite | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1453. arthrite psoriasique --- r_associated #0: 5 --> S.E.P.
    n1=arthrite psoriasique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1454. arythmie --- r_associated #0: 5 --> S.E.P.
    n1=arythmie | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1455. autoimmune --- r_associated #0: 5 --> S.E.P.
    n1=autoimmune | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1456. blessures dorsales --- r_associated #0: 5 --> S.E.P.
    n1=blessures dorsales | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1457. cancer cutané --- r_associated #0: 5 --> S.E.P.
    n1=cancer cutané | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1458. cancer de la peau --- r_associated #0: 5 --> S.E.P.
    n1=cancer de la peau | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1459. cancer gastrique --- r_associated #0: 5 --> S.E.P.
    n1=cancer gastrique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1460. carcinome gastrique --- r_associated #0: 5 --> S.E.P.
    n1=carcinome gastrique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1461. densité minérale osseuse --- r_associated #0: 5 --> S.E.P.
    n1=densité minérale osseuse | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1462. dermite herpétiforme --- r_associated #0: 5 --> S.E.P.
    n1=dermite herpétiforme | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1463. effusion pleurale --- r_associated #0: 5 --> S.E.P.
    n1=effusion pleurale | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1464. embole pulmonaire --- r_associated #0: 5 --> S.E.P.
    n1=embole pulmonaire | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1465. embolie du poumon --- r_associated #0: 5 --> S.E.P.
    n1=embolie du poumon | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1466. embolie pulmonaire --- r_associated #0: 5 --> S.E.P.
    n1=embolie pulmonaire | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1467. emphysème du poumon --- r_associated #0: 5 --> S.E.P.
    n1=emphysème du poumon | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1468. emphysème pulmonaire --- r_associated #0: 5 --> S.E.P.
    n1=emphysème pulmonaire | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1469. en:Magnolia State --- r_associated #0: 5 --> S.E.P.
    n1=en:Magnolia State | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1470. en:congenital anomaly --- r_associated #0: 5 --> S.E.P.
    n1=en:congenital anomaly | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1471. en:disseminated multiple sclerosis --- r_associated #0: 5 --> S.E.P.
    n1=en:disseminated multiple sclerosis | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1472. en:fasciculation --- r_associated #0: 5 --> S.E.P.
    n1=en:fasciculation | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1473. en:magnolia state --- r_associated #0: 5 --> S.E.P.
    n1=en:magnolia state | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1474. en:malignant neoplasm of skin --- r_associated #0: 5 --> S.E.P.
    n1=en:malignant neoplasm of skin | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1475. en:malignant tumor of cervix --- r_associated #0: 5 --> S.E.P.
    n1=en:malignant tumor of cervix | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1476. en:miss. --- r_associated #0: 5 --> S.E.P.
    n1=en:miss. | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1477. en:mississippi --- r_associated #0: 5 --> S.E.P.
    n1=en:mississippi | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1478. en:motor disability --- r_associated #0: 5 --> S.E.P.
    n1=en:motor disability | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1479. en:ms --- r_associated #0: 5 --> S.E.P.
    n1=en:ms | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1480. en:msc --- r_associated #0: 5 --> S.E.P.
    n1=en:msc | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1481. en:nerve fibre --- r_associated #0: 5 --> S.E.P.
    n1=en:nerve fibre | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1482. en:nerve fibre --- r_associated #0: 5 --> S.E.P.
    n1=en:nerve fibre | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1483. en:peripheral neuropathy --- r_associated #0: 5 --> S.E.P.
    n1=en:peripheral neuropathy | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1484. en:serous otitis media --- r_associated #0: 5 --> S.E.P.
    n1=en:serous otitis media | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1485. en:sm --- r_associated #0: 5 --> S.E.P.
    n1=en:sm | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1486. encéphalite à anticorps anti-récepteurs NMDA --- r_associated #0: 5 --> S.E.P.
    n1=encéphalite à anticorps anti-récepteurs NMDA | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1487. enzymologie --- r_associated #0: 5 --> S.E.P.
    n1=enzymologie | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1488. erreur de réfraction --- r_associated #0: 5 --> S.E.P.
    n1=erreur de réfraction | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1489. exophthalmie --- r_associated #0: 5 --> S.E.P.
    n1=exophthalmie | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1490. fibrillation et flutter auriculaires --- r_associated #0: 5 --> S.E.P.
    n1=fibrillation et flutter auriculaires | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1491. fr. DEXA --- r_associated #0: 5 --> S.E.P.
    n1=fr. DEXA | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1492. fracture du fémur --- r_associated #0: 5 --> S.E.P.
    n1=fracture du fémur | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1493. glomerulonéphrite --- r_associated #0: 5 --> S.E.P.
    n1=glomerulonéphrite | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1494. handicap moteur --- r_associated #0: 5 --> S.E.P.
    n1=handicap moteur | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1495. hémorroïde --- r_associated #0: 5 --> S.E.P.
    n1=hémorroïde | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1496. infection de nerf périphérique --- r_associated #0: 5 --> S.E.P.
    n1=infection de nerf périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1497. lipome --- r_associated #0: 5 --> S.E.P.
    n1=lipome | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1498. liquide céphalo-rachidien anormal --- r_associated #0: 5 --> S.E.P.
    n1=liquide céphalo-rachidien anormal | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1499. liquide rachidien anormal --- r_associated #0: 5 --> S.E.P.
    n1=liquide rachidien anormal | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1500. lésion nerveuse périphérique --- r_associated #0: 5 --> S.E.P.
    n1=lésion nerveuse périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1501. maladie des articulations --- r_associated #0: 5 --> S.E.P.
    n1=maladie des articulations | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1502. malformation congénitale --- r_associated #0: 5 --> S.E.P.
    n1=malformation congénitale | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1503. neuro-sciences --- r_associated #0: 5 --> S.E.P.
    n1=neuro-sciences | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1504. neuropathie du plexus brachial --- r_associated #0: 5 --> S.E.P.
    n1=neuropathie du plexus brachial | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1505. neuropathie périphérique --- r_associated #0: 5 --> S.E.P.
    n1=neuropathie périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1506. néphropathie à IgA --- r_associated #0: 5 --> S.E.P.
    n1=néphropathie à IgA | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1507. paralysie cérébrale --- r_associated #0: 5 --> S.E.P.
    n1=paralysie cérébrale | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1508. partie centrale du système nerveux --- r_associated #0: 5 --> S.E.P.
    n1=partie centrale du système nerveux | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1509. pneumo-encéphale --- r_associated #0: 5 --> S.E.P.
    n1=pneumo-encéphale | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1510. polyneuropathie alcoolique --- r_associated #0: 5 --> S.E.P.
    n1=polyneuropathie alcoolique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1511. polype adénomateux --- r_associated #0: 5 --> S.E.P.
    n1=polype adénomateux | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1512. retardation mentale --- r_associated #0: 5 --> S.E.P.
    n1=retardation mentale | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1513. sclérodermie généralisée --- r_associated #0: 5 --> S.E.P.
    n1=sclérodermie généralisée | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1514. sclérodermie systémique --- r_associated #0: 5 --> S.E.P.
    n1=sclérodermie systémique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1515. sclérose en plaques primaire progressive --- r_associated #0: 5 --> S.E.P.
    n1=sclérose en plaques primaire progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1516. sclérose en plaques rémittente progressive --- r_associated #0: 5 --> S.E.P.
    n1=sclérose en plaques rémittente progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1517. sclérose multiloculaire --- r_associated #0: 5 --> S.E.P.
    n1=sclérose multiloculaire | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1518. sep primaire progressive --- r_associated #0: 5 --> S.E.P.
    n1=sep primaire progressive | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1519. syndrome d'Ehlers-Danlos --- r_associated #0: 5 --> S.E.P.
    n1=syndrome d'Ehlers-Danlos | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1520. syndrome de fiessinger-leroy-reiter --- r_associated #0: 5 --> S.E.P.
    n1=syndrome de fiessinger-leroy-reiter | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1521. syndrome de reiter --- r_associated #0: 5 --> S.E.P.
    n1=syndrome de reiter | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1522. syndrome de sclérose combinée de la moelle --- r_associated #0: 5 --> S.E.P.
    n1=syndrome de sclérose combinée de la moelle | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1523. syndrome lymphoprolifératif avec autoimmunité --- r_associated #0: 5 --> S.E.P.
    n1=syndrome lymphoprolifératif avec autoimmunité | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1524. trouble nerveux périphérique --- r_associated #0: 5 --> S.E.P.
    n1=trouble nerveux périphérique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1525. tumeur bénigne des organes urinaires --- r_associated #0: 5 --> S.E.P.
    n1=tumeur bénigne des organes urinaires | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1526. tumeur maligne de l'estomac --- r_associated #0: 5 --> S.E.P.
    n1=tumeur maligne de l'estomac | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1527. tumeur maligne de la prostate --- r_associated #0: 5 --> S.E.P.
    n1=tumeur maligne de la prostate | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1528. tumeur maligne prostatique --- r_associated #0: 5 --> S.E.P.
    n1=tumeur maligne prostatique | n2=S.E.P. | rel=r_associated | relid=0 | w=5
  1529. épanchement pleural liquidien --- r_associated #0: 5 --> S.E.P.
    n1=épanchement pleural liquidien | n2=S.E.P. | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr